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Staphylococcus aureus is a bacterium which has gathered much attention over the
past decade due to the emergence of both antibiotic-resistant and hyper-aggressive
strains. These pose a significant threat to human health, particularly to individuals
already weakened through other illnesses.
When S. aureus enters the human bloodstream, it must adapt in order to survive
the challenging conditions faced. In particular, it must respond to the nutritional
environment of the blood which is depleted in essential cofactors such as free iron.
Additionally, S. aureus must survive attacks from the host immune system which will
attempt to kill the invader through phagocytes and the production of antibodies.
The work carried out here aimed to understand how small, non-coding RNAs (sRNAs)
regulate S. aureus’ adaptation to the host bloodstream. These sRNAs are typically as-
sociated with regulating the translational efficiency and stability of mRNAs. Through
use of a technique called “UV cross-linking, ligation and sequencing of hybrids”
(CLASH), I identified novel targets of many sRNAs. In particular, I studied how RsaA,
an sRNA involved in membrane homeostasis, regulates the translation of a trans-
membrane transporter involved in antiseptic and antibiotic resistance. Additionally,
I identified interactions between RsaE, an sRNA involved in metabolism, and several
toxin mRNAs from the phenol-soluble modulin class. This is a novel example of the
direct link between cellular metabolism and virulence.
However, the most striking finding was that not only do sRNAs target mRNAs, but
that they also target each other. I focused on two distinct sRNA – sRNA interac-
tions; one between RsaA and RNAIII, and another between RsaE and RsaOG. The
interaction between RsaE and RsaOG is an example of a so-called ’sponging inter-
action’, where RsaOG is able to antagonise the activity of RsaE. This has the effect
of freeing RsaE’s targets from their regulation. I hypothesise that this ultimately
induces the necessary metabolic changes required in order to survive the immediate
nutritional stresses incurred after entering the bloodstream. Regarding RsaA and
RNAIII, I hypothesise that this interaction is responsible for balancing virulent versus
dormant behaviour. I suggest that RsaA is able to induce the destruction of RNAIII in
order to steer the cell away from aggressive behaviour and into a more latent state.
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Additionally, the interaction between these two sRNAs also appears to operate on
exquisitely short timescales, demonstrating how capable bacteria are at adapting to
stresses.
Ultimately, this work suggests that interactions between sRNAs are likely to be
widespread and form a crucial aspect of stress responses in general. The experiments
detailed herein have certainly not exhausted the produced data and I suspect that it
will be utilised further in the future.
Lay abstract
Staphylococcus aureus is a bacterium which has gathered much attention over the
past decade due to the emergence of antibiotic-resistant strains, namely the hospital
‘superbug’ MRSA. This poses a significant threat to human life, particularly to those
individuals already weakened through other illnesses.
One of the most dangerous infections we can suffer from S. aureus is bacteraemia;
when the bacterium enters our bloodstream. This allows S. aureus to disseminate
around the body and induces panic in our own immune system that can cause sepsis
if left unresolved.
After entering our blood, S. aureus is challenged with several stresses that it must
survive. Firstly, it must find ways of obtaining the food and nutrients it needs. Next,
the host individual will elevate their body temperature as part of the inflammatory
response to infection. Such increased temperatures also cause stress for the invading
bacteria, similarly to how we may feel hot, sensitive inflamed areas as painful. In
addition, our defensive white blood cells will engage the bacterium and try to kill it.
Finally, if antibiotics are administered to the patient then the bacterium will need to
resist these as well. Thus, S. aureus must survive a wide variety of challenges in its
adaptation to our bloodstream
In this thesis, I studied how S. aureus adapts using small, regulatory molecules to
allow it to control its production of proteins, the machinery of the cell. It is known
that these small, regulatory molecules are produced at different rates during stress,
and I studied what they target, when they become active and what the final outcome
for the cell is. This type of science is aimed at understanding the fundamental aspects
of biology and laying the groundwork for the innovation of future therapies.
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1Introduction
„“My delight may be conceived when there were
revealed to me beautiful tangles, tufts and chains
of round organisms in great numbers, which
stood out clear and distinct among the pus cells
and debris...”.
— Sir Alexander Ogston
1.1 The discovery of Staphylococcus aureus
Staphylococcus aureus was first detailed in the late 19th century by the Scottish
surgeon Sir Alexander Ogston. This era in surgery was marked by an increasing
appreciation of the importance of sterility and the often dire consequences of bacte-
rial infection. Ogston was unconvinced by his contemporaries’ opinion that air was
the causative agent of wound suppuration and instead he examined a smear of pus
he isolated from one of his patient’s wounds under a microscope (Elek, 1959). His
observations form the introductory quote to this chapter.
The image of "beautiful tangles, tufts and chains" led Ogston to name these ‘Staphy-
lococci’ from the Greek ‘staphyle’, meaning a bunch of grapes. This nomenclature
was furthered by the German surgeon Anton Rosenbach, who isolated two strains
of Staphylococci and named them after their colony colour; Staphylococcus aureus
(golden) and Staphylococcus albus (white) (Rosenbach, 1884). Ogston would ad-
ditionally demonstrate the virulence of these microorganisms by injecting pus into
guinea pigs and mice and detail the resulting abscesses. He also noted how Staphylo-
cocci would enter into the blood of the recipient animal and progress into septicaemia
(Ogston, 1880).
1.2 S. aureus today
S. aureus is now realised as a ubiquitous bacterium that is commonly found on
the skin and mucosal membranes of the body, in particular the nose and throat.
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Indeed, it is estimated that 30% of the human population is colonised by S. aureus
(van Belkum et al., 2009). Such infections are usually asymptomatic but can
become a deadly threat to human health under particular circumstances. The
events that lead to S. aureus acting pathogenically are not entirely understood, but
immunocompromisation (including that caused by HIV/AIDS) and strain variation
are thought to be the major determinants, with other factors such as diabetes also
playing a role (Liu, 2009).
S. aureus frequently enters the body through an open wound or from an established
niche such as the nasal passages (Liu, 2009). Additionally, nosocomial infections of
S. aureus are associated with surgery and contaminated healthcare equipment such
as catheters (Fowler et al., 2003). S. aureus may then overcome host defences and
disseminate throughout the body, where it can cause a phenomenally broad range of
diseases; endocarditis (infection of the heart), osteomyelitis (infection of the bone),
pneumonia (infection of the lungs), soft skin infections, septicaemia (infection of
the blood) and sepsis (Gordon and Lowy, 2008). The outcome of this threat is
predictable; an estimate in 2012 attributed S. aureus with causing more deaths than
AIDS, tuberculosis and viral hepatitis combined (Hal et al., 2012) and the Centres
for Disease Control estimated that 23,000 deaths per year in the USA are associated
with S. aureus (CDC, 2018). Additionally, there is an obvious economic burden, with
one estimate in 2013 predicting that S. aureus costs the US economy 1.4-13 billion
USD per year (Lee et al., 2013).
With regards to strain variation within S. aureus, antibiotic susceptibility has played
a key role in its emergence as a global health concern. Methicillin, a β-lactam class
antibiotic, was introduced as an effective agent against S. aureus in 1959. However,
resistance was reported within a year (Gordon and Lowy, 2008). Methicillin’s
mode of action is through inhibiting cell wall synthesis by binding Penicillin-binding
proteins (PBPs), a class of transpeptidases that are essential in the production of the
peptidoglycan layer of the bacterial cell wall. Resistance to methicillin is conferred
by the mecA gene, which encodes for an alternative PBP, PBP2a, that has decreased
affinity for β-lactams. This mecA gene is encoded on a mobile genetic element,
SCCmec, and is flanked by recombinase genes that facilitate intra- and interspecies
horizontal transmission (Gordon and Lowy, 2008). Strains which acquire this
resistance are referred to as ‘Methicillin-resistant Staphylococcus aureus’, or MRSA.
These strains were originally associated with nosocomial infections and collectively
identified as ‘healthcare-associated MRSA’ (HA-MRSA). Their antibiotic resistance
makes them a great burden in such settings, where infected individuals typically
have weakened immune systems and rely on antibiotic administration for protection.
Indeed, Dantes et al., 2013, reported 65,000 cases of invasive HA-MRSA in the USA
in 2011.
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Following the emergence of MRSA strains in the 1960s, S. aureus infections were
overall contained in the healthcare setting and in particular to the elderly and unwell.
However, the 1990s saw the emergence of new, methicillin-resistant strains that were
observed to infect healthy and young individuals with no recent healthcare episodes
(Gordon and Lowy, 2008). Such strains are collectively identified as ‘community-
acquired MRSA’ (CA-MRSA). In 1989 and 1991, an outbreak of CA-MRSA was
observed in western Australia and the surrounding area (Udo et al., 1993; Gosbell
et al., 2001). Between 1997 and 1999, four children died in North Dakota, USA,
through a CA-MRSA strain that had a level of previously unwitnessed aggression.
(Centers for Disease Control and Prevention, 1999)
However, CA-MRSA started to grip attention with the emergence of a strain now
termed USA300. This strain was initially reported on from America and spread
quickly through skin-to-skin contact. In particular, outbreaks were observed amongst
prison inmates, soldiers and athletes (Gordon and Lowy, 2008). By 2011, USA300
was the most common isolate recovered from infections at all body sites (Diekema
et al., 2014).
In 2005, a closely-related relative of USA300, termed ‘USA300-Latin American
variant’, was isolated in Colombia and spread rapidly throughout the northern
region of South America (Planet, 2017). USA300 has also been observed in France,
Switzerland and England, although has not been able to establish itself to the same
degree as observed in the Americas (Glaser et al., 2016; Toleman et al., 2016; Von
Dach et al., 2016).
Strains of MRSA can be defined through a form of DNA fingerprinting. The bacterial
chromosome is purified, digested with the rare cutting SmaI restriction enzyme and
then ran on a gel and separated through pulse-field gel electrophoresis (Goering
and Winters, 1992; McDougal et al., 2003). Polymorphisms in seven housekeeping
genes (arcC, aroE, glpF, gmk, pta, tpi and yqiL) are used to define a unique allelic
profile (Enright et al., 2000). This allelic profile is then matched to a bank of 53
known ‘multilocus sequence types’ (MLST). Regarding USA300, this strain is defined
as being MLST8, positive for Panton-Valentine leukocidine, SCCmec type IV and
containing the arginine catabolic mobile element (Tenover et al., 2006). Additionally,
USA300 has been observed to express a number of additional virulence factors, such
as phenol-soluble modulins and δ- and α-toxin (Wang et al., 2007). These are
thought to contribute to the increased aggression and destructive capabilities of
USA300.
1.2 S. aureus today 4
1.3 Initial events of infection – from a
Staphylococcal perspective
S. aureus infections most frequently originate from nasal carriages (Kluytmans et
al., 1997). Individuals colonised here can either be persistent or only intermittent
carriers (Williams, 1963). Interestingly, while persistent carriers are frequently
colonised by only a single strain, intermittent carriers may harbour different ones
over time (Eriksen et al., 1995; Vanden Bergh et al., 1999).
S. aureus is usually inoculated into the nose through direct contact with the hands
(Wertheim et al., 2006). Once here, it must survive the defence systems of the host.
Nasal secretions contain immunoglobulins, lysozyme and antimicrobial peptides in
order to kill and immobilise invading bacteria (Chen and Fang, 2004; Kirkeby et
al., 2000; Lee et al., 2002). S. aureus resistance to these is conferred by several
mechanisms. For example, host secreted cationic antimicrobial peptides are thought
to disrupt bacterial membranes to induce membrane depolarisation and therefore
kill the cell (Bradshaw, 2003). However, S. aureus is able to resist these through
reducing the net negative charge of its cell wall and thus decreasing the affinity of
the peptide for its membrane (Peschel, 2002). One proposed mechanism for this
involves MprF, which modifies phosphatidylglycerol with L-lysine (Peschel et al.,
2001).
Secreted immunoglobulins facilitate phagocytosis and opsonisation once bound to
surface antigens on their target. Once bound, the Fc region points outwards and is
recognised by complement. However, S. aureus expresses protein A (prA) and Sbi
on its cell surface, both of which bind the Fc region of IgG in a manner to leave it
in an incorrect orientation for complement binding (Smith et al., 2012) . Indeed,
prA-deficient bacteria are more susceptible to neutrophil-mediated phagocytosis and
serum opsonins, and have reduced virulence in mouse models. (Palmqvist et al.,
2002; Patel et al., 1987). Interestingly, prA also has an offensive role in virulence;
it binds tumour necrosis factor receptor 1 on lung epithelial cells, which leads to
a proinflammatory response mediated by expression of IL-8 to attract the immune
system (Gómez et al., 2004). This increased inflammation damages the airway,
loosens tight junctions between cells and furthers bacterial invasion. (Foster et al.,
2014).
Following survival of the innate immune system, S. aureus must properly adhere
to the nasal carriage. The epithelial wall of a nostril is fully keratinised and this
offers an attachment site for S. aureus (Bibel et al., 1982). Clumping factor B (ClfB)
and bacterial cell wall-associated teichoic acid have been demonstrated to be key
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mediators in this (Weidenmaier et al., 2004; Wertheim et al., 2008). ClfB binds
the C-terminal of keratin 10, a cell surface component of squamous cells (Walsh
et al., 2004). Other proteins, including SdrC, SdrD and SasG, are also thought to
contribute to host cell adhesion but are not fully understood (Foster et al., 2014).
S. aureus can also enter host cells with a variety of fibronectin binding proteins.
FnBPA and FnBPB have been shown to be key mediators, both binding fibronectin
arrays on the host cell surface. Once bound, this complex is recognised by integrins
and internalisation of the bacterium ensues through endocytosis (Schwarz-Linek et
al., 2004).
Infection of the nasal carriages with S. aureus been found to be a risk factor in
the development of nosocomial infections after surgery (Kalmeijer et al., 2000;
Kluytmans et al., 1995). Here, the nasal population may serve as a reservoir of S.
aureus which can be spread to skin breakages during surgery. Additionally, nasal
infection has been associated with systemic infections following liver cirrhosis and
transplantation, in HIV-infected patients and for patients in intensive care units.
(Chang et al., 1998; Nguyen et al., 1999; Pujol et al., 1996). Here, the weakened
patient’s immune system may be unable to keep S. aureus in the nasal carriages
under control. Indeed, in at least 80% of cases, the nosocomial infection comes from
an isolate of S. aureus that was already found in the patients mucosal membranes
prior to their admittance (Wertheim et al., 2004).
Although the nasal carriages are thought to be the most common source of S. aureus
for an infection, it is important to note that other sites in the body can be colonised
independently as well, such as the skin, perineum and pharynx (Armstrong-Esther,
1976; Ridley, 1959). Additionally, contaminated hospital catheters have been found
to be a prime source of S. aureus and these can deliver the bacterium directly into
the blood. (Wertheim et al., 2004).
Once S. aureus delves deeper into its host tissue, it can no longer scavenge nutrients
from the environment. Instead, these must be taken from the host. As such, con-
siderable metabolic remodelling must occur to facilitate macromolecule catabolism.
Additionally, S. aureus must produce virulence factors to induce host cell lysis and
ultimately cause release of their nutrients. The exact changes in the metabolic
profile of S. aureus in pathogenic conditions is not well understood, but some linkage
between metabolism and virulence has been found. For example, starvation induces
a decrease in intracellular GTP and branched-chain amino acids. These molecules
act as allosteric activators of the CodY transcription factor and their loss results
in the upregulation of CodY-repressed genes, including virulence factors such as
haemolysins and RNAIII (Majerczyk et al., 2008; Stenz et al., 2011).
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Iron is another cofactor whose loss is closely associated with virulence. This metal is
essential to the growth and proliferation of S. aureus (Hammer and Skaar, 2011).
Indeed, it is theorised that loss of free iron is used by S. aureus as a signal that
it is in a vertebrate host through the iron-sensing Fur transcription factor (Skaar,
2010). Similarly to CodY and branched-chain amino acids, the absence of iron
leads to Fur repression and then upregulation of several of its targets such including
haemolysins, cytotoxins and iron-uptake transporters (Torres et al., 2010). Showing
the importance of Fur-mediated adaption, deletion of this transcription factor results
in S. aureus that are highly susceptible to neutrophils and also decreases the bacterial
burden that they can cause (Torres et al., 2010).
Thus, S. aureus’ transition from commensal to pathogenic bacterium is not a simple
opportunistic act or molecular switch. From its normal niche within the nasal
carriages, it may develop into a more systemic infection if the host immune system is
weakened and therefore cannot keep S. aureus under control. Alternatively, surgeries
or hospital equipment can bring S. aureus into direct contact with the interior of the
body. Under these conditions, the limited nutrient availability forces S. aureus to
induce virulent gene expression in order to extract the necessary materials for life.
1.4 Co-ordinating gene expression
The central dogma of biology whereby DNA is transcribed into RNA which is trans-
lated into protein describes the foundation of gene expression. Different environ-
mental cues will induce transcription of different RNAs which will produce different
proteins. Alternatively stated, the transcriptome of the cell will be modified by the
act of transcription in response to stress and this change will be reflected in the
expressed proteome, and therefore the behaviour, of the cell.
However, transcription is not the only means of altering the transcriptome. Crudely
put, this act can be viewed as ‘adding’ to the transcriptome – but what of the RNAs
already present within the cell that are no longer desired? For example, the shutting
down of a particular metabolic pathway could be just as crucial for survival as
activating another as it could drain the limited resources of the cell in non-essential
programs. Here, the role of RNases and non-coding RNAs are critical.
This next section will summarise transcription in bacteria and detail transcrip-
tional stress responses in S. aureus. Afterwards, it will describe the role of post-
transcriptional regulation in shaping the transcriptome, and therefore proteome, of
the cell and its demonstrated roles in stress adaptation and virulence.
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Transcription in Gram-positive bacteria
Transcription of RNA from DNA is performed by the holoenzyme RNA polymerase
(RNAP). Within eubacteria, the core of this enzyme is formed from four subunits;
two α, one β and one β’; all of these are essential for viability. RNAP relies upon so-
called ‘sigma factors’ (σ) for promoter recognition and the initiation of transcription
(Helmann and Chamberlin, 1988). In Gram-positive bacteria, there also exists
three smaller, accessory subunits; δ, ε and ω (Burgess, 1969). These are thought
to aid RNAP folding, assembly, promoter specificity and recycling (Weiss and Shaw,
2015).
Each σ factor has its own regulon, usually a set of genes that are involved in similar
cellular processes (e.g. ‘housekeeping’ processes, virulence, stress survival, etc).
These factors direct RNAP to their promoter elements located -10 and -35 base-pairs
upstream of the transcriptional initiation point. In E. coli, the RNAP core enzyme
is expressed at mostly constant levels throughout growth and is the limiting factor
in DNA transcription. Thus, competition occurs between σ factors during stress in
order to dictate which genes are expressed (Maeda et al., 2000).
Fig. 1.1: Transcriptional initiation in Gram-positive bacteria. The σ factor directs RNA
polymerase, composed of its core α2ωββ’ subunits, to its target promoter sites.
Transcriptional factors (TFs) can also further modulate the activity of RNAP by
interacting with the holoenzyme.
Within S. aureus, four σ factors have been identified. σA is considered to be the
housekeeping factor that is responsible for the transcription of most genes in active,
exponentially growing cells, acting homologously to σ70 in E. coli (Deora et al.,
1996).
The principle sigma factor responsible for the expression of virulence genes is σB. A
tiling array assay managed to identify 145 promoters as being dependent on this
sigma factor (Mäder et al., 2016). A first role of σB is to direct the expression of
several haemolysins and leukocidins, including hla, hlg and lukDE (Tuchscherr et al.,
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2015). σB expression has also been associated with chronic, long term infections,
reflecting its role in virulence promotion (Tuchscherr et al., 2015). However, σB
is not only associated with virulence; it is also involved in regulating cell envelope
composition, membrane transport and metabolism. Exemplifying this extensive
network, σB is induced in response to thermal and alkaline stress, suggesting a
role in stress adaptation and survival (Pané-Farré et al., 2006). However, even in
the absence of stress, σB displays a basal level of expression in S. aureus which
implies a role in general housekeeping (Mäder et al., 2016). Interestingly, this basal
expression is not observed in B. subtilis, a non-pathogenic Gram-positive bacterium
(Mäder et al, 2016). Thus, σB in S. aureus may have evolved to take on a more
central role.
σS is an additional stress-responsive factor. It is induced upon exposure to com-
pounds that induce DNA damage or cell wall stress, during nutrient starvation and
also through growth in serum (Miller et al., 2012). Deletion of σS led S. aureus to
be more prone to dying under these conditions (Shaw et al., 2008). Additionally, S.
aureus σS mutants exhibited a decreased infectious burden in a murine model of
septic arthritis, indicating a role in virulence (Shaw et al., 2008).
Although S. aureus is not genetically competent upon normal conditions, bioinfor-
matic analysis found a sigma factor that was homologous to one responsible for
competence in B. subtilis, σH (Morikawa et al., 2003). Under standard labora-
tory conditions, σH was not detectably expressed in S. aureus. However, artificial
induction led to the expression of comE and comG, components of the DNA up-
take machinery (Morikawa et al., 2003). Despite the initial failure to detect σH
expression, further study managed to identify a small subpopulation of cells with ex-
pression under specific growth conditions. Importantly, this subpopulation was able
uptake the SCCmecII genetic element to acquire methicillin resistance (Morikawa,
2012). As such, the authors hypothesised that a minor fraction of S. aureus exists
in a competent state, conferred through σH , and this facilitates the uptake of e.g.
antibiotic resistance cassettes.
In addition to sigma factors, the activity of RNAP can also be modulated by tran-
scription factors (TFs). These bind to DNA, typically at sites spatially near RNAP,
and can positively or negatively modulate its activity. Thus, TFs can be regarded as
activators or repressors of gene transcription. Additionally, TFs contain a second
domain that functions as a signal sensor through binding either small ligands or
proteins that regulate its DNA-binding or RNAP-interacting activity. (Mascher et al.,
2006). Thus, the architecture of TFs allows them to interpret environmental cues or
cellular signals and relay the information by modulating the activity of RNAP in order
to change transcription. Figure 1.2 summarises the core principle of transcriptional
initiation in S. aureus.
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Around 145 different TFs have been identified in S. aureus (Ibarra et al., 2013). This
number was obtained through bioinformatic screening, and interestingly the authors
noted that only around half of these had been characterised at the time of study.
Using sequence conservation, hypothetical functionality was attributed to all but
9 of these unknown TFs. This resulted in the potential identification of novel two
component regulatory systems and virulence and metabolism-related TFs (Ibarra et
al., 2013).
Although there is clearly much more to understand about TF biology in S. aureus,
some are well characterised. CodY and Fur were discussed in Section 1.4. AgrA is
involved in the quorum-sensing network and will be discussed in Section 1.6; others
of particular importance to this thesis are MgrA and Rot.
Strains lacking mgrA display attenuated virulence in an rabbit endocarditis model
(Crosby et al., 2016). MgrA has been found to regulate around 350 genes in
S. aureus, including important virulence-related transcripts such as nuclease, α-
toxin, coagulase, protease, prA and autolysins. Additionally, MgrA also negatively
regulates efflux pumps involved in vancomycin export and as such has a direct link
to antibiotic resistance (Chen et al., 2006). Finally, MgrA has been found to be
involved in regulating biofilm biology. It represses biofilm formation, at least in part,
through negative regulation of srtA, or sortase, which functions to anchor cell wall
proteins (Mazmanian et al., 2001, Trotonda et al., 2008). Additionally, MgrA also
represses the expression of phenol-soluble modulins in cells within a biofilm, which
effectively act as surfactants to induce cell release (Jiang et al., 2018). Thus, MgrA’s
extensive regulon affects many aspect of S. aureus biology.
Rot, or ‘repressor of toxins’, is a TF that is thought to dampen the expression of
virulence-related genes such as lipase, haemolysins and secreted proteases (Saïd-
Salim et al., 2003). It is also heavily involved in promoting biofilm formation and
deletion of rot was found to greatly reduce the biofilm burden in a murine catheter
model of infection (Mootz et al., 2015). This was confirmed as being a result of Rot
repressing the expression of extracellular proteases and the authors were able to
demonstrate direct Rot binding to their promoter regions, and their upregulation in
the absence of Rot (Mootz et al., 2015). As such, Rot is another crucial transcription
factor in S. aureus virulence.
Transcript elongation succeeds initiation. In this, RNAP extends the nascent RNA
transcript as it moves along the DNA template. However, this process is also highly
regulated. For example, RNAP contains a proofreading mechanism where, once a
copying error is detected, it can backtrack along the gene, leaving the 3’ end of the
RNA exposed. During this state, RNAP pauses and erroneous transcript is trimmed
back to the active RNAP core (Shaevitz et al., 2003). Pausing can also be a process
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involved in premature termination, and thus be a component of gene expression
regulation (Washburn and Gottesman, 2015).
Once RNAP reaches the end of a gene, the transcript must be terminated. This can
be mediated in a gene-autonomous manner, whereby the structure of the produced
RNA causes a stem-loop to form that induces the RNA to drop off of the polymerase.
Alternatively, a factor called Rho can bind to the transcript and induce RNA release.
Although rho in essential in E. coli, it can be deleted without a loss of viability or
virulence in S. aureus (Washburn et al., 2001). Thus, it seems that Rho-independent
termination is the dominant mode of termination in S. aureus.
Interestingly, non-coding RNAs (ncRNAs) have been shown to be able to attenuate
Rho-mediated transcriptional termination in E. coli. Although Rho canonically binds
to the 3’ end of a transcript to terminate transcription of a finished RNA, it is also able
to bind to the 5’ UTR of a nascent RNA in order to induce premature termination.
This occurs in a remarkable number of genes in E. coli and has been hypothesised to
be a form of stress adaptation. ncRNAs play a role in the halting of this premature
termination (‘antitermination’), having been found to bind to the 5’ UTR of targets
previously targeted by Rho and preventing its binding (Sedlyarova et al., 2016).
This mechanism therefore allows the cell to exist in a primed state where it can
immediately activate stress-responsive genes (after halting premature termination)
as they are already being transcribed.
Post-transcriptional regulation
Whilst transcription controls which RNAs are produced, the cell must also regulate
the RNAs already existing within it. This revolves around controlling the localisation,
stability and translational efficiency of RNAs, and is termed ‘post-transcriptional
regulation’ (PTR, Figure 1.3A). Indeed, it has been shown in a wide variety of
organisms that global mRNA levels do not correlate well with their respective
protein levels, thus indicating the extensive regulation that mRNAs are subject to
(Csárdi et al., 2015; Maier et al., 2009; Picard et al., 2009; Schwanhäusser et al.,
2011).
PTR ultimately serves to direct and control the kinetics of a response. For example,
in the case of a negative response, simply attenuating the transcription of a target
gene would stop new mRNAs being produced but those already existing within the
cell would continue to be actively translated. PTR is able to induce destruction of
unwanted mRNAs on very short time scales and thus facilitate immediate rewiring
of the transcriptome and proteome. This makes PTR a particularly important facet
of gene regulation during stress responses (Gottesman et al., 2006). Additionally,
PTR is able to suppress transcriptional noise of particular genes; this establishes
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a dynamic where a minimum threshold number of mRNAs must be produced in
order to induce a response. This can be useful for controlling the expression level
of potentially hazardous genes or for avoiding target expression in response to a
weak or transient signal (Nitzan et al., 2017). Additionally, PTR is able to shape
gene expression profiles into patterns more complex than simply ‘on’ or ‘off’, and
instead create pulses of varying amplitude and duration (discussed further in Section
1.10). Finally, whereas TFs typically regulate sets of functionally related genes, PTR
is able to control the expression of a wide variety of mRNAs that may be regulated by
different TFs or σ factors, thereby allowing cross-talk between various pathways.
In S. aureus, PTR has been found to be involved in the regulation of metabolism,
cell death and virulence. Exemplifying this, RNAIII is already known to positively
regulate the translation of hla and also mgrA, which itself drives transcription of hla.
As such, PTR acts to drive the expression of Hla in a coherent feed-forward loop,
and as a result induces expression at a maximal rate. Further examples of PTR will
be given in Section 1.7 and how they integrate into regulatory networks in Section
1.9.
1.5 RNA-binding proteins and sRNAs; the major
players of PTR
PTR relies on recognition of target transcripts to be repressed or activated, and
proteins to carry these acts out. In bacteria, the act of recognition is frequently
carried out by a class of ncRNAs often referred to as small RNAs (sRNAs). RNA-
binding proteins (RBPs) also act in concert with these sRNAs to modulate target
stability and translational efficiency. These players are described in more detail in
Sections 1.7, 1.8 and 1.9.
The canonical mode of ncRNA-mediated post-transcriptional repression of an mRNA
is represented in Figure 1.3B. In this example, an sRNA base-pairs with the Shine-
Dalgarno (SD) sequence and blocks the 30S ribosome from initiating translation.
Furthermore, this duplex can recruit RNases to degrade the mRNA. Conversely,
sRNAs can also induce translation of their target mRNA, as shown in Figure 1.3C. In
this example, an autoinhibitory loop in the mRNA prevents its translation. However,
this loop can be melted by an sRNA to free the SD sequence, potentially aided by
RNase-mediated cleavage.
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Fig. 1.2: The canonical mechanisms of post-transcriptional regulation. A.The central dogma
of biology, with the region under which post-transcriptional regulation exerts its
control highlighted. B. The typical mode of mRNA translational repression by
an sRNA. The Shine-Dalgarno sequence (SD) is occluded through sRNA binding,
preventing ribosome assembly. Furthermore, a nuclease can be recruited in order
to degrade the sRNA-mRNA duplex. C. An example of target upregulation by an
sRNA. An autoinhibitory loop on the mRNA which would otherwise occlude the SD
sequence is melted by an sRNA and then a recruited nuclease cleaves the duplex
in order to remove the inhibitory region.
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Architecture of sRNAs
Small RNAs are heterogenous in their size, structure and function. Although they
are typically 50-300 nucleotides in length, there are some of over 1,000 nucleotides.
Additionally, although typically non-coding, some do encode for short peptides
(Balaban and Novick, 1995).
Expression of sRNAs can either be cis to the target mRNA, i.e. encoded on the
opposite strand at the same genomic locus, or trans to the target mRNA, being
encoded at a separate locus (Figure 1.4).
Fig. 1.3: The architecture of cis- and trans-encoded sRNAs. Cis-encoded sRNAs are encoded
on the opposite strand of their target and exhibit perfect complementarity. Trans-
encoded sRNAs are encoded at a distant genomic locus, and thus exhibit only
partial complementarity to their targets. Figure adapted and redrawn from Prasse
et al., 2013.
Currently there are over 500 sRNAs annotated in S. aureus, with the majority of
these being identified through RNA sequencing experiments and in silico predictions
(Liu et al., 2018; Sassi et al., 2015). However, there is disagreement about how
many of these are bona fide sRNAs with a dedicated function in the cell, as opposed
to transcriptional noise or unstable transcripts; one estimate suggests that there are
only around 50 genuine sRNAs in S. aureus, discussed further in Section 1.8 (Liu et
al., 2018).
Cis-encoded sRNAs exhibit perfect complementarity with their target. Despite this,
the interaction between them is still thought to directed by an initial ‘kissing inter-
action’ starting between a few free nucleotides in accessible loops, before inducing
conformational changes in the two RNAs to facilitate longer interactions (Guillet
et al., 2013). Identified cis sRNAs to date revolve around replication machinery,
transposases and toxin-antitoxin systems. The natural Staphylococcal plasmid pT181
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regulates its own replication through production of RNAI, which is encoded cis- to
the plasmid replication initiation protein, repC (Novick et al., 1989). Other examples
include RsaOX, which exhibits perfect complementarity to the putative transposase
SA0062 and RsaOW with the transposase IS1181 (Bohn et al., 2010).
An example of a cis-encoded sRNA involved in a toxin-antitoxin system in S. aureus
is SprF1, which is part of the type I toxin-antitoxin SprG/SprF pair. SprG1 encodes
for two cytolytic peptides from a single open reading frame and these are capable of
inducing autolysis in S. aureus, but can also be secreted to lyse host erythrocytes.
Interestingly, these peptides are also capable of lysing E. coli and Pseudomonas
aeruginosa, two Gram-negative species of bacteria that frequently compete with
S. aureus. Thus, the SprG1 toxin has roles in autolysis, erythrocyte killing (and
therefore perhaps an indirect role in iron scavenging) and finally competition with
other bacterial species. The SprF1 RNA is a cis-acting sRNA encoded on the opposite
strand to SprG1 and is predicted to interfere with SprG1 translation and stability
through canonical means (Pinel-Marie et al., 2014.). In agreement with their
behaviour of a type I toxin-antitoxin system, the SprG1 sRNA has an incredibly long
half-life of 120 minutes while SprF1 has a half-life of 10 minutes. As such, SprF1
must be transcribed at much higher rates than SprG1 (Pinel-Marie et al., 2014).
Interestingly, there is an example of a cis-encoded sRNA acting in trans with its
target in S. aureus. The sRNA SprA1AS is part of type I toxin-antitoxin system. Here,
the stable toxin mRNA, SprA1, encodes for a cytolytic peptide that inserts into the
host cell membrane and disrupts its integrity. In order for the cell to survive, it
must continuously produce the labile SprA1AS antitoxin RNA to block translation
of SprA1. SprA1AS is transcribed from the complementary DNA strand of SprA1.
However, despite exhibiting perfect complementarity at its 3’ end with the 3’ end of
sprA1 in a 35 nucleotide tract, SprA1AS acts in trans by base-pairing to the 5’ end of
sprA1 to occlude the ribosomal binding site (RBS) (Sayed et al., 2012). There also
exists a proposed SprA2/SprA2AS pair in S. aureus, based upon sequence identity,
that may operate in a similar manner (Guillet et al., 2013).
Due to the fact that trans-acting sRNAs are encoded at distant genomic loci, they
exhibit only partial, and at times interrupted, complementarity with their target.
In S. aureus, these interactions are often extended in comparison to E. coli. This is
potentially due to its AT-rich genome; as the interaction between A and T is weaker
than that between G and C, a longer interaction is needed to compensate if it is
primarily composed of A-T bonds (Guillet et al., 2013). Interestingly, many of the
bona fide sRNAs rely on a conserved seed sequence to initiate binding to their target
(Liu et al., 2018). Exemplifying this, RsaE contains two UCCC seed sequences located
in conserved hairpins that are both capable of repressing target mRNAs (Rochat et
al., 2018). RNAIII also uses UCCC sequences found in three of its loops to interact
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with target SD sequences (Bronesky et al., 2016). Currently, most published sRNA
– mRNA interactions in S. aureus involve the sRNA pairing to the 5’ end of the
mRNA to prevent translation, but exceptions are known involving RNAIII and SprX
(discussed further in Sections 1.7 and 1.8).
1.6 RNAIII as a paradigm of sRNA-mediated
regulation in S. aureus
RNAIII is a 516-nucleotide long sRNA that operates as the effector molecule of the
quorum sensing, agr operon in S. aureus. This operon acts as a global regulatory
system that responds to cell density in order to control the expression of myriad
virulence factors. Indeed, given its crucial role in pathogenicity, there has been
considerable interest in the agr pathway as a potential therapeutic target (Painter et
al., 2014).
The quorum sensing machinery relies upon four proteins; AgrA, AgrB, AgrC and
AgrD, whose expression is driven by the P2 promoter. The main effector molecule,
RNAIII, is driven from the P3 promoter slightly downstream of the agr operon.
The agrD locus produces a 46 amino acid-long propeptide that is then processed
by the transmembrane protein AgrB. The product, autoinducing peptide (AIP), is
then secreted and binds to a transmembrane receptor kinase, AgrC, and induces its
autophosphorylation. This phosphorylated AgrC is then able to phosphorylate and
activate the cytosolic transcription factor AgrA, which dimerises and then binds to
the intergenic region between the P2 and P3 promoters in order to further drive
expression of the agr operon and also RNAIII (Painter et al., 2014). The agr operon
is pictorialised in Figure 1.5.
Interestingly, four allelic variants of AgrD, and therefore AIP, exist. Each variant can
only induce the autophosphorylation of their respective AgrC variant and they inhibit
the activity of others. When binding to their complementary AgrC, they induce a
conformational change in the C-terminal cytoplasmic helix that subsequently brings
the sensory and kinase domains together, enabling autophosphorylation. When a
heterologous AIP binds to AgrC, the cytoplasmic helix twists in the opposite direction
and so the sensory and kinase domains remain distant (Wang et al., 2014).
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Fig. 1.4: The structure and mechanics of the quorum sensing system in S. aureus. AgrD is
processed into autoinducing peptide (AIP) through the action of the transmem-
brane protein AgrB. AIP is then secreted and binds the transmembrane kinase
receptor AgrC, which then autophosphorylates and activates AgrA through phos-
phorylation. AgrA then drives expression from the P2 promoter to upregulate the
agr operon, and also the P3 promoter to drive RNAIII expression. RNAIII then
drives virulent gene expression. Adapted and redrawn from Painter et al, 2014.
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The agr pathway is also integrated into nutrient sensing networks. CodY, a tran-
scriptional repressor, acts to sense intracellular carbon and nitrogen sources. During
exponential growth these nutrient sources are high in concentration and CodY acts to
indirectly repress the agr operon (Roux et al., 2014). Thus, agr-regulated virulence
genes are coupled to nutrient status within the cell.
Once RNAIII expression is activated at high cell density, it acts to mediate the switch
from the expression of cell-surface associated proteins to pathogenic behaviour,
including the production and secretion of toxins. RNAIII itself encodes for a small,
26 amino acid-long cytolytic peptide, δ-haemolysin (Hld), that can insert into mem-
branes and cause cell lysis (Verdon et al., 2009). However, the principle mode of
action of RNAIII is through post-transcriptional regulation of its target mRNAs.
RNAIII is involved in the only documented cases of an sRNA upregulating the
translation of an mRNA in S. aureus. First, the 5’ UTR of the hld region binds
to the 5’ UTR of α-haemolysin and acts to free the SD sequence and recruit the
ribosome (Novick et al., 1993). Secondly, RNAIII is known to stabilise the mRNA of
a global pro-virulence transcription factor, MgrA (Gupta et al., 2015). Here, both
the 5’ and 3’ end of RNAIII interact with the long 5’ UTR of the mgrA mRNA at two
distinct regions and prevent its destruction by RNases. MgrA acts to repress biofilm
formation, promote metabolic remodelling , and positively regulates the expression
of several toxins including hlg, lukDE and lukMF (Luong et al., 2006). Thus, RNAIII
can indirectly cause major shifts in cell behaviour through regulating MgrA. Finally,
RNAIII has been shown to stabilise the map which encodes for a surface adhesion
protein that can prevent leukocyte adhesion and induce T-cell death (Ivain et al.,
2017; Liu et al., 2011).
However, RNAIII also acts as a negative regulator to repress targets and induce
RNase-mediated degradation (Boisset et al., 2007; Chevalier et al., 2010; Tomasini
et al., 2014) and it is not thought that RNAIII needs a protein chaperone to aid its
activity (Bronesky et al., 2016). Through direct base-pairing interactions, RNAIII
downregulates the expression of sbi, prA and fnBP (Boisset et al., 2007; Chabelskaya
et al., 2014; Huntzinger et al., 2005). Interestingly, the interaction between RNAIII
and sbi occurs at two distinct sites on the sbi mRNA; one at the 5’ UTR involving the
3’ end of RNAIII and another within the coding sequence that utilised the 5’ end of
RNAIII (Chabelskaya et al., 2014). This mechanism of action where RNAIII binds
both the translational initiation region at the 5’ UTR and within the coding sequence
is also observed for another of its targets, coa (Chevalier et al., 2010).
RNAIII also represses the translation of rot (‘Repressor of toxins’), a TF that directly
binds to the promoter regions of many toxin transcripts and blocks their transcription
(Saïd-Salim et al., 2003). Rot is also known to stimulate the expression of PrA, and
1.6 RNAIII as a paradigm of sRNA-mediated regulation in S. aureus 18
thus RNAIII represses the translation of this mRNA both directly and indirectly
(Oscarsson et al., 2006). RNAIII also represses the translation of lytM, a hydrolytic
enzyme involved in regulating cell wall homeostasis (Chunhua et al., 2012). The
activity of RNAIII is summarised in Figure 1.6.
In conclusion, RNAIII is a multifaceted RNA that acts to switch the cell from a more
dormant, ‘defensive’ state into pathogenic behaviour upon the reaching of a critical
cell density. This act is carried out on multiple levels. Firstly, RNAIII downregulates
the ‘front line’ proteins on the cellular membrane that are involved in host immune
system avoidance. Secondly, RNAIII stimulates the production of toxins which are
then secreted in order to attack the host. However, RNAIII also modulates key
transcription factors in the cell by downregulating rot and stabilising mgrA, thus
also changing the core transcriptional program of the cell. As such, RNAIII can be
regarded as a post-transcriptional molecular switch.
Fig. 1.5: The targets and regulatory mechanisms of RNAIII. RNAIII negatively regulates spa,
coa, sbi and rot through classical RBS occlusion. In the cases of spa, coa and rot,
this is accompanied by RNase III recruitment and transcript degradation. Con-
versely, RNAIII is able to stimulate translation of hla and mgrA through transcript
stabilisation and liberation of the SD from autoinhibitory loops. This image was
taken from Bronesky et al, 2016.
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1.7 Other sRNAs in S. aureus
The Spr and Rsa family of sRNAs are a heterogenous collection that have been
identified through in silico predictions and subsequent validation. Their shared
names do not represent collective function but rather their discovery.
The Spr family
The Spr (‘Small pathogenicity island RNA’) family of RNAs was identified in 2005, at
a time when only RNAI and RNAIII were known (Pichon and Felden, 2005). Multiple
approaches were used in order to identify the original Spr sRNAs; total RNA was
resolved on an agarose gel and stained in order to find highly expressed ncRNAs,
and intergenic regions were screened computationally and through microarrays.
This identified 7 sRNAs expressed from pathogenicity islands, named SprA to SprG,
and these vary in length from 90 to 400 nucleotides. Since their discovery, other
sRNAs have been added to this family (such as SprX), despite being encoded in the
core genome.
The original paper managed to obtain in vitro evidence that SprA regulated the
translation of an ABC transporter, SA2216. The role of other Spr sRNAs has since
been expanded. SprX is now known to directly bind the RBS of spoVG, repressing
its translation, through a C-rich loop at its 3’ end. SpoVG is a DNA-binding protein
that is involved in methicillin and vancomycin resistance. It regulates the expression
of extracellular protease, nuclease and lipase and has a role in capsule formation.
Indeed, plasmid-borne overexpression of SprX reduces S. aureus resistance to gly-
copeptide antibiotics (Eyraud et al., 2014). SprX is additionally known to repress
the translation of ecb, a protein involved in inactivating host blood complement
(Ivain et al., 2017) and upregulate the translation of clfB, coa and hld, and has
subsequent influence on the formation of biofilms and on virulence (Kathirvel et al.,
2016). SprD is known to repress the immune-evasive protein sbi in a similar manner
and deleting this sRNA results in a serious attenuation of virulence (Chabelskaya
et al., 2014, 2010). SprC is also known to be a negative regulator of virulence
and control Staphylococcal uptake by monocytes and macrophages; null-mutants for
SprC displayed a higher level of virulence and increased uptake by phagocytes. This
was found to be at least partially a result of SprC repressing the translation of atl,
an adhesin/invasin that interacts with host cells. As such, SprC was hypothesised
to be involved in attenuating virulence and therefore play a role in host-S. aureus
commensialism (Le Pabic et al., 2015).
The Rsa family
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The Rsa (‘RNA from S. aureus’) family of sRNAs was originally identified through in
silico predictions based on intergenic regions conserved in numerous Gram-positive
bacteria and also throughout S. aureus strains (Geissmann et al., 2009). Putative
sRNAs were then confirmed through microarray analysis and Northern blotting. This
identified 11 previously unknown sRNAs, named RsaA to RsaK. All but RsaK are
predominantly expressed in stationary phase in rich medium, but their expression
profiles change significantly in stringent medium, indicating that their expression
patterns are tightly controlled and respond to external conditions (Geissmann et al.,
2009). Adding to this idea, RsaA, RsaE and RsaI were induced under acidic pH and
oxidative stress (while RsaF and RsaG were not), and the expression of RsaC and
RsaD were significantly upregulated by cold shock (Geissmann et al., 2009).
The function of several of these sRNAs has now been elucidated. RsaE, a key
metabolic regulator, has been found to be conserved across firmicutes and in par-
ticular Bacillus subtilis (Durand et al., 2015). In S. aureus, RsaE regulates the
tricarboxylic acid (TCA) cycle by downregulating the translation of several com-
ponent enzymes, namely sucC, sucD, citB, citC, and citZ (Bohn et al., 2010). RsaE
also has a role in regulating the amino acid composition of the cell; its expression
induces transcription of valine, leucine and isoleucine-responsive operons (Guillet et
al., 2013). Additionally, it downregulates the arginine degradation pathway (Rochat
et al., 2018), and it has also been shown to downregulate the opp-3 operon that
encodes for oligopeptide transporters (Bohn et al., 2010). RsaE also downregulates
a component of the purine biosynthesis pathway, fhs (Bohn et al., 2010). RsaE’s
regulation of the TCA cycle and amino acid metabolism has led to suggestions that it
facilitates the transition between energy metabolisms from late-exponential phase
to stationary phase, where acetate and amino acids are used as alternative carbon
sources (Guillet et al., 2013). Finally, as RsaE expression is dependent upon the
agr pathway and its expression is σB-dependent, it has also been suggested that it
may play a role in virulence (Geissmann et al., 2009). In B. subtilis, RsaE (known as
RoxS) has been found to respond to oxidative stress, be involved in the regulation
of redox-related transcripts and also been predicted to regulate additional genes
involved in electron transfer (Durand et al., 2015, Durand et al., 2017).
The σB-dependent sRNA RsaA is involved in attenuation of virulence (Romilly et
al., 2014; Tomasini et al., 2017). An initial study by Romilly et al, 2014, deleted
the coding sequence for RsaA and analysed the cytosolic protein content. This
identified spoVG as a potential RsaA target, but also a number of proteins that are
part of the MgrA regulon. Further study also found that expressing RsaA from a
plasmid decreased the amount of MgrA protein produced. RsaA, through its UCCC
seed sequences, was subsequently found to bind to two distinct regions on mgrA;
one sequestering the RBS (and therefore blocking translation), and another which
acts to recruit RNase III to induce degradation. Deletion of RsaA also changed the
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protein levels of several cell surface proteins such as PrA, Ebh_1 and Ebh_3, ClfB and
others, although this effect is likely to be indirect and through regulation of MgrA
(Tomasini et al., 2017). The mutation also reduces biofilm formation and inhibits
capsule production, in agreement with its role as a negative regulator of MgrA.
Additionally, deletion was also found to induce a higher bacterial load in the blood
and spleen of mouse models (Romilly et al., 2014). Thus, RsaA is hypothesised to
attenuate invasiveness and aggressive pathogenicity, and therefore may be favoured
in commensal interactions with the host.
Several RsaA targets were identified through MAPS, where the target RNA is tagged
with an MS2 affinity tag, purified, and the RNAs bound to it identified through
sequencing (discussed further in Section 1.12). This revealed that RsaA has a role in
regulating components of the cell surface (Tomasini et al., 2017). This confirmed
that mgrA is a major target of RsaA, but also identified members of the Staphylococcal
secretory antigen A class (SsaA), which are involved in peptidoglycan metabolism,
and flr (encoding for FLIPr), a secreted immunomodulatory protein that inhibits
complement and IgG opsonisation of S. aureus. The distinctive UCCC motif in RsaA
was found to be essential for interaction with these transcripts and it binds to the
RBS to inhibit mRNA translation.
The Teg and Sau families
The Teg (‘Transcript from experimental method from Geneva’) family are a loosely
connected group of putative sRNAs originally identified through RNA sequencing
by the Francois group (Beaume et al., 2010). Originally, 150 were identified from
intergenic regions in the N315 core genome and 9 from a plasmid. Thirty-one were
hypothesised to be cis-acting riboswitches and 57 to be trans-acting, independent
transcripts. Additionally, 23 were the product of anti-sense transcription at a protein
coding gene and exhibited perfect complementarity with their respective mRNA;
several of these were antisense for transposes and also present in multiple copies.
In order to validate a subsection of these, RT-qPCR was performed on 26 chosen
putative sRNAs. Most were found to be highly expressed at stationary phase in
rich medium, and that several also responded to thermal, oxidative, or pH stress
(Beaume et al., 2010).
The Francois group then collaborated with the Stinear group in Australia to perform
similar work in two Australian S. aureus strains derived from ST239 (Howden et al.,
2013). One strain, JKD6008, displays intermediate vancomycin resistance while the
other, JKD6009, is vancomycin-sensitive. RNAseq was performed on each of these
strains after 2 and 6 hours of exposure to 4 different antibiotics and a no antibiotic
control. In total, they identified 409 putative sRNA sequences, with 79 of these being
encoded in the accessory genome. Of these 409, 171 were found to be products of
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antisense transcription at mRNAs and 94 contained a ‘UCCC’ motif that commonly
blocks the RBS, as seen for RsaA, RsaE and RNAIII. Additionally, they identified 70%
of the aforementioned Tegs in their analyses. In particular, 47 putative sRNAs were
identified that displayed significant differential regulation in response to antibiotic
exposure.
Although no validation of these transcripts has been performed, Howden et al,
2013, noted that many of the sRNAs responsive to an antibiotic are anti-sense
transcripts for mRNAs that operate in protein synthesis and ribosomal function.
For example, sRNA242 was downregulated in all antibiotic conditions and this
sequence is antisense to the 30S ribosomal protein S1. Thus, there may be a subset
of antisense sRNAs that act to regulate the expression of ribosomal and protein
production genes.
Similar RNAseq studies have been performed in a so-called ‘small colony variant’
(SCV) of S. aureus (Abu-Qatouseh et al., 2010). These SCVs display slower growth,
reduced virulence, decreased sensitivity to antibiotics and typically produce chronic
infections. RNAseq and computational analyses identified 142 potential sRNAs, each
termed ‘Sau-n’ (‘S. aureus ncRNA’). Seventy-eight of these were found to be products
of anti-sense transcription of known mRNAs, 16 partially overlapped with known
ORFs (and so may represent UTRs), and 48 derived from intergenic regions. Eighty
Sau transcripts were chosen for validation through Northern blots and signal was
detected for 18 of these. Comparing expression patterns of SCV and WT strains
led to the discovery of several Sau transcripts which exhibit differential regulation
in SCVs, such Sau-27 (an intergenic transcript) being lost in SCVs or Sau-66 (an
antisense product) being upregulated in SCVs (Abu-Qatouseh et al., 2010).
Finally, a tiling array study managed to identify 7 transcriptional units which were
theorised to be potential trans-acting sRNAs, simply named e.g. "S35" (Mäder et al,
2016). Two of these were observed to highly expressed in a large number of tested
conditions, two were upregulated in conditions that mimic bloodstream infection
and one was highly expressed when grown in human plasma. As such, some of these
candidates sRNAs may be involved in virulence.
sRNA curation in S. aureus
Given that multiple studies have been published each with their own naming con-
vention, an attempt to curate sRNAs in S. aureus has been attempted (Sassi et al.,
2015). For example, the transcript encoding for RsaA has been discovered in all the
studies mentioned above. As such, it has also named Sau-64, Teg88, sRNA132 and
finally given the systematic name srn_1510 by Sassi et al; the same applies for RsaE
(Sau20, Teg92, sRNA183, srn_2130). Integrating all of these identifications together
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has led to the curation of 539 sRNA sequences in NCTC8325, 530 in USA300 and
607 in JKD6008.
However, it is clear that only a handful of sRNAs have any meaningful functionality
attributed to them. It is therefore difficult to distinguish between bona fide sRNAs
from transcriptional noise and poorly annotated UTR sequences. Additionally, given
that trans-acting sRNAs are of greater interest than cis-actors due to their ability to
regulate a large number of transcripts and integrate several pathways and cellular
responses, it is important to be able to correctly identify these for future study.
As such, greater stringency must be applied when defining transcripts as putative
trans-acting sRNAs.
A study in 2018 attempted to perform such filtering of the sRNA database in HG003,
a NCTC8325 derivative (Liu et al., 2018). They defined a trans-acting sRNAs as one
with its own promoter and terminator; does not overlap with any gene from the
opposite strand; is not a processed UTR; is not a product of premature termination;
and contains a transcription factor/σ binding site. They identified putative promoters
in their strain using RegPrecise, which relies on comparative genomics to identify TF
binding sites (Novichkov et al., 2013); in order for an sRNA to be defined as having
its own promoter, it required one of these binding sites between -100 and +50
nucleotides of its 5’ end. In order to identify terminators, the authors assumed that
trans-acting sRNAs utilise Rho-independent terminators and so searched for these
using TransTermHP (Kingsford et al., 2007). This tool searches for charactersitic
markers of Rho-independent terminators, such as an A-rich tail in the 5’ end of the
gene, followed by a short, low-energy hairpin and finally ended with a T-rich tail.
From their pool of 527 putative sRNAs, they concluded that only 46 were genuine,
bona fide, trans-acting sRNAs, with the rest mostly being asRNAs and UTR sequences
(Liu et al, 2018). However, it should be noted that processed UTRs have been shown
to produce functional sRNAs in Gram-negative bacteria and these will be missed by
Liu et al’s strict definition (reviewed by Chao et al., 2012 and Ren et al., 2017, Iosub
et al., 2019). Overall, although the pool of sRNAs appear to be large in S. aureus,
scepticism is required in their interpretation.
1.8 RNA-binding proteins and sRNA-mediated
regulation
RNAs, including sRNAs, frequently require the activity of an RNA-binding protein
(RBP) in order to exert their function, and it is the resultant ribonucleoprotein
complex (RNP) that exerts the functional outcome. As such, the roles of RBPs have
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been a significant focus of research into post-transcriptional regulation, particularly
in Gram-negative bacteria. This section will detail the current knowledge of RBPs
in S. aureus and, where appropriate, compare this to current knowledge in Gram-
negatives such as E. coli and Salmonella typhimurium, and also the Gram-positive B.
subtilis.
Hfq
Hfq is an RNA chaperone that plays a central role in the functionality of trans-
encoded sRNA in several bacterial species. Overall, Hfq acts to stabilise sRNAs by
protecting them from ribonuclease cleavage and facilitates sRNA-target interactions
(Storz et al., 2011; Vogel and Luisi, 2011). It is present in a number of bacterial
phyla, including several firmicutes, actinobacteria and α-, β- and γ-proteobacteria.
Hfq operates as a homohexamer, forming a donut-like shape with two RNA-binding
faces on either side. Each face has a specific RNA target motif, with the proximal
face binding AU-rich sequences and the distal binding poly(A) sequences (Link et al.,
2009; Schumacher et al., 2002). This dual-activity of Hfq facilitates its binding to an
sRNA on one face and an mRNA on another. This increases the local concentration
of sRNA and target and may also induce conformational changes in the RNAs to
encourage base pairing. In E. coli, Hfq is also able to recruit RNase E in order to
degrade sRNA-mRNA pairs (Bandyra et al., 2012; Waters et al., 2017).
Deletion of Hfq in many pathogenic bacteria, such as uropathogenic E. coli and S.
typhimurium, leads to growth defects, increased susceptibility to stress and reduced
virulence (Chao and Vogel, 2010). In Salmonella, Hfq is thought to regulate around
20% of all genes, either directly or indirectly, and this includes those involved in host
cell invasion, motility, central metabolism, cell wall regulation and two-component
pathways (Chao and Vogel, 2010).
Although Hfq is found in many S. aureus strains, its role and importance in post-
transcriptional regulation is unclear. An initial study found that S. aureus Hfq was
able to bind RNAIII and spa RNAs in vitro (Huntzinger et al., 2005). However,
deleting the Hfq coding sequence in three S. aureus strains (COL, Newman and
RN6390) did not show significant changes in RNAIII expression or Protein A produc-
tion (Bohn et al., 2007). Additionally, this study examined the RN6390 ∆hfq strain
in more detail and performed around 2000 phenotypical assays (such as nutrient
source usage, sensitivity to chemical stresses, etc) but could detect no significant
or robust phenotypes. As such, this study concluded that either RNA-RNA interac-
tions in S. aureus do not require the aid of an RNA chaperone, or that currently
unidentified one(s) performs this role. In agreement with the former idea, several
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trans-acting sRNAs have been found to act completely independently of Hfq (Guillet
et al., 2013).
Western blotting analyses in wild-type RN6390 and COL revealed that Hfq is un-
detectable in these strains (Liu et al., 2010). This is potentially due to the loss of
the gene’s major promoter (Geisinger et al., 2006). However, RN6390 and COL are
laboratory-adapted strains and may not represent accurately an S. aureus strain in
the outside environment. In agreement with this, deleting hfq in S. aureus 8325-4
led to changed expression profiles of 116 genes as detected by microarray analysis
(fold change ≥ 1.5), and immunoprecipitating Hfq identified 49 of these mRNAs.
Included in these 49 were sbi, sucD and rot; all mRNAs with known sRNA regulators.
Additionally, deleting Hfq resulted in a decrease of virulence in a murine peritonitis
infection model and an increase in surface carotenoid pigment (Liu et al., 2010).
This effect on carotenoid pigment has also been confirmed in the N315 strain (Castro
et al., 2011). As such, Hfq may not be an indispensable tool across all S. aureus
strains and may exhibit strain specificity. Given that S. aureus does not express
RNase E, it may act to recruit other cellular nucleases, as described below.
Finally, deletion of Hfq does not cause a strong phenotype in B. subtilis (Rochat et
al., 2015). This has led to the suggestion the need for a general chaperone may not
be necessary in species with more stable sRNA-target interactions. This fits with the
idea of extended interactions due to the AT-rich genome, as described in Section 1.5.
Alternatively, it may be that species such as B. subtilis and S. aureus rely on more
condition-specific RNA chaperones, as opposed to a single, global one (Mars et al.,
2016). However, at the time of writing, dedicated RNA chaperones have not yet
been validated in S. aureus.
RNase III
RNase III is a magnesium-dependent endoribonuclease that contains a C-terminal
RNA-binding domain and an N-terminal ribonuclease domain. It targets double-
stranded RNA, such as sRNA-mRNA duplexes, loop-loop interactions and stacked
helices (Chevalier et al., 2008). It operates as a homodimer and cleavage results
in a 5’-phosphate and a 3’ dinucleotide overhang. In B. subtilis and E. coli, RNase
III has been shown to be involved in 30S rRNA processing in order to generate the
16S and 23S subunits (Srivastava and Schlessinger, 1990) and also regulates the
expression of phages, plasmids and cellular genes (Wagner et al., 2002). As RNase
III only recognises double-stranded RNA, it can be recruited through trans-acting
sRNAs.
Deletion of RNase III in S. aureus is viable and mutants appear without growth
defects (Huntzinger et al., 2005). In constrast to this, RNase III is essential in B.
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subtilis, and deletion in E. coli results in slow growth (Herskovitz and Bechhofer,
2000; Studier, 1975). The lethality in B. subtilis upon RNase III removal is a result
of its essential role in suppressing the translation of two toxin mRNAs, txpA and
yonT which are part of toxin-antitoxin systems of two prophages (Durand et al,
2012). These are targetted for degradation through the action of asRNAs which act
to recruit RNase III (Durand et al, 2012).
However, RNase III mutants in S. aureus display impaired processing of several
virulence-related transcripts. For example, ∆rnc strains cannot degrade spa mRNA
encoding for Protein A. As described in Section 1.7, the 3’ end of RNAIII is able to
duplex with spa to block the RBS, and this dsRNA structure is recognised by RNase
III and cleaved (Chevalier et al., 2008). This mechanism of action is not restricted to
spa and has also been demonstrated for fnBP, coa, sa1000, ssaA, and rot (Boisset et
al., 2007) and confirmed in vitro (Chevalier et al., 2008). Corroborating the role
of RNase III in regulating pathogenicity, a ∆rnc mutant was shown to secrete fewer
immunogenic proteins and toxins and had diminished virulence in a murine acute
peritonitis model.
RNase III has been the subject of RIP-seq experiments in order to identify its cellular
targets. As baits, both a wild-type RNase III and a catalytically-dead (E135A) mutant
were used (Lioliou et al., 2012). Corroborating its known links to rRNA process-
ing, rRNA transcripts were identified as major targets of RNase III . Additionally,
catalytically-dead RNase III was found to bind antisense transcripts of 1175 mRNAs
(44% of the genome). As such, RNase III likely plays a role in degrading cis-encoded
sRNAs in duplex with their partner mRNA, but also potentially products of pervasive
transcription. These pervasive transcription products are the result of e.g. failed
termination events and continued RNA polymerase elongation, promoter sequences
present in intergenic regions and bidirectional promoters (Wade et al, 2014). These
products are undesirable and non-coding transcripts that are then targetted for
degradation. RNase III was also found to bind key virulence factors such as rot
and spa, and interestingly also bound 58 different ncRNAs including sRNAs. These
include numerous sRNAs from the Spr and Rsa families, and RNAIII (Lioliou et al.,
2012). Thus, RNase III is also predicted to be a key player in sRNA-mediated decay
of mRNAs.
In conclusion, RNase III is an important RNase within the cell with clear links to
the regulation of pathogenesis. It is involved in degrading mRNAs that have been
targeted for destruction by sRNAs and this applies to key virulence factors.
RNase Y
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RNase Y has been described as the functional homologue of RNase E in S. au-
reus, which operates as the central degradosome scaffold in E. coli. It is a 5’
monophosphate-dependent endonuclease and has been found to be responsible
for initiating bulk mRNA decay in B. subtilis (Durand et al., 2012). Indeed, depletion
of RNase Y led to the dysregulation of 1,261 transcripts, representing just over a
quarter of B. subtilis’ gene expression. For many transripts after RNase Y cleavage,
RNase J1 then degrades the rest of the transcript (Durand et al, 2012). Additionally,
depletion of RNase Y led to the stabilisation of both known sRNAs and asRNAs,
indicating a role of RNase Y in degrading several of these transcripts. (Durand et al,
2012).
In S. aureus, RNase Y is essential for virulence (Marincola Gabriella et al., 2012).
RNase Y was found to be key in processing the saePQRS operon, of which saeR
and saeS act as a two-component system to regulate the expression of numerous
virulence genes such as spa, nuc, coa, and several haemolysin mRNAs. Deletion of
rny resulted in the differential regulation of 569 genes as detected by microarray
and included in these were the sRNAs RsaA and Sau63. The most common gene
ontology terms associated with the deregulated ORFs were pathogenesis, proteolysis,
transport and metabolic processes. In agreement with RNase Y’s role in pathogenesis,
a ∆rny mutant was found to have attenuated virulence in a murine bacteraemia
model (Marincola Gabriella et al., 2012). Interestingly, RNase Y was found not
to regulate RNAIII or any component of the agr pathway, thus this regulation of
virulence was proposed to be independent of the quorum sensing system.
RNase Y has also been hypothesised to be the backbone scaffold of the RNA degra-
dosome in both S. aureus and B. subtilis. After RNase Y cleavage, RNase J1 (a 5’-3’
exonuclease) and PNPase (a 3’-5’ exonuclease) subsequently degrade targeted tran-
scripts transcript (Durand et al., 2012). Deletion of the N-terminal tail of RNase Y
induced a growth defect (as opposed to deletion of the entire locus, which does not)
and thus cytosolic RNase Y may scavenge degradosome components and mislocalise
them (Khemici et al., 2015). The degradosome is discussed further in the section
below.
Khemici et al, 2015, also identified which transcripts are directly controlled by
RNase Y by mapping transcript ends through RNAseq. They found that deletion of
RNase Y significantly affected 248 transcripts; significantly less than that published
by Marincola et al., 2012. However, sarA and sarR were found by Khemici et al.,
corroborating Marincola et al’s description of RNase Y regulating the sae operon.
However, Khemici et al. found agrA and agrC upregulated upon RNase Y deletion,
which was not found in Marincola’s data. Khemici et al. also found six sRNAs
stabilised in the absence of RNase Y, including RsaA, SprX and RNAIII. Using 5’ end
mapping, Khemici et al. identified 99 RNase Y cleavage sites, of which 50 were
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in ORFs and the remainder in UTRs, ncRNAs and intergenic regions. The authors
concluded from these results that RNase Y is the prime regulator of only around 100
transcripts and therefore its activity is under considerable regulation and control
(Khemici et al., 2015). In conclusion, RNase Y is likely not an RNase involved in
bulk mRNA degradation in S. aureus, but rather involved in the processing and
degradation of virulence-related transcripts.
The degradosome – E. coli, B. subtilis and S. aureus
In E. coli, bulk mRNA degradation is mediated by a holoenzyme complex called
the degradosome. It is composed of the endonuclease RNase E, the 3’-exonuclease
polynucleotide phosphorylase (PNPase), RNA helicase B (RhlB) and the metabolic
enzyme Enolase (Carpousis, 2002; Py et al., 1994). RNase E is thought to be the
central player of this complex as it is the scaffold upon which the complex is built,
and it is also the initiating factor in RNA decay (Carpousis, 2002). The E. coli
degradosome is pictorialised in Figure 1.7A.
RNase E contains an N-terminal catalytic domain and a long, unstructured C-terminal
domain that contains RNA and protein-binding sites. It is on this C-terminal domain
that the degradosome is assembled (Carpousis, 2007). PNPase acts to degrade
mRNAs at the 3’ end through phosphorolysis, while RhlB melts short stretches of
duplexed RNA in order for it to be fed into RNase E/PNPase (Carpousis, 2007).
The functionality of Enolase in the degradosome is unclear. Enolase is a glycolytic
enzyme that catalyses the dehydration of phosphoglycerate to phosphoenolpyruvate.
It is an abundant cellular protein, but only a small fraction of it is bound to the
degradosome. It is thought that Enolase acts to somehow link information about
the energetic state in the cell to mRNA degradation, but the molecular basis or
consequences of this is unknown (Carpousis, 2007). Corroborating this idea in E. coli,
Enolase has been found to mediate the rapid degradation of a glucose transporter,
ptsG, in response to phosphosugar stress (Morita et al., 2004). Additionally, Enolase
has been found to be able to directly bind RNA in yeast and mammalian cells (Entelis
et al., 2006; Hernández-Pérez et al., 2011).
In comparison to E. coli, much less is known about the degradosome in Gram-positive
species. Most do not contain a direct RNase E orthologue, including B. subtilis and S.
aureus. In B. subtilis, a proposed degradosome is composed of the nucleases RNase
J1, RNase J2, PNPase and RNase Y, alongside cofactors CshA (an RNA helicase),
Enolase and phosphofructokinase (Pfk) (Commichau et al., 2009; Lehnik-Habrink
et al., 2010). RNase J1 and J2 are both bifunctional nucleases with endo- and
5’-3’ exonuclease activity and may act to initiate mRNA degradation, while CshA
is hypothesised to melt structured RNA regions in a manner similar to RhlB (Roux
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et al., 2011). RNase Y is known to be membrane-bound in both B. subtilis and S.
aureus and is thought to be the central anchor to the complex (Cascante-Estepa et
al., 2016, Khemici et al., 2015).
Only limited analyses have been performed on the S. aureus degradosome in the
form of bacterial two-hybrid assays and in vitro binding experiments. This led to
the conclusion that RNase J1 and J2 may act as a heteromultimer, and that J1 may
recruit PNPase and CshA. Additionally, CshA may bind RNase Y, Enolase, Pfk, and an
additional cellular RNase predicted to be involved in bulk mRNA degradation called
RnpA (Olson et al., 2011; Roux et al., 2011). Thus, the proposed degradosome
is composed mainly of RNase J1 and J2 acting to initiate bulk mRNA degradation
(potentially alongside RnpA) while RNase Y may target a specific subset of RNAs,
such as those with specific structural features (Roux et al., 2011).
Interestingly, CshA has been found to protect essential RNAs from degradation
by the toxin RNase MazF in S. aureus (Kim et al., 2016). This RNase is part of
a toxin-antitoxin system, where its ribonuclease activity is inhibited by the labile
MazE antitoxin. Whether this toxin RNase has any physiological benefit to the cell
is still under debate, but one hypothesis suggests that it acts to clear unnecessary
RNAs within the cell at times of extreme stress, and may also induce drug-tolerance
and biofilm formation (Schuster and Bertram, 2016). Interestingly, overexpression
of MazF induced cellular stasis but not cell death, and therefore it was proposed
that MazF activity inhibits growth and could therefore promote survival (Fu et
al., 2009). Transcriptomic analysis following MazF induction showed that mRNAs
encoding for virulence proteins such as hla and spa were degraded, while essential
‘housekeeping’ genes such as recA, sarA and gyrB were protected (Fu et al., 2009).
Using Northwestern blots, it was found that these proteins were likely bound to
a protective RBP and this was identified as being CshA in subsequent studies (Fu
et al., 2009; Kim et al., 2016). Deletion of cshA results in a loss of viability upon
MazF induction and a decrease in the expression of 22 sRNAs (alongside many
housekeeping mRNAs) (Kim et al., 2016). This result also suggests that certain
sRNAs are essential in cellular survival in times of duress. Thus, CshA may have
multiple roles within the cell; it may act as part of the degradosome to unwind
structured RNA regions but may also exist as a cytosolic pool independent of the
degradosome where it can protect key RNAs from degradation.
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Fig. 1.6: The degradosome of E. coli and proposed degradosome of S. aureus. A. E. coli
degradosome is built upon a tetramer RNase E, which acts as a central scaffold for
PNPase, Enolase and RhlB via its unstructured C-terminal domains. In addition to
this, RNase E initiates bulk mRNA decay. B. The S. aureus degradosome is not as
well understood as that in E. coli. It is potentially based built upon the membrane-
bound RNase Y, which can then interact with Enolase and CshA. Enolase can then
recruit PNPase, which in turn recruits the RNase J1 and J2 heteromer. CshA can
interact with both Pfk and RnpA. Data based off of (Khemici et al., 2015; Roux et
al., 2011).
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1.9 sRNAs and their integration into regulatory
networks
Given that sRNAs are capable of regulating the stability and translational efficiency
of mRNAs, they are well placed to act in concert with transcription factors to drive
and shape signalling responses.
Typically, a protein transcription factor or two-component system is used to sense a
change in the environment or detect a stimulus. These will then stimulate or repress
the expression of target genes, including sRNAs. This regulation exerted on the
sRNAs then drives secondary responses in their targets. Importantly, some sRNAs
can then feedback, positively or negatively, on the original transcription factor in
order to shape the timings and dynamics of the response. Overall, these integrated
transcription factor-sRNA networks can range from simple single input module (SIM)
and negative feedback loops (NFLs) motifs to more complex dense overlapping
regulons (DORs) and feedforward loops (FFLs) (Beisel and Storz, 2010).
Simple architectures; SIMs and NFLs
The SIM motif is the simplest form of a regulatory circuit that contains an sRNA. Here,
a transcription factor drives the expression of an sRNA, and this sRNA in turn exerts
regulatory effects on mRNA targets (Figure 1.8A). As such, the transcription factor
has an indirect effect on the targets. As an example from S. aureus, the transcription
factor AgrA drives expression of RNAIII, which then regulates numerous targets;
exemplified here with its positive regulation of hla and negative regulation of rot.
Computational predictions also suggest that a SIM can create a hierarchical response,
where the mRNAs that have extensive base-pairing with the sRNA are regulated
first and then those with less pairings afterwards. This would then add a temporal
aspect to the response and also a dose-dependent effect where only a strong stimulus
would induce enough sRNA for the lesser targets to be regulated (Beisel and Storz,
2010).
When the sRNA can repress its own inducing transcription factor, a negative feedback
loop is created. This has the benefit of exerting tighter control over the sRNA
and prevents over-accumulation which may have hazardous effects on the cell.
Additionally, cell-to-cell variation is reduced as the inducing TF is inhibited at
increasing rates as it accumulates, while low levels of TF are able to drive the
expression of the sRNA relatively unopposed. Finally, such loops also produce a
timed response that encode for their own shutdown; this is useful when inducing
a stress response and then shutting it down when the stress is resolved. This is
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Fig. 1.7: The architecture of single input modules (SIMs) and negative feedback loops
(NFLs) utilising sRNAs. A. SIMs consist of a single transcription factor that drives
expression of an sRNA, which then regulates its targets directly. B. In an NFL,
the sRNA then represses the translation of its own inducing transcription factor.
Modified from Beisel and Storz, 2010.
represented in Figure 1.8B, where the transcription factor OmpR is induced by
membrane stress in E. coli. OmpR then induces the expression of two sRNAs, OmrA
and OmrB, which in turn negatively regulate several outer membrane proteins,
including ompT (Guillier and Gottesman, 2006).
Complex architectures: DORs and FFLs
DORs represent a collection of multiple, overlapping SIMs. These are used to
incorporate multiple environmental stimuli and buffer them against each other. As
such, DORs may be used when controlling the expression rates of genes involved
in multiple biological processes (Beisel and Storz, 2010). Figure 1.9A shows an
example of a DOR involved in controlling the composition of the outer membrane,
in particular the OMPs, in E. coli and S. typhimurium. These OMPs are critical
determinants of cell viability as they determine what molecules can enter and
exit the cell, have a profound effect on membrane integrity and are recognised by
phages (Vogel, 2009). As such, their regulation is controlled through multiple stress
responsive pathways; σE (extracytoplasmic stress response), osmotic shock (OmpR)
and host cell invasion (HilD). Each of these pathways mediates its effect through an
sRNA, which in return negatively regulates a particular set of OMPs. As such, this
DOR mediates a coordinated response through a common set of sRNAs in order to
respond to a variety of membrane stresses, ultimately tuning the outer membrane
porin composition.
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FFLs are composed of two regulators, either sRNA or TF, controlling the expression
of a common gene. Every interaction in the circuit can be either positive or negative,
and this yields eight different network configurations. These eight can be divided
into two outcomes; coherent and incoherent. The coherent loops are formed when
both regulators jointly regulate their target in the same manner. Incoherent loops
are formed when the arms of regulation are in opposition to each other.
In Figure 1.9B, two examples of coherent FFLs are given. In S. aureus, RNAIII
stabilises the transcription factor mgrA and promotes the translation of a toxin,
hla (Gupta et al., 2015; Morfeldt et al., 1995). MgrA also acts in concert to drive
expression of hla. Thus, the concerted act of both RNAIII and MgrA drives Hla
expression faster than if they acted alone, and therefore toxin production can be
achieved at the maximal possible velocity. Another example of an FFL is represented
in Figure 1.9B from E. coli. It has been proposed that when in the gut, E. coli must
populate its outer membrane with OmpC, which has a relatively small pore size
(in comparison to porins such as OmpF) in order to exclude toxic bile salts. To
facilitate a swift transition, OmpR acts to induce production of ompC mRNA, but
also represses the expression of a repressor of OmpC, the sRNA MicA (Yoshida et
al., 2006). Thus, OmpR activates OmpC and inactivates its repressor, supporting
accumulation of OmpC. As such, coherent FFLs drive sustained responses at the
maximum possible rate.
On the other hand, incoherent FFLs can act to drive pulses of expression, where a
response is induced but ultimately timed to inactivate itself. They can also act to
ensure that a particular response is only committed when absolutely appropriate,
effectively acting to buffer transcriptional noise or low stimuli. The latter has been
demonstrated in E. coli, where σE drives expression of both RybB and htrG in times
of stress (Asakura and Kobayashi, 2009; Gogol et al., 2011). RybB is an sRNA
that represses the translation of several mRNAs, including htrG which induces cell
autolysis, likely through disruption of the cell membrane (Asakura and Kobayashi,
2009). In low-stress conditions, there is sufficient RybB to effectively repress htrG
translation. However, when the stress is strong enough (such as sustained nutrient
starvation), sufficient htrG is produced in order to overcome the RybB repression,
and this induces cell death. As such, the population of E. coli benefits from reduced
competition and may survive.
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Fig. 1.8: The architecture of dense overlapping regulons (DORs) and feedforward loops
(FFLs). A. DORs consist of several individual SIMs which converge on common
targets. This allows different signalling pathways to act in concert or to buffer
them against each other. B. FFLs are separated into coherent and incoherent
architectures. Coherent loops drive repression or stimulation from both a tran-
scriptional level and translational level, while incoherent loops contain properties
of both repression and stimulation. Modified from Beisel and Storz, 2010.
1.9 sRNAs and their integration into regulatory networks 35
1.10 sRNA sponges
RNA sponges, or decoys, are species which bind to and antagonise the activity of
regulatory RNAs (Ebert et al., 2007). As such, sponges can act as indirect regulators
of sRNA targets. However, unlike most sRNA-mRNA interactions, sRNA sponging
interactions do not always lead to degradation. The first description of an RNA
sponge was in plants, where phosphate starvation acts to induce expression of the
ncRNA IPS1 and this in turn directly binds miR-399 to inhibit its activity. Indeed,
overexpression of IPS1 leads to accumulation of miR-399 targets (Franco-Zorrilla et
al., 2007). Interestingly, both miR-399 and IPS1 are induced by phosphate starvation
and thus it is their relative transcription and degradation rates that act to dictate
target expression.
The first example of sRNA sponging in prokaryotes was found in S. typhimurium.
The constitutively expressed sRNA ChiX acts to repress the translation of chiP in
the absence of chitooligosaccharides. chiP encodes for a chitoporin required for
the uptake of these sugars, and upon their detection, the chb operon is transcribed.
This operon is involved in chitooligosaccharide metabolism and is subsequently
processed and one of the produced intercistronic fragments then acts as a sponge
against ChiX. This subsequently relieves chiP of its repression (Figueroa-Bossi et al.,
2009). Similarly, in E. coli, the 3’ UTR of pspG acts as a sponge against the sRNA Spf
(Melamed et al., 2016).
Sponges are also capable of affecting the activity of a whole regulon, and therefore
numerous pathways concurrently. In S. typhimurium and E. coli, the sRNA GcvB
is thought to regulate up to 1% of all mRNAs, including major ABC transporters,
amino acid biosynthesis proteins and major transcription factors (Vanderpool, 2011).
However, the processing of one of GcvB’s target polycistrons, gltIJKL, releases an
sRNA sponge, SroC, that binds to GcvB and induces its degradation by RNase E. Thus,
GcvB-mediated destruction of the gltIJKL polycistron acts to eventually downregulate
GcvB, which firstly facilitates gltIJKL translation. This also has wider implications for
the cell as other GcvB targets are then relieved of their regulation (Miyakoshi et al.,
2015).
sRNA sponges as buffers against noise
As sRNAs can act to cause widespread changes within the cell, their expression and
activity must be tightly regulated. An example of such behaviour comes from E.
coli.
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External transcribed spacer (ETS) sequences in tRNAs are excised and usually
degraded immediately. However, an ETS (3’ETSleuZ) produced from RNase E-
mediated processing of the glyW-cysT-leuZ pre-tRNA base pairs with two sRNAs,
RyhB and RybB (Lalaouna et al., 2015). Critically, the production of 3’ETSleuZ does
not respond to the intracellular levels of RyhB or RybB and instead remains constant;
as such, it is predicted to act as a buffer to antagonise transcriptional noise of these
sRNAs. Thus, in order for RyhB or RybB to have functionality within the cell, their
expression must pass a critical threshold which can only be induced by a continuous
and strong stimulus. Overall, the action of such sRNA sponges decreases extrinsic
and intrinsic noise of signalling responses, ensuring they are only activated when
absolutely appropriate. This behaviour is represented graphically in Figure 1.10A.
Sponges as regulators of sRNA activity
Sponges can also act to shape the dynamics of sRNA responses. As discussed
previously, several sRNAs in S. aureus have been shown to be downregulated by
stress and therefore their regulation is likely to be important for adaptation. As
shown in Figure 1.10B, the induction of an antagonistic sRNA sponge could help to
downregulate the activity of an sRNA quicker than simply turning off its transcription
(and could also induce its degradation through recruited RNases).
Sponges can also be used to generate ‘pulses’ of sRNA activity, where a stimulus
induces both the sRNA and also its antagonistic sponge, perhaps utilising a slight
delay. As shown in Figure 1.10C, the sRNA would be able to exert its activity while
the sponge lags behind in expression/activity. However, when the sponge manages
to reach a level that can effectively compete with the sRNA pool, the sRNA response
is downregulated. Such a network could be important for controlling sRNAs with
widespread effects across multiple pathways to ensure that they are effectively
controlled and that they are active only across a limited timeframe.
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Fig. 1.9: The role of sRNA sponges in shaping gene expression profiles. A. sRNA sponges can
act to buffer transcriptional noise of an sRNA, preventing unwanted repercussions
and ensuring that responses only occur upon a strong stimulus. B. sRNA sponges
can act to repress sRNA activity, leading to either rapid inactivation (left hand
side) or a timed response (right hand side). Figure A adapted from Lalaouna et al,
2015, and B and C from Ebert and Sharp, 2010.
Currently, only a few examples of sRNA sponging have been demonstrated in bacteria,
with the most well understood described above. However, it is becoming increasingly
clear that there remains much to be discovered. In enterohemorrhagic E. coli, a study
identified around 150 unique sRNA – sRNA interactions, suggesting that sponging
and induced degradation of sRNAs by sponges could be a common phenomenon
(Waters et al., 2017). Additionally, in S. aureus, RsaOG has been found to bind RsaE,
RsaD and RsaG, although biological significance has yet to be found (Bronesky et al.,
2018; Rochat et al., 2018).
1.11 Identifying sRNA – target interactions in vivo
Depending on one’s definition of what constitutes an sRNA, there are between 50
and 500 in S. aureus. However, the targets of only a few sRNAs have been identified
and validated, and even less is known about the dynamics of these interactions.
Under what conditions does the interaction take place? How does the interaction
respond to cellular stresses and external stimuli? How does the interaction confer a
survival or growth advantage to the cell?
As described in Section 1.8, in silico predictions have been critical in identifying both
sRNAs and their targets. However, predicting targets of sRNAs is difficult as the
interaction region is typically small. Additionally, predictions remain just that until
properly validated in vivo. In silico methods are also susceptible to false positives and
negatives, where they incorrectly predict interactions where they don’t exist and miss
out those that do. Finally, a computational prediction offers no concrete information
about the nature of the regulation, be it positive or negative. To gain genuine insight
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into the global functions of regulatory RNAs, one must use techniques to capture
their interactomes.
CLASH
Several techniques exist to capture sRNA interactomes on a global scale, including
CLASH, MARIO, PARIS, and RILseq (Kudla et al., 2011; Lu et al., 2018; Melamed
et al., 2016; Nguyen et al., 2016). Of interest to this thesis is CLASH (Crosslinking,
lligation and sequencing of hybrids), a technique which uses an RBP as bait for
capturing bound RNAs. Using a proximity-based ligation of basepaired RNAs, CLASH
can identify RNAs in complex with each other. CLASH has already been utilised in
yeast, mammalian cells and E. coli (Helwak and Tollervey, 2014; Iosub et al., 2018;
Kudla et al., 2011; Waters et al., 2017). As such, it is an appropriate technique to
discover novel sRNA – target interactions in S. aureus.
Briefly, CLASH involves expressing an RBP of interest tagged with a tandem affinity
tag, namely an HTP (His6-TEV cleavage site-Protein A) or HTF (His6-TEV cleavage
site-FLAG) tag (Figure 1.11). The recombinant cells are then exposed to 264 nm UV
radiation in order to induce covalent bonds between RBPs and their cognate RNAs.
The protein is subsequently purified using either IgG-agarose beads or anti-FLAG
magnetic beads (dependent upon if HTP or HTF was used) for the primary capture,
eluted using TEV protease, and then captured onto nickel-agarose beads under
highly denaturing conditions. This latter step is crucial as the stringency enacted by
the denaturing conditions ensures that covalently cross-linked RNAs are enriched
and reduces noise by removing background binding to the beads. A fraction of the
RBPs bound to the beads will have bound RNA-RNA duplexes and these duplexes
can be ligated together to form a single molecule through RNA ligation. Sequencing
adaptors are then ligated onto the ends of the RNAs, and then they are eluted from
the protein, reverse transcribed, amplified by PCR and sequenced (Helwak and
Tollervey, 2014; Kudla et al., 2011). The produced sequencing data will then contain
so-called ‘chimeric’ reads which represent two distinct RNAs that were previously
duplexed together. These chimeric reads can be detected using the Hyb pipeline
(Travis et al., 2014). The read sequences can then be folded in silico in order to gain
insight into how the RNA fragments form a duplex.
It is important to note that CLASH is a slightly modified version of an older protocol
termed CRAC (Crosslinking and analysis of cDNAs; Figure 1.11) (Granneman et al.,
2009). CRAC was developed as an improved CLIP protocol, utilising the HTP/HTF
tag to reduce background noise as described above. The main difference between
CRAC and CLASH is that CLASH utilises a dedicated intermolecular ligation step in
order to induce RNA-RNA ligation, while CRAC foregoes this step. The enzymatic
steps in CLASH are usually also done at lower temperatures to ensure that short RNA-
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RNA interactions are preserved during the whole procedure (Helwak and Tollervey,
2014). As a result, the sequencing data from CRAC is a list of single reads which
represent single RNAs bound to the RBP. However, as not all captured RBPs are
bound to RNA duplexes and RNA-RNA ligation is very inefficient, CLASH will also
give ‘CRAC data’, i.e. single reads. Representing this fact, the data obtained from
performing CLASH on RNase E in E. coli contained chimeric reads at a rate of just
1% and around 99% single reads (Waters et al., 2017). Thus, performing CLASH
allows one to detect RNA-RNA interactions but also uncover the RNA targets of a
chosen RBP.
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Fig. 1.10: The CRAC and CLASH methodologies. Both utilise an HTF-tagged RBP as bait,
which is cross-linked to its bound RNAs through UV irradiation. The RBP is
then captured under highly denaturing conditions following lysis. In CRAC,
sequencing adaptors are ligated onto the bound RNAs, which are then isolated,
reverse transcribed, and sequenced. This produces ‘single read’ data, where the
RNAs bound to the RBP are identified. CLASH utilises the same methodologies,
but includes a ligation step where RNA duplexes, such as sRNA-target interactions,
are joined to create a single entity. Thus, CLASH produces chimeric reads, which
can identify RNA interacting partners.
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MAPS
Once an sRNA has been properly identified, one can tag the genetic sequence with
a variety of RNA-based tags. This allows the RNA and its interacting partners to
be pulled down in a very similar manner to that of tagged proteins (Carrier et al.,
2016). One technique that has gained traction in the RNA field is termed MAPS
(MS2-affinity purification coupled with RNA sequencing’) (Lalaouna et al., 2015).
Here, the sRNA of interest is genetically tagged with the MS2 stem-loop aptamer
RNA. This tag is derived from the bacteriophage genome and its usefulness stems
from the fact that it will bind tightly the MS2 coat protein (this protein itself tagged,
traditionally with maltose binding protein). Thus, one can generate a cell lysate
from a tagged strain and apply this to an amylose resin on which MBP-MS2 has been
immobilised. The column can then be washed, the MS2::sRNA-target complexes
eluted with maltose, and then reverse transcribed for RNA sequencing. Additionally,
LC-MS/MS can be performed on the eluates in order to identify protein binding
partners of the sRNA, which can help to identify e.g. chaperones required or RNases
which could imply a degradation event (Lalaouna et al., 2015).
One potential bottleneck of the MAPS technology is that it requires prior knowledge
of an RNA to be an effective bait. Additionally, it operates on a single RNA scale;
although this can give valuable insight into the functionality of a chosen RNA, it
does not give a truly global snapshot of the sRNA networks operating within a cell
in vivo. As discussed in Section 1.8, MAPS has already been applied to RsaA, RsaE
and RsaC in S. aureus to good effect, demonstrating its viability in this organism
(Bronesky et al., 2019; Lalaouna et al.; Tomasini et al., 2017).
1.12 Investigating the role of sRNAs in mediating
adaptation to stress
Several Rsa, Spr and Teg transcripts have already been demonstrated to exhibit
changed expression in response to antibiotic, oxidative, pH and thermal stresses
(Section 1.8). Although these research fields have not been exhausted, it is even
less clear how sRNAs shape the transcriptome in virulent conditions. As detailed
in Section 1.7 and 1.8, RNAIII and SprD have been shown to be crucial players in
regulating virulence-related transcripts. However, the studies that elucidated these
interactions were carried out using static models that do not accurately recapitulate
the environment when S. aureus becomes virulent; they relied on techniques such as
genetic knockouts followed by northern/western blots in rich culture mediums, or
in vitro methods such as ribosomal toeprinting. It still remains unclear how sRNAs
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immediately shape the transcriptome of S. aureus on a global level in response to
virulent conditions.
CLASH is well suited for answering such questions. The Granneman lab has col-
laborated with a private company, UVO-3, to create a system that facilitates the
crosslinking of cells on very short timescales followed by rapid harvesting through
vacuum filtration. This system has already demonstrated its utility in studying how
the yeast S. cerevisiae adapts to glucose deprivation on minute timescales (Nues et
al., 2017). This system was used here in combination with CLASH to study how
sRNAs shape S. aureus’ adaptation to conditions that mimic the stresses incurred
when entering the human bloodstream.
A study by Mäder et al, 2016, used tiling arrays to examine the transcriptome
architecture of cells grown under various conditions. They found that a commercially
available medium, RPMI-1640, induces a very similar response in S. aureus as human
blood plasma, with particular overlap in iron-responsive genes (Mäder et al., 2016).
As such, CLASH was performed on cells exposed to this medium to examine how
sRNAs shape the response to the stresses induced when S. aureus enters the human
bloodstream. By identifying the targets of sRNAs, CLASH acted as a first step in
elucidating the functionality of sRNAs that are active in these conditions, allowing
further experimentation and validation.
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2.1 Bacterial strains and culture conditions
An overview of all E. coli and S. aureus strains used in this study is provided in Table
2.1. The E. coli DH5α strain was used for general plasmid propagation, while the S.
aureus RN4220 strain was used as an intermediate for transforming plasmids into S.
aureus USA300. RN450 was used to produce and harvest phage for transduction of
USA300.
CLASH was performed in the S. aureus strains JKD6008 RNase III::HTF, JKD6008
RNase Y::HTF and USA300 RNase III::HTF. CRAC was performed on USA300
RpoC::HTF. In these strains, the genes encoding for RNase III (rnc), RNase Y (rny)
or RpoC were chromosomally tagged by Pedro Arede Rei with the dual affinity HTF
tag (His6-TEV-3xFLAG). These strains generated through allelic exchange using the
pIMAY plasmid (Monk et al., 2012) with the help of Pedro Arede Rei.
Both JKD6008 strains were provided by Jai Tree (UNSW, Sydney), USA300 and
RN450 were provided by Ross Fitzgerald (Roslin Institute, Edinburgh), and RN4220
by Baolin Sun (University of Science and Technology of China, China).
For plasmid propagation, E. coli DH5α were grown in lysogeny broth (LB) at 37°C
with shaking at 200 rpm. The medium was supplemented with either ampicillin
(100 µg/mL) or chloramphenicol (25 µg/mL) when required. Overnight cultures were
grown in 5 mL volumes and purified with a miniprep kit according to manufacturer’s
instructions (ThermoFisher).
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Tab. 2.1: Strains used in this study
Strain Genotype Reference
E. coli DH5α fhuA2 lac(del) U169 phoA
glnV44 80’ωlacZ(del)M15
gyrA96 recA1 relA1 endA1
thi-1hsdR17
Taylor et al, 1993
S. aureus RN4220 Restriction-deficient deriva-





Encodes for 80α phage under





Prototype MRSA strain, ST8,
β-lactamase positive
McDougal et al,




















2.2 Shift experiments and UV crosslinking
Cells were firstly plated out onto TSA from a glycerol stock and a single colony
was inoculated into 5 mL of TSB and grown overnight at 3737◦C with shaking.
This overnight culture was then diluted 1:500 into 500 mL of TSB and grown until
OD600=3 with the same conditions.
For CLASH, a 65 mL aliquot of the culture was taken at OD600=3 and crosslinked in a
Vari-X-Linker (UVO3) with 250 mJ of UV. The cells were then quickly harvested with
a vaccuum filtration device (UVO3) and flash-frozen in liquid nitrogen. Afterwards,
another 65 mL aliquot was was harvested through vacuum filtration and then were
resuspended in 65 mL of RPMI medium (Gibco). After 15 minutes, the cells were
crosslinked and harvested as described above.
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For the RNAseq and qPCR experiments, the experimental set up was similar. 50 mL
of culture was shifted to RPMI and samples were then taken after 5, 10, 15 and 30
minutes, plus a time zero (before shift) reference sample. 5 mL of culture was taken
and harvested through centrifugation at 13,000 g for 1 minute at room temperature
in 5 mL tubes.
As a control in the qPCR and RNAseq experiments, an independent experiment where
the cells were resuspended back into their own TSB supernatant was performed in
order to study any mechanical stresses as a result of the shift.
The composition of TSB as follows; tryptone 17 g/L, soytone 3.0 g/L, glucose 2.5
g/L, sodium chloride 5 g/L, dipotassium phosphate 2.5 g/L. The composition of
RPMI can be found on the ThermoFisher website, reference R7513.
2.3 Construction of pIMAY plasmids for HTF
tagging
Table 2.2 lists the plasmids used and constructed, Table 2.3 lists the primers, and
Table 2.4 all gene fragments used in in this study. This includes those for the
construction of pIMAY plasmids required for tagging genes with the HTF tag.
Tab. 2.2: Plasmids used in this study




ing HTF tag sequence
Ampr Nues et al., 2017
pIMAY
Vector for allelic ex-
change in S. aureus
Cmr, pWV01ts replicon Monk et al., 2012
pUC19
Cloning vector and tem-







ing sfGFP under a pTufA
constitutive promoter
Emr, pT181 replicon Ivain et al., 2017
pICS3
Shuttle vector for sRNA
expression
Cmr, pC194 replicon Ivain et al., 2017
pRMC2







Cloning vector for blunt-
end ligation of PCR
products and gBlocks
Ampr, pBR322 replicon ThermoFisher
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For tagging genes with the HTF tag, Gibson assembly was used to create the required
plasmid. Firstly, a forward primer was designed to anneal to the sequence 500
basepairs upstream of the natural stop codon of the target gene, and a sequence
designed to overlap with the pIMAY plasmid, upstream of the KpnI site, was added
to the 5’ end (Table 2.3, pIMAY fw). A reverse primer was then generated to amplify
this sequence, finishing on the nucleotide immediately before the stop codon. To
this reverse primer, a sequence designed to overlap with the HTF tag was added to
the 5’ end (Table 2.3, HTF overlap 1).
Secondly, primers were designed to amplify the HTF tag from the pBS1539::HTF
plasmid. The forward primer was designed with a 20 nucleotide overlap of sequence
immediately before the stop codon of the gene to be tagged. The reverse primer was
then designed to contain the natural stop codon and then 17 nucleotides upstream of
it. To these sequences, HTF fw and HTF rev (Table 2.3) were added respectively.
Thirdly, a reverse primer was designed to anneal to the sequence 500 basepairs
downstream of the natural stop codon of the target gene, and a sequence designed
to overlap with pIMAY downstream of the KpnI site was added (Table 2.3,pIMAY rev
1). A forward primer, starting at the natural stop codon, was designed to amplify
this sequence and contained a 20 nucleotide overlap with the HTF tag (Table 2.3,
HTF overlap 2).
The PCRs were performed using Q5 polymerase (NEB) with the manufacturer’s
recommended conditions. The annealing temperature was calculated through use
of a Tm calculator (NEB, https://tmcalculator.neb.com/). PCR products were then
resolved on an agarose gel and the band of interest gel purified using the MinElute
gel extraction kit (Qiagen). In order to assemble the fragments into pIMAY, 2 µg of
the plasmid backbone was first digested with 2 U of KpnI-HF (NEB). The fragments
were then assembled into pIMAY using the Gibson Assembly Mastermix (NEB)
according to manufacturer’s instructions. The Gibson Assembly products were then
transformed into E. coli DH5α, single colonies were then grown, the plasmids purified
and finally confirmed via sequencing.
Tab. 2.3: Primers
Oligonucleotide name Sequence (5’ to 3’) Purpose
pIMAY fw 1 TCACTAAAGGGAACAAAAGC
TGG
Overlaps pIMAY up-
stream to the digested
KpnI site.
HTF overlap 1 ATAATCATGGTGATGGTGAT
GGTGCTCCATGGATCC
Overlaps with the start
of the HTF tag
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Tab. 2.3: Primers
Oligonucleotide name Sequence (5’ to 3’) Purpose
HTF fw GGATCCATGGAGCACCATCA Amplifies HTF tag
HTF rev ACGCGGCCGCAGAATTCTCA Amplifies HTF tag
HTF overlap 2 GATGACGACGATAAAGACTA
CAAAGATGACGACGATAAAT
Overlaps with the end
of the HTF tag
pIMAY rev 1 GTCGACCTCGAGGGGGGGC
C
Overlaps pIMAY up-
stream to the digested
KpnI site












RNase III 501-656 fw TATAAGCAATTAAAACAAAT
TAAAGGATCCATGGAGCACC
ATCA
Generates HTF tag with
RNase III overlap
RNase III 501-656 rev GTCGTATCATATAAATTTCT
AACGCGGCCGCAGAATTCTC
A
Generates HTF tag with
RNase III overlap













ment for RNase Y::HTF




RNase Y 501-656 fw TAGAGCAGTAGAATATGCGA
AAGGATCCATGGAGCACCAT
CA
Generates HTF tag with
RNase Y overlap
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Tab. 2.3: Primers
Oligonucleotide name Sequence (5’ to 3’) Purpose
RNase Y 501-656 rev CTAATTTGTGAGGGAGACAA
AAATTAACGCGGCCGCAGAA
TTCTCA
Generates HTF tag with
RNase Y overlap


















RpoC 501-656 fw AATCTCAAACTGAAGTAACG
GAAGGATCCATGGAGCACCA
TCA
Generates HTF tag with
RpoC overlap
RpoC 501-656 rev ATTAGCCTCTGTTATATACT
TGTTACTCACGCGGCCGCAG
AATT
Generates HTF tag with
RpoC overlap






















for cloning into pRMC2
and pICS3
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Tab. 2.3: Primers













for cloning into pRMC2
and pICS3








Tab. 2.4: Gene fragments used in this study
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Tab. 2.4: Gene fragments used in this study
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2.4 Construction of inducible sRNA expression
plasmids
For inducible expression of RsaA and RNAIII, the pRMC2 expression vector was used
(Corrigan and Foster, 2009). This utilises a pTetO promoter which induces gene
expression upon addition of anhydrotetracycline.
For cloning RsaA and RNAIII into pRMC2, PCR was used to amplify the sequence
from isolated genomic DNA using the respective primers (Table 2.3). The PCR was
carried out as previously described in Section 2.2, and the products were resolved
on an agarose gel and the band of interest purified. The produced RsaA and RNAIII
fragments were then blunt-end cloned into pJET1.2, transformed into DH5α and
confirmed via sequencing following purification.
The inserts were then cut out of pJET1.2 using 3 U of EcoRI-HF and 3 U of KpnI-HF
(NEB) in reactions containing 3 µg of recombinant plasmid. Digests were carried
out at 37◦C for 1 hour. Concurrently, 3 µg of pRMC2 was digested in the same way,
and then dephosphorylated for 1 hour at 37◦C using 1 U of rSAP (NEB). Following
digestion, all reactions were resolved on an agarose gel, and digested pRMC2 and
isolated RsaA and RNAIII fragments were purified using the MinElute gel extraction
kit.
Following extraction, RsaA and RNAIII were ligated into pRMC2. Ligations were
set up using 50 ng of digested pRMC2, and inserts were added in 3:1 ratios, with
400 U of T4 DNA ligase. Reactions were left overnight at 16◦C, and subsequently
transformed into DH5α. Plasmids were purified from single colonies and screened
through restriction digest using KpnI-HF and EcoRI-HF, as described above.
2.5 Construction of mRNA-GFP fusion and partner
sRNA plasmids
For examining the role of selected sRNAs in regulating the translation of chosen
targets, sRNAs were cloned with the pTufA promoter into pICS3, while a portion of
the 5’ UTR and coding sequence of the target was cloned into pCN33-GFP.
Generation of pICS3::RsaA and pICS3::RNAIII was performed as described in Sec-
tions 2.2 and 2.3. Importantly, the produced products included a constitutive
promoter, pTufA, when utilising the PstI and EcoRI sites.
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For producing the GFP fusions in pCN33, gene fragments were designed to include
around 80 nucleotides of the 5’ UTR, the start codon, and 30 nucleotides of the
coding sequence. These gene fragments were cloned into pJET1.2, transformed into
DH5α and confirmed by sequencing. The inserts were then excised using EcoRV and
PstI, and ligated into pCN33 as described in Section 2.3.
2.6 Construction of in vitro transcription plasmids
For producing in vitro transcribed RNA, chosen sRNAs were cloned into the pUC19
plasmid. This plasmid was used due to its lack of T7 promoter and high copy
number.
Chosen sRNA constructs were designed to include for a BamHI site at the 5’ end,
followed by a T7 promoter, the sRNA sequence, a XhoI site, and finally ending in a
SalI site. The BamHI and SalI sites are used for cloning into pUC19, while the XhoI
site is used for linearising the plasmids for transcription.
The constructs for RsaA, RNAIII interacting, RNAIII non-interacting, RNAIII, RsaE,
RsaOG, 09902, 09903 and 5S are shown in Table 2.4, and were ordered from IDT as
gBlocks. Two mutant versions of RsaE in which one or both of the CCC motifs were
mutated to GGG (RsaE single mutant and RsaE double mutant) were also produced
in order to study their roles in mediating the interaction between PSMs and RsaE.
These gene fragments were cloned into pUC19 as described above and in section
2.3.
2.7 Genomic DNA extraction
Extraction of genomic DNA from S. aureus was accomplished through the Bacterial
Genomic DNA Extraction Kit (EdgeBio) according to manufacturer’s instructions,
with one modification. From an overnight culture, 1 mL of cells were harvested
through centrifugation at 13.4K for 1 minute. The supernatant was decanted, and
the pellet resuspended in 100 µl of the kit’s spheroplast buffer. To this, 5 µl of 10
mg/mL lysostaphin (Prospect Bio) solution was added and incubated for 1 hour at
37°C in order to degrade the outer cell wall. The manufacturer’s instructions were
subsequently followed, with the final DNA pellet resuspended in 50 µl of water.
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2.8 E. coli chemically competent cell generation
and heat shock transformation
Chemically-competent E. coli cells were produced using the Inoue method. Briefly, a
single colony was inoculated into 25 mL of LB and grown overnight at 37◦C, shaking
at 200 rpm. This overnight culture was then used to inoculate 250 mL of LB. The
culture was then grown overnight at 18◦C, shaking at 200 rpm.
Culture growth was continued until a final OD600 value of 0.5, and afterwards the
cells were transferred to an ice water bath for 10 minutes. The cells were then spun
for 10 minutes at 4,600 g, 4◦C, and the supernatant was decanted and residual
medium removed with a pipette. The cells were then resuspended in 80 mL of
ice-cold Inoue transformation buffer (55 mM MnCl2.4H2O, 15 mM CaCl2.2H2O, 250
mM KCl, 10 mM PIPES). The cells were then collected again through centrifugation
and subsequently resuspended into 20 mL of Inoue transformation buffer, and 1.5
mL of DMSO was added and the cells left on ice for 10 minutes. The cells were then
aliquoted and flash-frozen in liquid nitrogen before being stored at -80◦C.
For transformation, 100 µl of cells were thawed on ice for 10 minutes. The plasmid
to be transformed was then added (1 µl for whole plasmids, or 10 µl for ligation
products) and the samples left on ice for 30 minutes. The cells were then heat
shocked at 42◦C for 60 seconds, left on ice for 2 minutes, and then recovered
through addition of 800 µl of SOC medium and incubation at 37◦C for 1 hour with
shaking. Cells were subsequently pelleted through centrifugation at 3,000 g for 3
minutes, before being resuspended in around 200 µl of residual medium and plated
onto LB agar with the appropriate antibiotic. Cells were then grown overnight at
37◦C.
2.9 S. aureus electrocompetent cell generation and
electroporation
S. aureus RN4220 was plated out onto TSA (Oxoid) and a single colony was inoc-
ulated into 5 mL of TSB (Oxoid) and grown overnight at 37◦C. The next day, this
overnight culture was diluted 1:500 into 500 mL of TSB and grown to OD600 =
0.5.
The cells were then transferred to an ice-water bath for 10 minutes and collected
afterwards through centrifugation at 4600 g for 10 minutes at 4◦C. The cell pellet
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was resuspended in 50 mL of ice cold 0.5 M sucrose, and then the cells were
collected again through centrifugation. The supernatant was subsequently discarded
and the cells resuspended in 25 mL of sucrose. The cells were then left on ice for
20 minutes before being collected again. The supernatant was discarded and the
cells resuspended in 500 µl of sucrose. Aliquots of 50 µl were then dispensed and
flash-frozen in liquid nitrogen, and stored at -80◦C until use.
Competent cells were thawed on ice when required for 10 minutes. For routine
plasmids, 250-500 ng of plasmid was added to the cells in a volume no more than
5 µl. The cells were then transferred to an ice-cold 0.1 cm cuvette (BioRad) and
pulsed in a BioRad cell-pulser with the following conditions: 200 ω, 25 µF, 2.1 kV.
Immediately after electroporation, the cells were recovered in 1 mL of prewarmed
TSB and grown for 1 hour at 37◦C, before being pelleted and plated out onto TSA
with the appropriate antibiotic as previously described.
For pIMAY constructs, plasmids were concentrated to around 5 µl/µg and 10 µl of
plasmid was used for electroporation. The plasmids were electroporated as described
above, but the cells recovered in TSB for 2 hours at 30◦C. Following plating onto
TSA-chloramphenicol 5 µg/mL, the cells were grown for 48-72 hours at 30◦C.
2.10 Phage transduction of USA300
Phages were generated using the RN450 strain. First, cells were plated onto TSA
and grown overnight at 37◦C. Afterwards, a single colony was inoculated into 5
mL of TSB and grown overnight at 37◦C with shaking at 200 rpm. The following
day, 250 µl of overnight culture was inoculated into 25 mL of TSB and grown until
OD600 = 0.3. Mitomycin C was added to a final concentration of 2 µg/mL in order
to induce phage production and the cells shaken slowly with 80 rpms at 32◦C until
completely lysed. The phages were then filtered through a 0.4 µm filter and stored
at 4◦C until use.
The plasmid to be transduced into USA300 was firstly electroporated in RN4220
as described in Section 2.8. The produced RN4220::pDNA strain was then grown
overnight at 37◦C on a BHI slant (Oxoid). The cells were then resuspended in 1 mL
of TSB, and CaCl2 was added to a final concentration of 5 mM. To six Falcon tubes,
10 µl of these cells were added.
The phages were then serially diluted in phage buffer (1 mM MgSO4, 4 mM CaCl2,
50 mM Tris pH7.8, 100 mM NaCl, 0.1% gelatin) from 10-3 to 10-8, and 10 µl of each
dilution was added to a 15 mL Falcon tube containing the cells. Afterwards, 3 mL
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of liquid phage top agar (0.3% casamino acids, 0.3% yeast extract, 100 mM NaCl,
0.5% agar) was added and the cells poured and spread onto 20 mL plates of phage
bottom agar (0.3% casamino acids, 0.3% yeast extract, 100 mM NaCl, 1.5% agar).
The plates were then incubated overnight at 30◦C, and USA300 was also inoculated
onto a BHI slant to grow overnight at 37◦C.
The transduction plate that gave near-confluent lysis was then selected and 2 mL
of phage buffer was added. The plate was left at 4◦C for 1 hour, and then the top
layer of agar was scraped off and put into a Falcon tube, along with the phage buffer.
This was then centrifuged at 4600 g for 30 minutes at 4◦C, and then the supernatant
collected and filtered twice through 0.4 µm filters. These plasmid-containing phages
were then stored at 4◦C until use.
The USA300 cells grown on the BHI slant were recovered in 1 mL of TSB and
CaCl2 was added to a final concentration of 5 mM. Afterwards, 50 µl of these cells
were added to a Falcon tube containing 150 µl of phage buffer, and then 50 µl of
plasmid-containing phages were added. The Falcon tubes were then moved to a
37◦C incubator for 20 minutes, shaking at 200 rpm. Afterwards, 3 mL of liquid 0.3
GL top agar (0.3% casamino acids, 0.3% yeast extract, 100 mM NaCl, 0.15% sodium
lactate, 0.1% glycerol, 1.5 mM trisodium citrate, 0.5% agar, pH 8) was added and
then the cells poured over 20 mL plates of 0.3 GL bottom agar (0.3 GL top agar
but with 1.5% agar) containing the appropriate antibiotic. The plates were then
incubated overnight at 37◦C and single colonies chosen for validation.
2.11 Colony PCR
Colony PCR was used on S. aureus in order to confirm the presence of pIMAY. A
portion of the colony of interest was resuspended in 100 µl of lysis buffer (20 mM
Tris pH 8, 3 mM MgCl2, 0.5% Tween 20, 0.5% NP-40, 60 µg/µL proteinase K) and
then incubated at 55◦C for 1 hour, followed by an incubation at 95◦C for 10 minutes.
The contents were then centrifuged at 20000 g for 10 minutes in order to pellet
cell debris, and then PCR was performed using 5 µl of the supernatant and Taq
polymerase as per the manufacturer’s instructions (NEB).
2.12 FACS sorting
pCN33-GFP and its derivatives were transformed into RN4220 by electroporation
as previously described. Electrocompetent cells were prepared from the resulting
transformants and pICS3:: RsaA or pICS3::RNAIII were transformed by electropora-
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tion. Single isolated colonies were inoculated into 5 mL of BHI and grown at 37◦C
overnight, shaking at 200 rpm.
Cultures were diluted the day afterwards 1:40 into 2 mL of phosphate buffered
saline. Translation of GFP fusions was monitored on the LSRFortessa Special Order
Research Product (BD) from a 500 µl aliquot of PBS-diluted samples on a 530/30
nm bandpass filter. Sample acquisition of 100,000 events was performed on the
built-in Diva (LSRFortessa SORP) software. Median fluorescence intensity (MFI) was
determined using the FlowJo software where FSC and SSC were used to gate any
fluorescence attributed to cellular background. The average median fluorescence
intensity and standard deviations were calculated and plotted. These experiments
were performed by Julia Wong in Jai Tree’s group.
2.13 S. aureus genetic manipulation using pIMAY
Following pIMAY electroporation into RN4220, single colonies were selected and
grown in TSB at 30◦C overnight. Plasmid-containing phages were then generated
and transduced into USA300 as described in Section 2.9, with the modification that
overnight growth was performed at 30◦C. Colonies were then screened through
colony PCR using pIMAY MCS fw and pIMAY MCS rev to confirm the presence of
replicating pIMAY in the cytosol.
Integration of the plasmid into the chromosome was then forced through growth
in TSB-Cm at 37◦C for 48 hours, and then re-inoculating into fresh TSB-Cm and
growing again at 37◦C for 24 hours. The culture was then serially diluted from
10-1 to 10-4, and 50 µl of each dilution plated out onto TSA-Cm. Plates were grown
overnight at 37◦C, and then colonies were screened for integration of pIMAY into the
chromosome through colony PCR. Potential integrants were screened for integration
at the 5’ end of the gene of interest through a forward primer designed to anneal
550 basepairs upstream of the gene, amplified using the MCS rev primer. Integration
at the 3’ end of the gene of interest was tested through a reverse primer designed to
anneal 550 basepairs upstream of the gene, amplified using the MCS fw primer.
Once integration into the chromosome was confirmed, excision of the pIMAY back-
bone was forced through growth at 30◦C for 4 days in TSB. Following this, the
culture was serially diluted from 10-1 to 10-4 and 50 µl of each dilution was replica-
plated out onto TSA and TSA-Cm and grown overnight at 37◦C. Colonies which
grew on TSA but not on TSA-Cm were then screened for loss of the pIMAY plasmid
through colony PCR with MCS fw and MCS rev primers. Colonies confirmed to be
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negative for pIMAY were then tested for successful HTF tag integration through
Western blotting or qPCR in the case of sRNA deletion.
2.14 Northern blotting
Cells were harvested in 5 mL Eppendorf tubes and collected via centrifugation at
20000 g for 1 minute. Cells were resuspended in 550 µl of GTC-phenol and lysed via
vortexing with 100 µl of zirconia beads (Biospek Products). RNA was then extracted
through acid guanidinium thiocyanate-phenol-chloroform extraction as described in
Chomczynski and Sacchi, 1987.
RNA was resolved on an 8% polyacrylamide TBE-urea gel and then transferred to
a nitrocellulose membrane through electroblotting for 4 hours at 50 V. RNA was
then crosslinked to the membrane through exposure to 1200 mJ of 254 nm UV
radiation.
For hybridisation, membranes were firstly prehybridised in 7 mL of UltraHyb (Am-
bion) for 1 hour at 42◦C. A DNA primer was concurrently radiolabelled using 3µL of
32P-γATP (Perkin Elmer) and 30 U of T4 PNK (NEB), afterwards being cleaned up
through a Quick Spin Oligo Column (Roche). Following prehybridisation, the radio-
labelled probe was added to the UltraHyb and left to hybridise overnight at 42◦C.
Membranes were then washed twice in 2xSSC with 0.5% SDS for 10 minutes, before
rinsing briefly in 2xSSC. Membranes were then imaged using a phosphorimager
screen and FujiFilm FLA-5100 scanner using the IP-S filter. For 5S rRNA, imaging
was also performed through radiosensitive film (GE Healthcare).
Probes for northern blotting used in this study are detailed in Table 2.5.
Tab. 2.5: Oligonucleotide used for Northern blots
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2.15 In vitro RNA transcription and RNA
radiolabelling
10 µg plasmid was first linearised with 10 U of XhoI for 2 hours at 37◦C and then
isolated after being ran on an agarose gel. In vitro transcription was then carried out
using a MEGAscript T7 transcription kit (ThermoFisher) as per the manufacturer’s
instructions. Briefly, the reagents were thawed on ice and then transcription reactions
set up using 2 µg of plasmid as a template in a 20 µl volume. Reactions were incubated
at 37◦C for 2 hours. Afterwards, 3 µl of 10X TURBO DNase buffer and 25 µl of water
were added, followed by 4 U of TURBO DNase in order to degrade the plasmid.
The RNA was then purified through addition of RNAClean XP beads and processed
as per the manufacturer’s instructions (Beckman Coulter). The beads were finally
resuspended in 11 µl of structure buffer (25 mM Tris pH 7.5, 150 mM KCl, 1 mM
MgCl2). In order to check the purity of produced RNA, 1 µL was resolved on a 6%
polyacrylamide TBE-urea gel and stained with SYBR Safe.
To radiolabel RNA samples, 1 µg of RNA was firstly dephosphorylated using 1 U of
TSAP (Promega). The RNA was then purified using RNAClean XP beads and eluted
in 10 µl of water. The dephosphorylated RNA was then radiolabelled using 10 U of
T4 PNK and 3 µl of 32P-γATP (Perkin Elmer) for 1 hour at 37◦C. The RNA was again
purified using RNAClean XP beads, and resuspended in 10 µl of 1X FA dye (NEB).
The RNA was then heat denatured at 85◦C for 3 minutes and snap-chilled on ice for
5 minutes before being resolved on a 6% polyacrylamide TBE-urea gel. The RNA
was imaged through radiography, and the radioactive band excised and extracted
by shaking in extraction buffer (20 mM Tris pH 7.5, 100 mM NaOAc, 10 mM EDTA,
0.1% SDS). Finally, the RNA was purified through phenol:chloroform extraction as
described previously and resuspended in structure buffer. The concentration was
obtained through use of a Qubit 4 and the RNA broad spectrum dye (Invitrogen).
2.16 Electrophoretic mobility shift assays
The RNAs of interest, generated through in vitro transcription as described above,
were first refolded in a thermal cycler by heating to 95◦C for 1 minute, then cooled
slowly to 25◦C and finally incubated at 25◦C for 20 minutes. Binding reactions
between the radiolabelled mRNA and cold sRNA were then set up in 1:0, 1:5, 1:10,
1:20, 1:80 and 1:320 molar ratios of mRNA:sRNA, and incubated at 25◦C for 20
minutes. Native loading buffer was added to a 1X concentration (10% sucrose, 0.1X
TBE, 0.04% bromophenol blue) and then RNA complexes were resolved on an 6%
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acrylamide TBE gel, running at 400 V for 2 hours. The gel was then dried under
vacuum for 1 hour at 80◦C and imaged as described in section Northern blotting.
2.17 Structure probing
In vitro transcription was used to generate 1 µg of RNAIII interacting and RsaA as
previously described. The RNA was then refolded through incubation at 95◦C for
1 minute, and then cooled slowly to 25◦C over 2 minutes, and incubated at 25◦C
for 15 minutes. The SHAPE reagent 2-methylnicotinic acid imidazolide (NAI) was
then added to a final concentration of 50 mM, and the reaction left to proceed for
20 minutes at room temperature.
This modified RNA was then used as an input for reverse transcription using Super-
Script III (Invitrogen) using a 32P-radiolabelled primer. Primers were annealed to
the RNA through heating to 85◦C for 3 minutes, followed by snap-chilling on ice.
The reverse transcription was then performed for 1 hour at 45◦C and afterwards
treated with 25 U of RNase If (NEB) for 30 minutes at 37◦C. The reaction was
stopped through addition of 2X RNA loading dye (NEB). Sequencing ladders were
generated using the Sequenase v2.0 kit (Affymetrix) according to the manufacturer’s
instructions, utilising plasmid used for the original in vitro transcription. Samples
were then resolved on a 6% polyacrylamide TBE-urea gel, dried under vacuum for
1 hour at 80◦C and then imaged using a phosphorimager screen and a FujiFilm
FLA-5100 scanner
2.18 CLASH
Described here is the final CLASH protocol following optimisation.
S. aureus strains expressing chromosomally tagged RNase Y and RNase III were
grown overnight in TSB at 37◦C with shaking at 200 rpm. This starter culture was
then diluted 1:500 in fresh TSB and regrown to OD600=3. As a control, an untagged
parental strain was used to examine background protein binding to the antibody
and nickel beads.
Cells were then crosslinked and harvested as described in Section 2.2. For CLASH
libraries, cells were shifted to RPMI for 15 minutes and crosslinked with 250 mJ of
254 nm UV radiation. Following harvesting, the filters were stored in Falcon tubes at
-80◦C until required.
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Cells were harvested from the filters through two washes with 10 mL of PBS, and
then pelleted through centrifugation at 4600 g for 10 minutes, 4◦C. The supernatant
was discarded and the cell pellets weighed. The pellets were then resuspended
in 2 volumes of TN150-lysostaphin (50 mM Tris pH 7.8, 150 mM NaCl, 100 µgµL
lysostaphin, 0.1% NP-40, 0.5% Triton X-100), and 60 U of DNase RQ1 (Promega)
and 200 U of SUPERasin (Invitrogen) were added. The cells were then incubated for
1 hour at 20◦C in order for the lysostaphin to degrade the outer cell wall. The cells
were then transferred to 15 mL Falcon tubes and lysed through bead beading with
0.1 mm zirconia beads (Biospek Products) for 5 minutes, and 2 volumes of TN150
antipeptidase was then added (50 mM Tris pH 7.8, 150 mM NaCl, 0.1% NP-40, 0.5%
Triton X-100, 10 mM EDTA, 1 mini cOmplete protease inhibitor per 10 mL (Roche))
The beads were then separated from the lysate by centrifugation at 4600 g for 20
minutes at 4◦C and then the lysate transferred to Eppendorfs. The insoluble and
soluble fractions of the lysate were then separated through centrifugation at 20000
g for 20 minutes at 4◦C.
Magnetic anti-FLAG M2 beads (Sigma Aldrich) were washed three times in TN150
(50 mM Tris pH 7.8, 150 mM NaCl, 0.1% NP-40, 0.5% Triton X-100), with 75 µl
taken for each sample. The beads were resuspended in a noted volume, dependent
upon the number of samples, and distributed equally between the cleared lysates.
The beads were then incubated with the lysate for 2 hours at 4◦C with rotation.
Following capture, the beads were washed three times in TN1000 (50 mM Tris pH
7.8, 1 M NaCl, 0.1% NP-40, 0.5% Triton X-100) for 10 minutes at 4◦C with rotation.
The beads were then rinsed three times in TN150, and then resuspended in a final
volume of 250 µl TN150. In order to cleave the RNases from the FLAG beads, 10 µl
of homemade TEV protease was added, and the samples incubated for 2 hours at
room temperature with rotation.
Following cleavage, an extra 350 µl of TN150 was added to the samples and the
eluate collected following separation from the beads using a magnetic rack. The
eluates were then RNase digested through incubation for 7 minutes at 20◦C with 1 µl
of a 1:100 dilution of RNace-It (Agilent). The RNase digestion was stopped through
the addition of 0.4 g of guanidium hydrochloride (GuHCl, Sigma Aldrich). Following
digestion, 100 µl of nickel-NTA agarose beads (Qiagen) was added, prewashed in
wash buffer 1 (50 mM Tris pH 7.8, 0.1% NP-40, 5 mM β-mercaptoethanol, 0.5%
Triton X-100, 300 mM NaCl, 10 mM imidazole, 6M GuHCl) and proteins were
captured overnight.
The capture solutions were then transferred to Pierce spin columns and the beads
washed three times with wash buffer 1 and three times with NP-PNK (50 mM
Tris pH 7.8, 0.1% NP-40, 5 mM β-mercaptoethanol, 0.5% Triton X-100, 10 mM
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MgCl2). Afterwards, the RNAs were dephosphorylated on-column using 4 U of TSAP
(Promega) in the presence of 80 U of rRNasin (Promega) in 1X PNK buffer (50
mM Tris pH 7.8, 10 mM MgCl2, 10 mM β-mercaptoethanol, 0.1% Triton X-100)
for 1 hour at 20◦C. The beads were then washed once with wash buffer 1 in order
to inactivate the enzyme and then three times with NP-PNK to remove residual
guanidium. The RNAs were then radiolabelled at the 5’ end using 30 U of T4 PNK
and 3 µl of 32P-ATP in 1X PNK buffer for 100 minutes at 20◦C, after which cold ATP
to a final concentration of 1 mM was added and the reaction left to proceed for
another 40 minutes in order to ensure complete phosphorylation of the RNAs at the
5’ end. Following phosphorylation, the beads were washed three times with wash
buffer 1 and three times with NP-PNK.
In order to increase the number of chimeric reads attained, a dedicated intermolecu-
lar ligation step was performed. In this, 15 U of T4 RNA ligase 1 was used to ligate
the 5’ end of one RNA to the 3’ end of one in complex with it. This reaction was
carried out in the presence of 40 U of rRNasin and 1 mM ATP, and left to proceed
for 2 hours. Afterwards, the beads were washed once with wash buffer 1 and three
times with NP-PNK.
Sequencing adaptors were then ligated to the ends of the RNAs. First, an L5 adaptor
was ligated to the 5’ end using 200 µmoles of adaptor and 40 U of T4 RNA ligase,
in the presence of 80 U of rRNasin and 1 mM ATP in 1X PNK buffer, for 16 hours
at 16◦C. The beads were subsequently washed once with wash buffer I, and three
times with NP-PNK. Afterwards, 60 µmoles of App_PE adaptor was ligated onto the
3’ end using 600 U of T4 RNA Ligase 2 truncated K227Q (NEB). This reaction was
carried out in 1X PNK buffer with 10% PEG-8000 and 30 U of rRNasin for 6 hours at
25◦C. Afterwards, the beads were washed once in wash buffer I and three times in
wash buffer two (50 mM Tris pH 7.8, 10 mM β-mercaptoethanol, 0.1% NP-40, 0.5%
Triton X-100, 50 mM NaCl, 10 mM imidazole).
The protein-RNA complexes were then eluted from the beads through addition of
200 µl of elution buffer (wash buffer two with 250 mM imidazole), repeated for a
total of two times. The proteins were then pooled and precipitated through addition
of trichloroacetic acid (Sigma Aldrich) to a final concentration of 20%, and left to
precipitate on ice for 20 minutes. The samples were then centrifuged at 20000 g
for 20 minutes at 4◦C. The pellets were then washed with 800 µl of acetone and
dried for two minutes in a fume hood, before being dissolved in 20 µl of 1X NuPAGE
buffer (Novex) and resolved on a 4-12% Bis-Tris gel. The protein-RNA complexes
were visualised through autoradiography as described previously and the gel piece
containing these excised. The RNAs were then extracted through incubation in 4
mL of extraction buffer (50 mM Tris pH 7.8, 0.1% NP-40, 5 mM β-mercaptoethanol,
1% SDS, 5 mM EDTA, 50 mM NaCl, 60 µg/µL proteinase K) at 55◦C for 2 hours.
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Following this, the RNAs were purified through phenol:chloroform extraction as
previously described and the RNA resuspended in 20 µl of DEPC-water.
The RNAs were afterwards reverse transcribed using the PE_reverse primer and
SuperScript IV according to the manufacturer’s instructions. The template RNA was
subsequently degraded through addition of 10 U of RNase H (NEB). Afterwards, the
cDNA was purified through RNAClean XP beads and resuspended in a final volume
of 11 µl. Half of this cDNA was then used a template for PCR using Pfu polymerase,
using a BC and the P5 primers. The cycling conditions were as follows: 95◦C for 2
min; 24 cycles of 95◦C for 20s, 52◦C for 30s and 72◦C for 1 min; final extension
of 72◦C for 5 min. The PCR product was treated with 40 U of Exonuclease I (NEB)
in order to degrade free primer and the DNA library purified using RNAClean XP
beads. The library was then resolved on a 2% MetaPhor (Lonza) gel and 175-300 bp
fragments were excised and gel extracted through a MinElute column. The library
was quantified using a 2100 Bioanalyzer and a DNA HS assay (Agilent).
Individual libraries were then pooled together to produce an equimolar solution
and sequenced through paired-end sequencing on an Illumina HiSeq 4000 platform
(Edinburgh Genomics).
All L5 and BC adaptors are described previously (Iosub et al, 2019).
2.19 Western blotting
Western blotting was used to analyse the efficiency of protein capture when optimis-
ing CLASH. Samples for western blotting were taken after cell lysis, lysate clearing,
and TEV elution. Samples were resolved on a homemade 8% polyacrylamide gel
and transferred to a nitrocellulose membrane for 2 hours at 100V. Membranes were
blocked for 1 hour in blocking solution (5% non-fat milk, 0.1% Tween-20 in 1X
phosphate-buffered saline). Primary antibody probing was performed overnight at
4◦C using a rabbit anti-TAP antibody (1/5000, ThermoFisher). The membrane was
then washed in PBST (PBS with 0.1% Tween-20) for 10 minutes, three times. In
order to detect the primary antibody, an HRP-linked goat anti-rabbit antibody (1/500,
Abcam) in blocking solution was incubated with the membrane for 1 hour at room
temperature. The membrane was washed again three times with PBST, rinsed in PBS
and imaged using Pearce enhanced chemiluminescence solutions (ThermoFisher)
according to the manufacturer’s instructions.
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While optimising CLASH, the protein-RNA complexes were blotted onto nitrocellu-
lose using an iBlot (Invitrogen), and the proteins visualised by Western blotting after
autoradiography using the method described above.
2.20 CRAC
CRAC was carried out on S. aureus USA300 rpoC::HTF. This was performed in a
nearly identical way as the CLASH protocol, with the only differences being that the
lysostaphin treatment, TSAP and T4 PNK labelling steps were carried out at 37◦C.
The dedicated intermolecular ligation step of CLASH was also left out.
2.21 RNAtag-Seq
RNA sequencing libraries of cells grown in TSB and shifted to RPMI medium were
generated utilising the RNAtag Seq protocol (Shishkin et al., 2015).
RNA was first extracted from cells as previously described and then quantified
using a 2100 Bioanalyzer and the RNA nano assay. Ten samples were processed
simultaneously with 1 µg taken for each. 20 U of SUPERasin was then added and the
volume increased to 16 µl. Afterwards, 4 µl of 10X FastAP buffer (ThermoFisher) was
added and then the RNA was fragmented in a thermal cycler through incubation at
92◦C for 2 minutes. The samples were then snap-chilled on ice. The RNA was then
dephosphorylated and DNase-treated. 10 U of FastAP and 8 U of TURBO DNase were
added, alongside 40 U of rRNasin. The reaction was left to proceed for 30 minutes at
37◦C. Afterwards, the RNA was purified using RNAClean XP beads and eluted in 11 µl.
A unique sequencing adaptor was then ligated onto the 3’ end of the RNA. 10 µl of
RNA was taken and 200 µmoles of adaptor was ligated onto it through addition of 36
U of T4 RNA ligase 1 in the manufacturer’s T4 RNA ligase buffer, supplemented with
9% DMSO, 1 mM ATP, 20% PEG-8000 and 16 U of rRNasin. The reaction was left to
proceed for 90 minutes at 22◦C. After the ligation step, 120 µl of RLT buffer (Qiagen)
was added to inhibit the enzyme. The samples were then pooled and extracted
through phenol:chloroform precipitation, with the final RNA pellet resuspended in
26 µl of DEPC-H2O. The concentration of the RNA sample was determined using a
Qubit 4 and the RNA broad range assay and 5 µg of sample was then taken, made up
to 26 µl and used as input for rRNA depletion via a Ribo-Zero kit (Illumina), carried
out according to the manufacturer’s instructions. The rRNA-depleted RNA was then
reverse transcribed into cDNA using the AR2 primer and SuperScript IV, according
to the manufacturer’s instructions. Afterwards, the RNA was degraded through
addition of NaOH to a final concentration of 100 mM. The samples were incubated
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at 70◦C for 12 minutes, at then HCl was added to a final concentration of 100 mM in
order to neutralise the NaOH. The cDNA was then purified using RNAClean XP beads
and eluted in 11 µl of water. The 3Tr3 adaptor was then ligated onto the 5’ end of the
cDNA. 1 µl of 80 µM adaptor was added to the DNA using CircLigase according to
the manufacturer’s instructions. The reaction was then cleaned up using RNAClean
XP beads, and then this clean up repeated a second time in order to ensure that as
much primer as possible had been removed. The cDNA was then amplified using
AccuPrime polymerase according to the manufacturer’s instructions, utilising the
2P_univP5 and 2P_rev_2 primers. The cycling conditions were as follows: 98◦C for
2 min; 20 cycles of 98◦C for 30s, 55◦C for 30s and 65◦C for 1 min; final extension of
65◦C for 10 min. The PCR product was treated with 40 U of Exonuclease I (NEB) in
order to degrade free primers and the DNA library was purified using RNAClean XP
beads. The library was then resolved on a 2% MetaPhor (Lonza) gel and 175-300 bp
fragments were excised and gel extracted through a MinElute column. The library
was quantified using a 2100 Bioanalyzer and a DNA HS assay (Agilent).
The RNA adaptors and PCR primers used for are detailed by Shishkin et al, 2015.
2.22 Reverse-transcription quantitative PCR
qRT-PCR was performed on RNA samples extracted from cells shifted from TSB to
RPMI and from the TSB to TSB control.
First, a DNase treatment step was performed to ensure that no contaminating DNA
was present in the sample; 8 µg of RNA was taken and digested with 1.8 U of TURBO
DNase according to manufacturer’s instructions for 1 hour at 37◦C in the presence of
2 U of SUPERasin. The RNA was purified using RNAClean XP beads and then eluted
in a final volume of 20 µl.
The RNA concentration was then quantified using a Qubit 4 and the RNA broad
range assay and diluted to a concentration of 5 µg/µL. Afterwards, the RNA was
aliquoted and stored at -80◦C until required.
The PCR was then performed using Luna Universal One-Step RT-qPCR kit (NEB),
according to the manufacturer’s instructions, and 5 ng of RNA. The PCR was run
on a LightCycler 480 (Roche) with the cycling conditions as recommended by NEB:
55◦C for 10 min for reverse transcription; 95◦C for 1 min for initial denaturation;
40 cycles with single acquisition mode of 95◦C for 10s and then 60◦C for 30s; melt
curve at 65◦C (0.11 ramp rate with 5 acquisitions per ◦C, continuous).
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The IDEAS2.0 software was used to calculate Ct values using the absolute quan-
tification/fit points method with default parameters, and the fidelity of the PCR
was examined through melt curve genotyping analyses. To calculate the relative
fold-change of genes, the 2ddCt method was employed using 5S as a control. Each
qPCR experiment was performed in technical triplicate. For final data analyses, the
mean and standard error of the mean of three biological triplicates was calculated
and plotted.
2.23 Bioinformatic analyses
Pre-processing of raw sequencing data
Raw sequencing data were first processed using the pyCRAC package (Webb et al.,
2014), available from https://bitbucket.org/sgrann/. In particular, the CRAC_Pipeline_PE.py
pipeline was used with the following command:
CRAC_Pipeline_PE.py -f forward_reads.fastq -r reverse_reads.fastq –-novoindex
reference_genome.novoindex –-gtf USA300/JKD6008.gtf -c chromosome_length_file.txt
-b L5_adaptors.txt -a adaper_file.fasta
This pipeline firstly demultiplexed the data based on the in-read barcode sequences
found in the L5 adaptors using pyBarcodeFilter.py. Flexbar then removed the 3’
adaptor sequences and any flanking nucleotides with a Phred score below 23. The
reads were then collapsed to remove PCR duplicates and then aligned to either the
S. aureus JKD6008 or USA300 genome using NovoAlign (www.novoalign.com) and
a Gene Transfer Format (GTF) file. The GTF file was kindly provided by Jai Tree.
Note that in the analyses carried out here, UTR coordinates were simply defined as
100 nucleotides upstream and downstream of the start and end codons respectively.
The pyReadCounters.py script then used the output from NovoAlign to quantify the
number of reads for each transcriptional unit.
Hyb analyses
The hyb pipeline was used to detect and annotate chimeric reads (Travis et al., 2014).
As hyb does not accept paired-end data, FLASh was used to combine the forward and
reverse reads of the demultiplexed .fastq files into a single contig with the following
parameters (FLASh is available from https://ccb.jhu.edu/software/FLASH/):
flash forward_reads.fastq reverse_reads.fastq -m 5 -M 65 -O -r 65
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FLASh generates an output file containing the uncombined forward and reverse
reads and the uncombined forward reads were combined with the FLASh output:
cat combined_forward_reverse.fastq uncombined_forward > final.fastq
A hyb database was then created and exported using a .fasta file of the genome:
make_hyb_db genome.fasta
export HYB_DB=/hyb_db
Hyb was then used to detect chimeras:
hyb preprocess qc=flexbar link=NAGATCGGAAGAGCACACG check detect
align=bowtie2 in=final.fastq db=hyb_db anti=1
In order to calculate the folding energy and to map the genomic coordinates to gene
names, custom scripts written by Sander Granneman were used. When visualising
hybrids using a genome browser, the .ua_hyb output file was converted to a GTF
file using a custom script, written by Sander Granneman. GTF files could then be
converted to .sgr files if desired, using the pyCRAC pyGTF2sgr.py script.
RNAtag-Seq analysis
Following pre-processing of the data using the pyCRAC_Pipeline_PE as previously
described, the output from pyReadCounters.py for each experimental condition was
merged together. In order to normalise the data and to account for variations in
sequencing depth, the data was converted into ‘Transcripts per million reads’ (TPM).
The number of raw read counts for each gene was first divided by the length of
the gene in order to create a normalised transcript expression value. The sum of
all normalised transcript values was then divided by 1,000,000 in order to create a
scaling factor, and then each normalised transcript expression value was divided by
this scaling factor to yield the TPM value. All data could then be normalised to the
t0 sample when desired in order to examine relative fold change.
In order to cluster genes into common expression patterns, the ‘Short Time-series
Expression Miner’ (STEM) was used (Ernst and Bar-Joseph, 2006). Data was log2
normalised and clustered using the STEM clustering method with 50 model profiles.
In order to examine which genes showed changed expression following shift to RPMI
as compared to the control, Differential expression analysis 2 (DESeq2 (Love et al.,
2014)) was used. Only differentially expressed genes with an adjusted p-value of
0.05 or lower were considered for future analysis.
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Conservation analyses and sequence alignments
When comparing sRNA sequences between S. aureus strains, the Staphylococcal Reg-
ulatory RNA Database (SRD, Sassi et al., 2015) was used to retrieve the homologous
sequences. When comparing sequences between Staphylococcal species, BLAST was
used with the S. aureus USA300 sequence used as a reference. JalView was then used
to align the sequences using the MAFFT algorithm and visualise the conservation
(Waterhouse et al., 2009).
2.23 Bioinformatic analyses 88
2.24 Bibliography
Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry
162:156–159. doi:10.1016/0003-2697(87)90021-2
Corrigan RM, Foster TJ. 2009. An improved tetracycline-inducible expression vector
for Staphylococcus aureus. Plasmid 61:126–129. doi:10.1016/j.plasmid.2008.10.001
Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton
HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome
sequence of USA300, an epidemic clone of community-acquired meticillin-resistant
Staphylococcus aureus 367:9.
Ernst J, Bar-Joseph Z. 2006. STEM: a tool for the analysis of short time series gene
expression data. BMC Bioinformatics 7:191. doi:10.1186/1471-2105-7-191
Ivain L, Bordeau V, Eyraud A, Hallier M, Dreano S, Tattevin P, Felden B, Chabelskaya
S. 2017. An in vivo reporter assay for sRNA-directed gene control in Gram-positive
bacteria: identifying a novel sRNA target in Staphylococcus aureus. Nucleic Acids
Research 45:4994–5007. doi:10.1093/nar/gkx190
Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol 15. doi:10.1186/s13059-
014-0550-8
McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC.
2003. Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus
aureus Isolates from the United States: Establishing a National Database. J Clin
Microbiol 41:5113–5120. doi:10.1128/JCM.41.11.5113-5120.2003
Monk IR, Shah IM, Xu M, Tan M-W, Foster TJ. 2012. Transforming the Untrans-
formable: Application of Direct Transformation To Manipulate Genetically Staphylo-
coccus aureus and Staphylococcus epidermidis. mBio 3:e00277-11.
doi:10.1128/mBio.00277-11
Nair D, Memmi G, Hernandez D, Bard J, Beaume M, Gill S, Francois P, Cheung AL.
2011. Whole-Genome Sequencing of Staphylococcus aureus Strain RN4220, a Key
Laboratory Strain Used in Virulence Research, Identifies Mutations That Affect Not
Only Virulence Factors but Also the Fitness of the Strain. Journal of Bacteriology
193:2332–2335. doi:10.1128/JB.00027-11
2.24 Bibliography 89
Norrander J, Kempe T, Messing J. 1983. Construction of improved M13 vectors using
oligodeoxynucleotide-directed mutagenesis. Gene 26:101–106. doi:10.1016/0378-
1119(83)90040-9
Nues R van, Schweikert G, Leau E de, Selega A, Langford A, Franklin R, Iosub I,
Wadsworth P, Sanguinetti G, Granneman S. 2017. Kinetic CRAC uncovers a role for
Nab3 in determining gene expression profiles during stress. Nature Communications
8:12. doi:10.1038/s41467-017-00025-5
Sassi M, Augagneur Y, Mauro T, Ivain L, Chabelskaya S, Hallier M, Sallou O, Felden
B. 2015. SRD: a Staphylococcus regulatory RNA database. RNA 21:1005–1017.
doi:10.1261/rna.049346.114
Shishkin AA, Giannoukos G, Kucukural A, Ciulla D, Busby M, Surka C, Chen J,
Bhattacharyya RP, Rudy RF, Patel MM, Novod N, Hung DT, Gnirke A, Garber M,
Guttman M, Livny J. 2015. Simultaneous generation of many RNA-seq libraries in a
single reaction. Nature Methods 12:323–325. doi:10.1038/nmeth.3313
Taylor RG, Walker DC, Mclnnes RR. 1993. E. coli host strains significantly affect the
quality of small scale plasmid DNA preparations used for sequencing. Nucleic Acids
Research 21:1677–1678. doi:10.1093/nar/21.7.1677
Travis AJ, Moody J, Helwak A, Tollervey D, Kudla G. 2014. Hyb: A bioinformatics
pipeline for the analysis of CLASH (crosslinking, ligation and sequencing of hybrids)
data. Methods 65:263–273. doi:10.1016/j.ymeth.2013.10.015
Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ. 2009. Jalview Version
2–a multiple sequence alignment editor and analysis workbench. Bioinformatics
25:1189–1191. doi:10.1093/bioinformatics/btp033
Waters SA, McAteer SP, Kudla G, Pang I, Deshpande NP, Amos TG, Leong KW, Wilkins
MR, Strugnell R, Gally DL, Tollervey D, Tree JJ. 2017. Small RNA interactome of
pathogenic E. coli revealed through crosslinking of RNase E. The EMBO Journal
36:374–387. doi:10.15252/embj.201694639
Webb S, Hector RD, Kudla G, Granneman S. 2014. PAR-CLIP data indicate that
Nrd1-Nab3-dependent transcription termination regulates expression of hundreds of
protein coding genes in yeast. Genome Biology 15:R8. doi:10.1186/gb-2014-15-1-
r8
2.24 Bibliography 90
3CLASH in S. aureus
3.1 Introduction
RNAs often rely on RNA-binding proteins (RBPs) to exert their function and this has
led to great interest in understanding the dynamics between RBPs and RNAs. A first
breakthrough came with the emergence of RIP-chip, where an RBP is immunoprecip-
itated and its bound RNAs identified through microarrays or sequencing (Keene et
al., 2006). Building on RIP-chip led to the development of improved protocols such
as CLIP, HITS-CLIP and CRAC (Granneman et al., 2009; Licatalosi et al., 2008; Ule
et al., 2003).
In order to study RNA-RNA interactions in vivo, a modified CRAC technique, termed
CLASH, was developed (Kudla et al., 2011). This technique relies on tagging an RBP
with a tandem affinity purification tag, followed by UV-crosslinking of cells expressing
this recombinant RBP in order to covalently link it to its bound RNAs. The RBP is
then purified through two affinity capture steps, the second of which is carried out
under denaturing conditions to greatly reduce background signal. Crucially, if two
RNAs bound to an isolated RBP are in close proximity to one another (such as during
an sRNA-mRNA interaction), enzymatic treatment can induce an intermolecular
ligation between them to make a single hybrid RNA. Adaptor sequences are then
ligated onto bound RNAs, the RNA is isolated and finally a cDNA library of the RNA
is made and sequenced (Figure 1.10).
One particular technical challenge in CRAC and CLASH is retaining RNA integrity
until the RNase digestion step. The aim of this step is to trim the cellular RNAs to
sizes of around 50-100 bases to facilitate sequencing. After trimming, the RNAs are
then transferred to a highly denaturing buffer, thus protecting them from further
degradation. However, RNA degradation can occur before this digestion step, par-
ticularly following cell lysis due to the release of cellular RNases. This degradation
results in RNAs which are too short to sequence effectively. As such, steps must be
taken to minimise RNA degradation.
Another challenge is optimisation of the crosslinking step. Cells are exposed to 254
nm UV radiation in order to induce covalent bonds between RBPs and their bound
RNAs. However, over-crosslinking has been reported to induce RNA and protein
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degradation (personal communications with Ross Cordiner). Additionally, as over-
crosslinking involves increasing the UV irradiation time, the exposed cells activate
DNA damage response pathways which can introduce noise into the produced
experimental data (Nues et al., 2017). As such, optimisations to find a UV exposure
time that produces sufficient RBP-RNA crosslinking but minimises RNA degradation
must be performed.
CRAC and CLASH have been successfully utilised in human cells, yeast and E.
coli, (Granneman et al., 2009; Helwak and Tollervey, 2014; Iosub et al., 2018;
Waters et al., 2017). However, they have never been performed in Gram-positive
bacteria. In this study, an initial experiment was performed using a published CLASH
protocol optimised for use in cultured human cells (Helwak and Tollervey, 2014),
but this method resulted in both very poor RNA and protein recovery. Thus, it was
hypothesised that S. aureus itself presents unique challenges to the CLASH protocol.
As such, the first aim of this project was to create an optimised CLASH method for
use in S. aureus.
In this chapter I detail the numerous optimisation steps that were undertaken
which aimed to improve cell lysis and RBP recovery, alongside minimising RNA
degradation. Additionally, in order to maximise the potential of the data after
sequencing, numerous additions were made to the in silico data analysis pipeline. In
sum, the optimisations performed resulted in the creation of a CLASH protocol that
is applicable for use in S. aureus.
3.2 Optimisation of CLASH for S. aureus
RNase III and RNase Y were chosen as candidate bait proteins for the discovery of
sRNA – target interactions as a result of their already proven role in mediating sRNA
activity (Section 1.10).
The outcome of the initial CLASH test using the published methodology was very
poor, with the autoradiogram requiring a 56-hour exposure in order to visualise
the radiolabelled RNA (Figure 3.1A, upper panel). The requirement for such a
long exposure represents the fact that not enough RNA was being obtained after
the purification. This could be due to inefficient RBP purification (and thus a poor
harvest of crosslinked RNA-RBP complexes) and RNA degradation occurring during
the purification itself. The western blot showed that very little protein was actually
purified (Figure 3.1A, lower panel), and since these proteins are themselves RNases,
both purification efficiency and minimising RNA degradation were taken as avenues
of optimisation. Overall, my first aim was to reduce this 56-hour autoradiogram
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exposure to around a 3-hour exposure, which would represent purifying enough
RNA to obtain high quality CLASH data. We used RNase III for the optimisations as
this was considered a higher priority than RNase Y due to its known dsRNA binding
activity. RNase III is also a soluble protein, as opposed to the membrane-bound
RNase Y, thus was thought to have a higher chance of successful purification. The
optimisations were performed in the S. aureus strain JKD6008 due to the necessary
tagged strains already being available (kind gift from Jai Tree, Sydney).
Due to expense, modifying several purification variables was tested concurrently.
Firstly, I investigated if treating S. auerus with lysostaphin, an enzyme which degrades
the outer peptidoglycan layer of the cell wall, prior to mechanical disruption would
improve cell lysis. In combination with this, EDTA was added to the buffer used
in the primary anti-FLAG capture. Since RNase Y and RNase III are dependent on
divalent ions for catalysis, I hypothesised that the addition of EDTA would inactivate
the activity of these RNases, as well as that of other endogenous RNases. However,
as lysostaphin is zinc-dependent, EDTA was only added after this initial enzymatic
treatment. Finally, we also tested if longer UV exposure times would aid crosslinking
efficiency.
As seen in Figure 3.1.1B, changing the UV exposure time had no major impact on
crosslinking efficiency. UV exposure times of 13, 30, 60 and 90 seconds were tested
using the UVO3 Vari-X-linker (https://www.vari-x-link.com). These values relate to
roughly 55, 125, 250 and 375 mJ of UV. The 13 second exposure gave both the best
autoradiogram and western blot signal, with a continuous decrease in intensities
being observed as the cells were crosslinked for longer periods. Similar results in
human cells have been observed in the Granneman lab (Ross Cordiner, unpublished
data) and it is hypothesised that excessive UV exposure results in both RNA and
protein degradation. Thus, a UV exposure time of 13 seconds was chosen for future
crosslinkings.
The combined addition of a lysostaphin treatment and EDTA in the primary capture
buffer had a positive effect on both protein and RNA recovery. In the experiment
represented by Figure 3.1B, sufficient radiolabelled RNA was present to facilitate
an overnight exposure for the autoradiogram, as opposed to the previous 56 hours.
The lysostaphin treatment is likely to have improved significantly the cell lysis and
therefore RNase III recovery, as concluded from the strong western blot signal. It
is impossible to deduce absolutely whether EDTA helped to reduce RNA degrada-
tion due to the concurrent testing of multiple experimental variables, but it was
maintained in future experiments regardless.
CLASH has been performed in E. coli on RNase E. (Waters et al, 2017). Here,
the authors suggested that the first anti-FLAG step should be done overnight to
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get optimal recovery of the protein. However, I hypothesized that this lengthy
incubation step would result in unwanted degradation of the RNA. RNAs only
become protected from degradation during the secondary capture as this is carried
out under denaturing conditions. Thus, I next tested if reducing the initial primary
FLAG capture to two hours would reduce RNA degradation. Although an overnight
capture will presumably capture more protein than that of a two hour, this leaves
the RNAs crosslinked to the RBP in contact with endogenous RNases for an extended
period of time. Thus, getting to the secondary capture stage as quickly as possible
was hypothesised to maximise RNA recovery, even if at the cost of reduced protein
capture. In order to compensate for this reduced capture time, the amount of anti-
FLAG resin was increased 8-fold. Additionally, it was noted that autoradiograms
from previous experiments gave too defined a signal, indicating over-digestion of
the crosslinked RNAs. Thus, different concentrations of RNase-IT, the RNase cocktail
used for RNA digestion, were tested.
As seen in Figure 3.1C, the two-hour FLAG capture greatly increased the amount of
intact RNAs present, facilitating a three-hour autoradiogram exposure. In the sample
untreated with RNase-It, (Figure 3.1C, lane 1), it is also observed that a wide range
of RNAs are being pulled down with the protein, with signal extending from 32 kDa
up to 58 kDa. Agreeably, it is also seen that decreasing the amount of RNase-IT
results in an a more diffuse autoradiogram signal, and the 1/100 concentration was
chosen for future experiments.
As RNase Y is known to be membrane bound (Khemici et al., 2015), Triton X- 100
(TX-100) was added to all buffers in an attempt to improve RNase Y purification.
This was hypothesised to aid RNase Y solubility but it was unknown if the presence
of TX-100 would negatively impact the affinity capture or enzymatic steps. Thus,
included in this test was RNase III as a positive control. Additionally, a parental,
untagged strain was used in order to visualise non-specific binding to the beads.
Figure 3.1D shows that TX-100 had no negative impacts on the purification of RNase
III nor on the phosphorylation of its bound RNAs. As such, I concluded that TX-100
has no noticeable adverse effects on the experimental system. With regards to RNase
Y, the protein purification is very inefficient in the absence of TX-100, with a poor
autoradiogram signal observed after 3 hours and only a small amount of protein in
the western blot. However, the addition of TX-100 greatly improved protein capture
(~4X by densitometry), and this facilitated an observable autoradiograph signal
after three hours of exposure. Finally, the parental strain exhibits no observable
signal, indicating that the signal observed is specific to the chosen proteins.
Using the described optimisations, CLASH was performed on RNase Y and RNase
III in cells grown in TSB, and also on cells transferred from TSB to RPMI medium.
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As seen in Figure 3.1E, upper panel, the signal from the autoradiogram of RNases
purified from cells exposed to RPMI is significantly stronger than that of cells
grown only in TSB, indicating that these enzymes are highly active during the stress
response and are binding more RNAs. Additionally, this experiment required just a
1.5-hour autoradiogram exposure, representing the cumulative effects of including
the optimisations. The cDNA libraries from these CLASH experiments are shown in
Figure 3.1E, lower panel, and these were successfully sequenced.
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Fig. 3.1: Optimisation of the CLASH protocol. A. Initial CLASH experiment using published
protocols. The very long autoradiogram exposure represents poor efficiency of
RNA recovery. B. Testing the effect of different crosslinking times (13, 30, 60
and 90 seconds) and also the addition of a lysostaphin treatment and EDTA to
the primary capture buffer on recovery of crosslinked RNAs. RNase III was used
as the bait. C. Testing the effect of different RNase-IT concentrations (untreated,
1/25, 1/50, 1/100, 1/250, 1/500), and also a two hour FLAG capture, on recovery
of crosslinked RNAs. RNase III was used as the bait. D. Testing the effect of
Triton X-100 on recovery of crosslinked RNAs with RNase Y and RNase III. E.
Autoradiogram and cDNA library of a successful CLASH experiment on RNase Y
and RNase III, obtained from cells grown in TSB and also from cells shifted from
TSB to RPMI for 15 minutes.
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3.3 Discussion
CLASH has proven to be a useful tool for identifying RNA-RNA interactions in human
cells, yeast and E. coli, but use of an already published protocol failed when applied
to S. aureus. As such, optimisations were performed and these yielded conditions to
be used for subsequent CLASH experiments.
Firstly, this optimised protocol uses a lysostaphin treatment to aid cell lysis. This
reflects the inherent difficulty in lysing Gram-positive bacteria due to their tough
outer cell wall composed of peptidoglycan. Previous CLASH protocols utilised only
bead beating for cell lysis, but it is clear that this was not sufficient for S. aureus. In S.
aureus, the peptidoglycan wall is typically 20-30 nm thick and is crosslinked through
pentaglycine bridges. Lysostaphin is able to hydrolyse these crosslinks and thus
greatly reduce the strength of the cell wall, and this is likely to facilitate subsequent
lysis through bead beating and detergent usage.
Additionally, the protocol described here has taken several steps to minimise RNA
degradation during the initial capture stages. EDTA was added to the primary
capture buffer and the FLAG capture was reduced to 2 hours. It is hypothesised
that EDTA is able to chelate the metal ions that are essential for RNase activity,
thus inactivating them, while reducing the FLAG capture time decreases the contact
between the RNAs and the RNases.
Finally, the protocol described here addresses other logistical issues necessary for
successful CLASH. After testing several UV exposure times, 125 mJ of UV has
been chosen for RNA-RBP crosslinking which represents around 30 seconds in the
Vari-X-Linker. Additionally, a 1/100 RNase-IT concentration is used for trimming
bound RNAs, and it was confirmed that Triton X-100 could be used in order to aid
solubility of membrane-bound proteins without any adverse effects on enzymatic
steps. Overall, these optimisations will be able to be collated into a small, publishable
paper to allow other groups to perform these experiments.
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4Global analyses of RNA
expression and sRNA activity
4.1 Introduction
As described in Chapter 3, RNase III and RNase Y were chosen as bait proteins
for CLASH due to their already known roles in mediating RNA degradation and
sRNA-mediated decay. These RBPs have also been implicated in the regulation
of virulence (Introduction, Section 1.9), and thus were hypothesised to be active
players in S. aureus’ adaptation to the human bloodstream.
Using the optimised CLASH protocol as described in Chapter 3, I aimed to identify
sRNAs that are involved in adaptation to the stresses S. aureus encounters when
entering the human bloodstream. Additionally, as CLASH also gives single-read
data (‘CRAC data’), I also examined how these RNases themselves shape adaptation
through their degradation of target RNAs.
CLASH was performed on S. aureus in a rich medium, TSB, and on cells which had
been shifted to a medium called RPMI 1640. RPMI was originally designed to culture
human leukocytes but has been shown in a study by Mäder et al, 2016, to induce a
very similar response in S. aureus as human blood plasma, with particular overlap
in iron-responsive genes. In order to move cells from one medium to another, a
vacuum-based filtration system that facilitates shifting on minute timescales was
utilised (Nues et al, 2017). As such, a model was created to mimic as well as possible
the stresses induced when S. aureus moves from the environment into the human
bloodstream (Figure 4.1).
In order to complement the CLASH data, I also performed RNAseq on cells in order
to deduce RNA steady-state levels. Importantly, we also performed RNAseq on cell
shifted back to their original medium, which allowed us to determine whether the
filtration step itself induces significant stress. Additionally, CRAC on the polymerase
(via the RpoC subunit) was performed because the data can be used as a proxy
for transcription. Finally, with the help of a postdoctoral researcher in the lab
(Liangcui Chu), I am also preparing protein samples to quantify changes in protein
levels by mass-spectrometry. This would give me a readout what proteins are being
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synthesized and degraded during the stress. Collectively, these analyses provided a
detailed systems-level view of how RNA transcription and RNA degradation shape
RNA stability and protein abundance.
Fig. 4.1: Experimental set up for global analyses. Cells were grown in TSB until OD600=3,
and then a reference sample was taken. The cells were then harvested through
vacuum filtration and resuspended in RPMI medium A. For CLASH, a sample was
taken after 15 minutes and subsequently crosslinked. For RNAseq, samples were
taken after 5, 10, 15 and 30 minutes. As a control for the RNAseq data, cells were
shifted back into the original medium (B.) and samples were taken after 5, 10, 15
and 30 minutes.
The results presented in this chapter show firstly that there is a large degree of
change in the expression of sRNAs after the imposition of stress induced by RPMI
medium, implying that sRNAs are active players in the adaptation process. Through
CLASH, targets for many of these sRNAs can be identified and several of these change
in response to stress, implying that they are specific to the adaptation process. Finally,
I identified a large number of sRNA-sRNA interactions, which suggests that sRNA
activity is also regulated through other sRNAs. This chapter will overall seek to show
that CLASH is a suitable method for identifying sRNA interactions in S. aureus and
suggest novel targets for several trans-acting sRNAs.
4.2 sRNA expression undergoes significant
remodelling in response to RPMI stress
RNAseq was performed on cells that had been shifted to RPMI and on cells shifted
back to the original TSB medium in order to examine the changes in RNA steady
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state levels in response to these stresses (Figure 4.1). In order to visualise the
immediate responses, cell samples were taken after 5, 10, 15 and 30 minutes.
Firstly, I examined whether the shift to RPMI incurred cell death or caused a slowing
of growth. I shifted an aliquot of cells to RPMI and then took OD600 measurements
after 5, 10, 15 and 30 minutes, comparing to an unshifted control (Figure 4.2). This
revealed that the shifted cells grew at the a comparable rate to the unshifted control.
Thus, I concluded that shifting S. aureus from TSB to RPMI does not prevent the
cells from growing normally.





















Growth following RPMI shift
Unshifted
RPMI shifted
Fig. 4.2: Optical density measurements following the shift to RPMI as compared to an
unshifted control.
Next, the expression of sRNAs after the shift was examined. A list of sRNAs was
curated from the Staphylococcal Regulatory RNA Database (Sassi et al., 2015) and
the expression of sRNAs that had statistically significant change after 30 minutes was
plotted (DESeq2, Benjamini-Hochberg adjusted p-values < 0.05; Figure 4.3A, left
panel). Figure 4.3A, right panel, shows the expression of these sRNAs in the control
TSB-TSB shift. The sRNAs were also grouped into clusters of similar expression
patterns (Figure 4.3B).
After 30 minutes of exposure, 55 sRNAs were observed to have statistically signif-
icantly changed expression after the shift to RPMI. Significance was calculated as
compared to the 30 minute timepoint of the control TSB-TSB shift. Of these 55, 7
are known to be bona fide, trans-acting sRNAs, as defined by Liu et al, 2018; RNAIII,
RsaD, RsaOG, SprA3, srn_3810, srn_1520, srn_2975 and srn_4520. Additionally,
RsaOG and RsaH (which also meet the criteria for trans-acting sRNAs) were observed
to have significantly changed expression after 15 minutes of exposure, but then
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return to basal levels by 30 minutes. The specific expression profiles of these sRNAs
is shown in the form of line plots in Figure 4.4.
The expression profiles show that sRNA responses are not simplistic up- or downreg-
ulation, but rather are complex, dynamic and change throughout the timecourse.
Figure 4.3B shows the expression of the sRNAs in chosen clusters and their mean
expression profile.
In cluster 1, it can be observed that two sRNAs exhibit strong and continuous
downregulation for 15 minutes before starting to recover. Thus, these sRNAs may
be unwanted during the immediate response to stress and so are repressed, but are
then relieved of this repression in later adaptation stages and start to return to basal
levels. Both of the sRNAs in this clusters are also slowly decreasing in expression
in the TSB-TSB shift, but not to the same degree. Interestingly, the pro-virulence
factor RNAIII is included in this cluster, which is significantly downregulated after
the RPMI shift, as shown in Figure 4.4.
Cluster 2 shows sRNAs which are initially repressed during the first 5 minutes but
are then actively upregulated to levels above their initial expression. Thus, these
sRNAs may be unwanted in the immediate face of stress (and so are destroyed)
but may play a role in the later stages of adaptation and so actively upregulated
afterwards. RsaD is included in this cluster, which is already known to respond to
oxidative stress and contains the distinctive UCCC motif of the Rsa class (Geissmann
et al., 2009). The expression of RsaD is shown in Figure 4.4, where it is observed
that is strongly upregulated almost 10-fold after 30 minutes in RPMI, as compared
to its flat expression in the TSB control.
Clusters 3 and 6 show sRNAs which are upregulated during the first 5 minutes of
adaptation but then downregulated afterwards until 15 minutes when they appear
to be relieved of their repression. Cluster 4 exhibits a similar overall pattern but acts
slower. Thus, these three clusters of sRNAs may be important for the initial response
to stress but then must be removed afterwards. The sRNAs srn_3810 and srn_1520
belong to cluster 3, but nothing is known about their functionality. SprA3, RsaOG and
RsaH belong to cluster 6 and these sRNAs are better understood. SprA3 is encoded
in a pathogenicity island and is a target of RNase III (Lioliou et al., 2012; Pichon and
Felden, 2005) and also exhibits strong sequence similarity to the anti-toxin sRNA
SprA. RsaOG, also known as RsaI, is involved in an intricate network of multiple
sRNAs which regulate sugar metabolism and uptake, and has also been predicted
to play a role in the metabolic balancing of virulence and dormancy (Bronesky et
al., 2019). RsaH has been reported to accumulate in either pre-stationary phase or
stationary phase, but its function has not been found (Bohn et al., 2010; Geissmann
et al., 2009). Both RsaOG and RsaH have a continuous decrease in expression in
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the TSB-TSB shift, thus their strong upregulation during the first 15 minutes of
RPMI exposure appears to be specific to the adaptation process. The individual
profiles of these sRNAs, as shown in Figure 4.4, contains a common ‘triangular’ shape
where each sRNA is upregulated for a short period of time before being repressed
afterwards.
Finally, cluster 5 contains sRNAs which are strongly upregulated after stress, and
this continues throughout the whole time course. Thus, these sRNAs may play an
active role in shaping adaptation. None of the sRNAs in this cluster meet the criteria
for trans-acting sRNAs as defined by Liu et al., 2018, and nothing is known of their
function.
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Fig. 4.3: sRNA expression in response to RPMI stress. A. Heatmap showing sRNAs with
statistically significant changed expression after 30 minutes of RPMI exposure,
as compared to the control. sRNAs have been clustered into patterns of similar
behaviour, as calculated by STEM (Ernst and Bar-Joseph, 2006). Bone fide, trans-
acting sRNAs are labelled (Liu et al., 2018). The expression of RsaOG and RsaH has
been also added, both of which exhibit statistically significantly changed expression
after 15 minutes but then recover by 30 minutes. B. Line graphs showing chosen
expression clusters.
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Fig. 4.4: Expression of bona fide, trans-acting sRNAs that exhibit significantly changed
expression after either 15 or 30 minutes of RPMI exposure.
After examining the expression of sRNAs in response to RPMI, the expression of
the entire transcriptome was examined. As seen in Figure 4.5A, the transcriptome
undergoes significant remodelling in response to RPMI medium. Overall, 735 genes
exhibit significantly changed expression after 30 minutes of exposure. In a similar
manner to the sRNA responses, many of the expression profiles are dynamic and
changing. This is in opposition to the expression patterns seen in the TSB-TSB
control shift, where genes are simply either up- or down-regulated continuously.
This leads to the idea that the physical act of shifting the cells from one medium
to another incurs minimal non-specific stresses and rather the expression changes
are simply due to the effect of time. In support of this, genes which are known to
decrease in expression during stationary phase versus exponential, such as spa, fruB,
ald, ilvA, and adhE, also decrease over the time course. Conversely, genes which are
known to be upregulated in stationary phase, such as ssaA and SAUSA300_0229,
also increase over the TSB shift time course (Weiss et al., 2016).
4.2 sRNA expression undergoes significant remodelling in response to RPMI stress 106
Examining the different clusters of expression in RPMI shows similar patterns to that
observed for the previously discussed sRNAs (Figure 4.5B). Cluster 1 contains genes
which are initially downregulated for the first five minutes but are then upregulated
afterwards. STRING analyses reveals that ‘metal ion binding’ is in an enriched
term for this cluster, and several genes involved in iron transport can be identified
such as SAUSA300_1028, SAUSA300_1029, SAUSA30_2134, SAUSA300_1978, and
SAUSA300_1005. Additionally, lipoteichoic acid synthesis, a central component of
the cell wall, was also an enriched STRING term.
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Fig. 4.5: Transcriptome-wide changes in response to RPMI. A. Left: heatmap showing genes
with statistically significant changed expression after 30 minutes of RPMI exposure,
as compared to the control. Genes have been clustered into patterns of similar
behaviour as calculated by STEM. Right: heatmap showing genes with significantly
changed expression after 30 minute of TSB shift B. Line graphs showing chosen
expression clusters.
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Clusters 2, 3 and 5 display a common pattern of behaviour, with varying amplitudes
and timing; for brevity, only cluster 2 is shown in Figure 4.5B. Overall, these clusters
increase initially, with clusters 3 and 6 reaching their maximum expression by five
minutes and cluster 4 reaching this at 15 minutes. After reaching the maximum,
their expression is decreased and drops to levels below the basal. STRING analysis
reveals that this group is enriched for genes involved in metabolic processes, and
indeed ‘glycolysis’ is a statistically significant enriched Uniprot term due to genes
such as eno, gpmL and pgk. Additionally, ‘virulence’ is also a statistically significant
enriched annotation term for these clusters due to genes such as clfA, sarT, sspA, eno
and crtN.
The fifth cluster from the RPMI data includes genes which are significantly upreg-
ulated throughout the timecourse. This differs from the TSB control upregulated
cluster as the RPMI cluster reaches a far higher maximum expression. In the TSB
data, only 7 genes are upregulated at least 4-fold, with the maximum being a ~9-fold
change. Regarding the RPMI data, 173 genes are upregulated at least 4-fold, and
over 40 genes have changes of at least 32-fold. This cluster 5 also has enrichment
for metabolic genes, and in particular (branched-chain) amino acid biosynthesis,
carboxylic acid biosynthesis and diaminopimelate biosynthesis.
Manual examination of the transcripts with the highest degree of up- and down-
regulation gives insight into the types of metabolic changes the cell must undergo
in order to survive. Figure 4.6 shows the results of a DESeq analysis comparing
the expression of genes in TSB versus those in RPMI after 30 minutes of exposure
(Love et al., 2014). This reveals that there is a large cluster of iron-uptake related
transcripts with increased expression. Several operons involved in amino acid uptake
and biosynthesis are also increased, such as the opp, leu, and ilv operons. There
is also remodelling of sugar metabolism, with the fructose transporters fruA and
fruB being strongly downregulated. Additionally, SAUSA300_0755, a glycolytic
operon regulator; malR, a maltose uptake repressor; and SAUSA300_0194, a sucrose
transporter, are also downregulated.
4.3 CLASH identifies bona fide sRNA-target
interactions in S. aureus
Given that there is significant change in the expression of sRNAs, I hypothesised
that some of these could play a role in the adaptation process. CLASH was used to
identify the targets of many of these sRNAs in both TSB and after 15 minutes of
RPMI shift, and thus allowing one to begin to uncover the role of selected sRNAs in
shaping adaptation.






































Differential gene expression following RPMI exposure
Iron-related
Fig. 4.6: Differential gene expression following RPMI shift. Expression 30 minutes after
RPMI shift was compared to the reference, unshifted sample.
As S. aureus is known to show considerable genetic variability between strains,
CLASH was performed on an Australian VISA strain (vancomycin-intermediate sensi-
tive; JKD6008) and an American VSSA strain with enhanced virulence (vancomycin-
sensitive; USA300 LAC). Overall, JKD6008 is viewed as an S. aureus strain with a
wide range of antibiotic restistances, but not only that is particularly virulent. It is
ST239 and contains a type 3 SCCmec plasmid. Additionally, JKD6008 contains a
φSPβ-like prophage that has been hypothesised to potentially confer aminoglycoside
resistance (Holden et al., 2010).
Conversely, USA300 is a strain that is considered to be extremely aggressive and a
major driver of community-acquired MRSA. For example, in some parts of the United
States, USA300 was isolated from almost every soft skin and tissue infection (Moran
et al., 2006, Talan et al., 2011). USA300 is ST8 and contains a type 4 SCCmec
cassette. Additionally, USA300 contains the msr(A) erythromycin resistance genes
and a prophage-encoded Panton-Valentine leukocidin (McDougal et al., 2003). In an
attempt to explain the increased pathogenicity of USA300, its genome was compared
to 10 other S. aureus strain. This revealed the presence of a novel pathogenicity
island containing two enterotoxins and the arginine catabolic mobile genetic element
(Diep et al., 2006). Additionally, USA300 has been observed to have an increased
capacity to express toxins encoded on the core genome, such as Hla and phenol-
4.3 CLASH identifies bona fide sRNA-target interactions in S. aureus 110
soluble modulins, however the genetic basis of this has not been precisely explained
(Li et al., 2009).
Interestingly, it has been proposed that ST239 strains, such as JKD6008, is a hybrid
between ST8 and ST30, created by a large chromosomal replacement (Robinson and
Enright, 2004).
For JKD6008, CLASH was performed on both RNase III and RNase Y, while only
RNase III was used in USA300 as this proved to be a much better bait in enriching
for sRNA-target interactions.
An average of 1% of the total reads from RNase III CLASH represented hybrids,
although significant variability was observed between samples (Figure 4.7A). This
number is in line with previous studies (Iosub et al., 2018; Waters et al., 2017).
However, RNase Y did not yield as many hybrids, averaging only ~0.3%. This was
surprisingly lower than the parental control, which yielded ~0.4%. However, it is
important to note that CLASH performed on the parental strains produced a very
small number of reads (around 500,000) thus any non-specific hybrids account for
a relatively large percentage. Conversely, RNase III and RNase Y produced a very
large number of total reads; around 96 million and 18 million respectively. Thus, the
percentages represent a large number of interactions. Note that in these analyses,
tRNA – rRNA interactions were removed as these are highly abundant RNAs that
are the most likely to form non-specific interactions. Moreover, predicted rRNA –
rRNA and tRNA-tRNA interactions were also not considered as their rRNA and tRNA
genes are present in many copies and the sequence identity is very similar, making it
difficult to determine if these were indeed intermolecular interactions.
Examining the composition of the hybrids reveals RNase III CLASH in particular
was able to enrich for sRNA – mRNA hybrids. CLASH on the untagged parental
strains allowed me to calculate the background binding of cellular RNAs to the
binding resin. This revealed 23 unique hybrids involving sRNAs in TSB and 12 in
RPMI, representing ~5.5% and ~4% of the total interactions found (Figure 4.7B).
However, CLASH on RNase III in both JKD6008 and USA300 increased this number
dramatically. In USA300, 1800 hybrids containing sRNAs were identified in TSB
and 26627 in RPMI. For JKD6008, 7866 were identified in TSB and 6390 in RPMI
(Figure 4.7B).
CLASH on RNase Y was only performed in JKD6008 during the initial stages of this
thesis. This is because it was far less effective at identifying RNA interactions in
general and also those involving sRNAs in particular. I identified just under 600
sRNA-containing hybrids with RNase Y in TSB and RPMI (Figure 4.7B and C). Thus,
RNase III was prioritised in future experiments.
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However, it is important to note that a single interaction can be represented by many
hybrids. Collapsing the hybrid data into single interactions revealed the number of
unique interactions obtained (Figure 4.7D). RNase III CLASH yielded 208 unique
interactions between sRNAs and mRNAs in TSB, with 78 occurring within the protein
coding sequence (CDS) of the mRNA and 130 within the 5’ UTR. For RPMI, 229
interactions between sRNAs and mRNAs were found, with 136 within the CDS and
93 within the 5’ UTR. I also identified 51 interactions between two sRNAs in TSB
and 180 in RPMI. Interestingly, there is a huge number of interactions between
intergenic regions and sRNAs, and between intergenic regions and 5’ UTRs in the
USA300 RPMI dataset (Figure 4.7D)
Examining the RNase Y CLASH data in JKD6008 reveals that it uncovers a similar
number of unique interactions as RNase III CLASH (Figure 4.7D). Although these
have been filtered for statistical significance, the vast majority of these interactions
are supported by only a single hybrid. Exemplifying this, only 17 interactions
between sRNAs and mRNAs were supported by more than 1 hybrid in the RNase Y
data. This reemphasizes that RNase Y is not a great bait for identifying sRNA-target
interactions and suggests it may not play a major role in this process.
The statistical analysis pipeline used for this analysis takes into account the number
of single reads for an RNA and compares this to the number of hybrids obtained
(Waters et al., 2017). Such a methodology is weak at filtering non-specific hybrids
which involve RNAs with a low number of reads. Although the lab has found that
hybrids represented by only a single read can represent genuine interactions (and
this thesis has identified known interactions in S. aureus represented by only single
hybrid), I treat these with greater suspicion. This is because proximity-dependent
ligation experiments are subject to false-positives as a result of spurious ligation
events, mapping artefacts and errors incurred during reverse transcription and PCR
(Ramani et al., 2015). As such, RNase III was focused on for future experiments
due to it being able to extract a greater number of hybrids, and as such increase the
confidence in the data.
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Fig. 4.7: CLASH hybrid incidence and composition. A. The incidence of hybrid reads in
CLASH for RNase III, RNase Y and the parental strains. Both JKD6008 and USA300
data have been merged for the RNase III and the parental strain data, while RNase
Y CLASH was only carried out in JKD6008. B. and C. Hybrid composition for
RNase III and RNase Y in USA300 and JKD6008, alongside the respective parental
strain. Left hand panel shows the total number of hybrids involving each RNA class
and this data is presented as a percentage in the right hand panel. Interactions
between rRNAs and tRNAs were removed from the data and the parental strain
data (USA300 and JKD6008) were merged. Note that for the purpose of this
analysis, reads mapping to 5’ UTR, CDS and 3’ UTR were merged into the umbrella
term of ‘mRNA’. D. Total number of each interaction type for RNase III and RNase
Y in TSB and RPMI. .
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To further these analyses, I examined between which RNA classes these interactions
were occurring (Figure 4.8). Regarding RNase III in USA300 and JKD6008, inter-
actions between sRNAs and both the 5’ UTR and protein coding regions of mRNAs
represent significant classes, representing from ~6% to 11% of the total hybrid
reads. Interactions between sRNAs and other sRNAs also consistently represented
around 2% of the hybrid reads. Interestingly, interactions between intergenic regions
and 5’ UTRs, coding sequences and sRNAs represent significant interaction classes;
these intergenic regions may represent a pool of potentially undiscovered sRNAs.
Overall, the hybrid incidence is similar when comparing the data from TSB to RPMI
in USA300, although I note that interactions between 5’ UTRs are only found in
RPMI and not significantly in TSB. Some more pronounced differences are observed
in JKD6008 where interactions between protein coding sequences and other protein
coding sequences are the most abundant transcript class in RPMI but are not present
significantly in TSB. This is difficult to explain and these interactions could represent
poorly annotated genes. Additionally, interactions between 5’ UTRs and other 5’
UTRs are only found in TSB and not in RPMI.
The data for RNase Y is less rich. In TSB, “other combinations” make up the most
abundant interaction type; these represent lowly abundant interactions, but also
interactions in which one composing RNA maps to multiple locations e.g. a 5’
UTR and then into the coding sequence. Of note, interactions between sRNAs and
either 5 UTRs or protein coding sequences represent roughly 6% of the interactome.
However, interactions between intergenic regions represent significant proportions
of the interactome in both TSB and RPMI, as are interactions between protein coding
regions in RPMI.
4.4 CLASH identifies canonical sRNA – mRNA
interactions
In order to gain confidence in the CLASH data, I examined which regions of mRNAs
were being targeted by sRNAs. As sRNAs canonically bind to the 5’ UTR of mRNAs,
it was hypothesised that reads for mRNAs found in sRNA – mRNA hybrids should be
enriched in this region. Two methods were employed to examine this.
Firstly, the read profile around the starter codon was examined. Here, reads for
mRNAs found in sRNA – mRNA hybrids were mapped across the AUG (Figure 4.9A).
To generate this, the data was collapsed so that identical hybrids are only counted
once in order to prevent a single, highly abundant interaction dominating the data.
This revealed that for both USA300 and JKD6008, mRNA reads mapped preferentially
to the 5’ UTR and start codon and then immediately decreased downstream.
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Fig. 4.8: Intermolecular RNA transcript combinations as detected by RNase III and RNase Y
CLASH. Interactions were first filtered for statistical significance and then interac-
tions containing rRNAs and tRNAs were removed. Interaction types of interest are
annotated, and ‘Other combinations’ represents merged lowly abundant combina-
tions. Each RNA interaction was then plotted as a percentage of the total. Note, a
single interaction can be represented by many individual hybrids.
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Secondly, mRNAs involved in sRNA – mRNA hybrids were separated into 100 equally-
sized fragments (’bins’) and then the reads were mapped relative to these (Figure
4.9B). This data was again processed such that each hybrid was only counted once.
This revealed that for both USA300 and JKD6008, reads were again concentrated at
the 5’ end of the mRNAs. However, for both for JKD6008 and USA300, there is a
sharp spike in the middle of the coding sequence, particularly true for the USA300
data.
The mRNAs which mapped to this ‘spike’ region were examined and this revealed
that many of these were components of operons. Of the 18 genes within this region,
9 belonged to operons. A tentative suggestion is that sRNAs could be targeting a
central portion of the gene in order to recruit RNase III to mediate processing of the
operon. Additionally, rot was found within this spike region and this is known to
be targeted by RNAIII within its coding sequence (Boisset et al., 2007). Thus, these
interactions may also represent genuine targeting in the middle of the transcript.
Next I examined if CLASH recovered interactions containing validated sRNAs. As
discussed in Section 1.8, a previous study by the Bouloc group bioinformatically
filtered the current list of sRNAs to try ascertain which of these are trans-acting, bona
fide sRNAs. For this, they only considered sRNAs which contain their own promoter
and terminator and do not overlap any other gene or antisense transcription (Liu
et al., 2018). Although this strict definition is imperfect as it excludes UTR-derived
sRNAs, it serves as a useful tool for examining if our data contains confirmed sRNAs.
As shown in Figure 4.9C, CLASH recovered 16 of the 39 ‘bona fide’ sRNAs. This is a
positive result as I did not expect to recover all the sRNAs in S. aureus as many are
only expressed at specific growth stages and under specific conditions.
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Fig. 4.9: RNase III CLASH identifies canonical sRNA – mRNA interactions. A. The reads
mapping to mRNAs involved in sRNA – mRNA interactions were plotted relative
to the starter codon. B. The same reads were plotted across the mRNA genomic
sequence, split into 100 equally sized bins. C. All of the sRNAs involved in sRNA-
mRNA interactions in both USA300 and JKD6008 were extracted and the overlap
between them was plotted as a Venn diagram. Additionally, in order to see how
many of these sRNAs are highly verified, the curated list of ‘bona fide’ sRNAs as
described by Liu et al., 2018, was integrated into this Venn diagram.
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4.5 CLASH identifies known sRNA interactions
I next examined if the CLASH data contained known sRNA interactions. As discussed
in the Introduction, several sRNA – mRNA and sRNA – sRNA interactions have been
validated in S. aureus and uncovering some of these would give credence to any
novel interactions proposed.
The most abundant sRNA – mRNA interaction detected was between sprA1 and
SprA1AS with over 4,500 unique hybrids found across the pooled datasets. This
interaction was previously found by the Felden group (Sayed et al., 2012). Although
the structure of the sprA1 - SprA1AS duplex has not been experimentally validated,
it was computationally predicted to involve the SD sequence and start codon. Figure
4.10A shows the interaction uncovered through CLASH, visualised in silico through
RNAcofold (Lorenz et al., 2011). The region highlighted in blue on Figure 4.10A
denotes the regions predicted to be involved in base pairing by Sayed et al, 2012
and excellent overlap is seen with the CLASH data.
The sRNA SprX is known to regulate the translation of spoVG, a protein involved
in antibiotic resistance, the production of virulence factors and capsule regulation
(Eyraud et al., 2014). The structure of this interaction has been found through
in vitro structure probing, and again the precise interaction sites were identified
through CLASH with over 200 unique hybrids identified (Figure 4.10B). Although
the start codon of spoVG, which is known to be targeted by SprX, is not shown in
duplex, this is due to inaccurate prediction by RNAcofold as opposed to inaccuracies
in CLASH.
Another known interaction identified through CLASH is between SprF and sprG
(Pinel-Marie et al., 2014). No structure probing or in silico structural predictions
were made in the original paper, but it was found that SprF represses the translation
of sprG. The CLASH data uncovered both the start codon of sprG and a portion of 5’
UTR which fits the canonical mode of translational repression (Figure 4.10C).
Many interactions between RsaA and RsaE with already known targets were also
found. These include RsaA’s interaction with mgrA, SsaA2_3 and JKD6008_01954,
and RsaE’s interaction with RsaOG, purK, opp3-B, sucD and purH (Figure 4.11A). As
RsaA, RsaE and RNAIII will be discussed in dedicated chapters, these interactions are
detailed later. Some of these interactions were only uncovered with a small number
of respective hybrids. Thus, this demonstrates that interactions found with CLASH
are not only valid when in abundance, but that even small numbers of hybrids can
represent true, bona fide interactions.
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Fig. 4.10: Examples of known targets identified through CLASH; SprX-spoVG (A.), SprF1-
sprG1 (B.) and sprA1-SprA1AS (C.). Structures were generated by extracting
the CLASH read sequences as input for RNAcofold, which was used to predict
the interaction structure. For SprA1AS - sprA1, computational predictions of
the interaction were made by the authors and are highlighted in blue (Sayed et
al., 2012). For SprX-spoVG, the structure of this interaction has been validated
previously through in vitro structure probing, and the regions of spoVG known to
be targeted by SprX are highlighted in blue (Eyraud et al., 2014).
As will be detailed in subsequent chapters, CLASH also identified a large number
of novel interactions. Figure 4.11A shows the individual interactomes of RsaA,
RsaE and RNAIII as uncovered from CLASH experiments performed in this study.
The interactions composing these interactomes have been filtered for statistical
significance and any interactions with rRNAs and tRNAs have also been removed.
This latter point is due to the fact that I am unsure if interactions between rRNAs and
tRNAs are genuine or artefacts due to these transcripts’ abundance. However, it can
be seen that CLASH is able to identify potentially novel mRNA and sRNA targets of
all of these well-known sRNAs. Future studies to be discussed in this thesis will focus
on RsaA’s interaction with RNAIII and qacAB, and RsaE’s interaction with RsaOG,
SAA6008_09901 and SAA6008_09902. Finally, Figure 4.11B shows an example of a
whole cell interactome as obtained from CLASH; in this case, from RNase III after
RPMI exposure in USA300. This Figure illustrates the power of CLASH to identify
complex networks of interactions, alongside smaller connections.
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Fig. 4.11: Examples of interactomes obtained from CLASH. A. Individual interactomes of
RsaA, RsaE and RNAIII from merging all the RNase III and RNase Y CLASH
datasets. Interactions that have already been reported are highlighted in blue.
These data have been filtered for statistical significance and any interactions with
rRNAs and tRNAs have been removed. The edge weight indicates the number
of unique interactions obtained. B. Overall interactome obtained from CLASH
on RNase III in USA300. The most abundant interaction, that between sprA1
and SprA1AS is highlighted. Additionally, the locations of RsaA, RNAIII and
RsaE are shown. These data have been filtered for statistical significance and
any interactions with rRNAs and tRNAs have been removed. The edge weight
indicates the number of unique interactions obtained.
From the data presented here and in Section 4.5, I determine that CLASH is able
to recover sRNA – mRNA interactions that agree with the current paradigm of
sRNA-mediated regulation. Additionally, CLASH is able to identify interactions
involving validated sRNAs and many known interactions are recovered - these
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positive validations give credence to any novel interactions proposed by CLASH.
Thus, I conclude that CLASH is a suitable method for identifying both validated and
novel sRNA – target interactions.
4.6 CRAC analysis reveals target classes of RNase
III and RNase Y
Although I am primarily interested in RNA – RNA interactions, the CLASH methodol-
ogy also provides data on the single RNAs bound to the precipitated protein. This
is relevant to this study as CLASH was performed on two RNases and as such the
target RNAs may be transcripts targeted for degradation. Thus, examination of these
single reads may reveal target classes that are marked for destruction after the shift
to RPMI.
In both JKD6008 and USA300, I observed that RNase III increasingly targets protein
coding sequences after the shift to RPMI (Figure 4.12A, upper panel) – in USA300,
from ~4% in TSB to ~11% in RPMI and in JKD6008, from ~10% to ~13%. Ad-
ditionally, 5’ and 3’ UTRs are also increasingly targeted at a similar rate, and small
decreases are observed for rRNAs, tRNAs and intergenic regions. The shift does not
seem to impact the targeting sRNAs which consistently represent ~6% of the total
targets. Thus, RNase III may increasingly target mRNAs for degradation after the
shift to RPMI, as represented by increasing targeting of UTRs and protein coding
sequences.
I next examined if any common sequence motifs could be found within RNase III’s
target genes (Table 4.1). This was performed by filtering the CRAC data for false-
positives and then generating peaks of RNase III binding. Afterwards, these peaks
were analysed for common motifs between 4 and 8 nucleotides long. These motifs
are scored by ‘Z-score’, which represents how many standard deviations the motif
exhibits from the mean binding. Looking at the top 5 motifs found in both TSB and
RPMI, it is clear that RNase III has a preference for purine-rich sequence such as
GAAG, AGA and GGA.
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Fig. 4.12: RNase III and RNase Y target composition. Each panel shows the target classes of
RNase III (A.) and RNase Y (B.) as raw counts (left) and as a percentage of the
total (right).
4.6 CRAC analysis reveals target classes of RNase III and RNase Y 122
RNA classes targeted by RNase Y do not significantly respond to the shift to RPMI. A
small decrease is observed in intergenic regions and sRNAs (~3% and ~2% respec-
tively) and a small increase for protein coding (~3%) after the shift to RPMI, but
other transcript classes remain virtually stable (Figure 4.12B, upper panel). Inter-
estingly, although RNase Y has not been associated with targeting rRNA transcripts,
I identify the 23S, 16S and 5S transcripts as being targets. Looking at the target
motifs again revealed a preference for G-A rich sequences (Table 4.2).
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4.7 Discussion
The first aim of this chapter was to explore the transcriptome of S. aureus in response
to RPMI stress and confirm that sRNAs are likely to form a major component of
the stress response. Next, this chapter aimed to prove that CLASH was a suitable
method for detecting sRNA-target interactions. This latter aim was achieved through
examining the data from a global perspective to see if found interactions fit the
canonical sRNA mode of activity, and then at a finer level to examine if known sRNA
interactions were identified.
sRNAs exhibit complex responses in response to stress
One of the most interesting aspects of the data presented in this chapter is the
dynamism exhibited by sRNAs in response to RPMI. Many sRNAs were observed to
have complex expression patterns that exhibited sharp changes on short timescales.
Additionally, many sRNAs switched from being downregulated to upregulated, or
vice versa, at different points in the timecourse. Firstly, this data shows the power
of short-term timecourse experiments to resolve complex cell responses. Whilst
the Staphylococcal field has traditionally examined sRNA expression profiles after
time periods ranging from half an hour to 6 hours after stress (Bronesky et al.,
2019; Geissmann et al., 2009; Howden et al., 2013), I demonstrate here that sRNAs
are capable of acting on timescales as short as 5 minutes. Additionally, the entire
response profile of some sRNAs to stress takes less than 30 minutes, such as RsaOG
and RsaH in response to RPMI. These responses may be crucial for the initial stages
of adaptation but would be missed in by traditional approaches to study them.
Finally, the fact that some sRNAs can exhibit both up- and down-regulation within a
30-minute window suggests that within a specific stress, a single sRNA can be only
desired at a particular time period, e.g. during the initial moment of adaptation but
becomes unwanted and destroyed thereafter. As such, the role of sRNAs in stress
adaptation may not be a simple case of ‘turned off’ or ‘turned on’.
RPMI medium causes S. aureus to undergo significant transcriptional remodelling
After exposing the cells to RPMI, a huge number of transcripts exhibited significant
differential expression. Some study into the behaviour of S. aureus in RPMI medium
has already been carried out by the field. Dörries and Lalk, 2013, grew the S.
aureus strains COL and HG001 in RPMI and found that it uptakes amino acids in the
exponential phase of growth. Here, cells were shifted at late-exponential phase into
RPMI and several operons involved in amino acid uptake and biosynthesis increased
significantly in expression. In my data, I observed an upregulation in amino acid
transporters, such as the opp operon, and also in the ilv operon which is involved
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in the biosynthesis of branched chain amino acids. Given that CodY is known to
bind branched chain amino acids such as isoleucine, CodY could be mediating this
response (Majerczyk et al., 2008). Mäder et al, 2016, found that growing cells in
RPMI led to increased expression in many iron-responsive genes, and here a large
cluster of iron-related transcripts were observed to increase in expression after the
shift. This could be mediated by inactivation of the Fur repressive transcription
factor as a result of low intracellular iron after the shift to RPMI.
However, the RNAseq data carried out here also contributes novel findings. It was
found that immediately after the shift to RPMI, several genes involved in glycolysis
were upregulated during the first 5 minutes but then downregulated thereafter to
levels below basal. As such, it may be that S. aureus tries to adapt to the initial
phases of stress by upregulating glycolysis as a means to immediately generate the
energy it requires to survive, before shutting it off – perhaps to utilise a different
metabolic pathway afterwards.
Additionally, several virulence-related genes exhibited the same expression pattern
as these glycolytic genes. The link between metabolism and virulence is becoming
increasingly appreciated in bacteriology and is discussed at length in Chapter 5.
However, I briefly mention here that this small correlation also adds to this idea.
Thus, the RNAseq data here serves to show that the experimental system recapitulates
what is already known in the field, giving weight to the idea that this is a useful
tool for examining sRNA-mediated regulation. Secondly, it gives further insight into
the nature of sRNA expression, demonstrating their changing behavioural patterns.
Finally, this data will be further discussed in Chapters 5 and 6 to examine the
expression of novel targets of sRNAs to gain insight into sRNA-mediated destruction
and sRNA sponging.
CLASH uncover sRNA – target interactions in S. aureus
Using RNase III as a bait protein for CLASH discovered many unique sRNA – target
interactions. The first aim of my CLASH analysis was to demonstrate that this dataset
was of high quality and could be used to uncover novel interactions. Satisfying this
aim, I was able to identify many known interactions and also recover a significant
number of interactions containing validated sRNAs. Secondly, examining the data
from a global perspective revealed that interactions found between sRNAs and
mRNAs frequently obeyed the canonical thought of sRNA-mediated regulation, with
binding enriched in the 5’ UTR and start codon region of the mRNA. As such, I
conclude that the CLASH data presented here is a useful tool for uncovering novel
sRNA targets.
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One surprising aspect of the CLASH data is the large number of interactions between
intergenic regions and mRNAs (including their 5’ UTRs). This potentially suggests
that there is a pool of unidentified sRNAs in S. aureus currently annotated as inter-
genic regions. Indeed, such regions are already a topic of focus in the bacteriology
field (Argaman et al., 2001; Fuli et al., 2017; Rath et al., 2017; Tsai et al., 2015).
One of the main advantages in using CLASH to discover these potentially novel
sRNAs is that it also uncovers their potential targets and as such gives immediate
insight into their possible function and avenues of future research.
Additionally, RNase III CLASH consistently found that 2-4% of the total interac-
tome was represented by sRNA-sRNA interactions. The interaction between sRNAs
themselves is becoming increasingly appreciated, and CLASH on RNase E in E. coli
identified 150 sRNA-sRNA interactions, representing just under 2% of the total cap-
tured interactome (Waters et al., 2017). Additionally, Hfq CLASH in E. coli identified
90 sRNA-sRNA interactions, again representing just under 2% of the total (Iosub
et al., 2018). Thus, interactions between sRNAs may be a consistent and sizeable
proportion of the interactome across different bacterial species.
However, it is important to note that as sRNAs are able to bind multiple mRNA
targets, they integrate many different signals into a single molecule. Thus, the single
act of one sRNA binding to and sponging another away from its targets has the
capacity to induce changes in the stability or translational efficiency of many target
mRNAs. As such, while interactions between sRNAs may represent only ~2% of the
interactome, the impact of these interactions may be much larger.
The RNase III CLASH data in RPMI identified a large number of interactions between
sRNAs and intergenic regions. Similarly to that discussed above relating to mRNAs,
these may represent novel sRNA – sRNA interactions. If this was the case, then this
would greatly increase the incidence of this interaction type and would suggest that
sRNA – sRNA interactions are more abundant than previously thought. Additionally,
as RNase III was used to identify these, this would place RNase III as a major
regulator of these interactions.
RNase III CLASH was also able to identify potentially novel mRNA targets of relatively
well-understood sRNAs, namely RsaA, RsaE and RNAIII. It is noteworthy that for
RsaA and RsaE, already known mRNA targets were identified. However, this was
not the case for RNAIII. This is initially surprising as the targetome of RNAIII is
expansive; it may be that at the growth stage CLASH was performed, RNAIII has
already induced the degradation of its negatively regulated targets such as sbi and rot.
Alternatively, it is possible that some interactions between RNAIII and mRNA targets
are not directly recognized by RNase III and therefore not efficiently captured.
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Examining the novel targets of RsaA, RsaE and RNAIII reveals encouraging avenues
of future research. RsaA was found to interact with an antiseptic drug transporter,
qacAB. This transporter belongs to the qac class and is involved in the export of qua-
ternary ammonium compounds, intercalating dyes and β-lactam antibiotics (Jaglic
and Cervinkova, 2018). Currently, RsaA is understood to indirectly regulate cell
membrane homeostasis through its regulation of mgrA, a transcription factor that in
turn regulates many membrane proteins (Tomasini et al., 2017). Additionally, MgrA
is known to regulate capsule formation which is linked to antibiotic resistance (Cam-
pos et al., 2004; Geisinger and Isberg, 2015) and deletion of mgrA, in combination
with sarA, causes increased susceptibility to cell wall-active antibiotics (Trotonda et
al., 2009). Thus, the finding that RsaA may directly regulate a membrane protein in-
volved in antibiotic and antiseptic resistance fits its already known role in membrane
homeostasis, but with the novelty of being a direct interaction. This interaction is
further investigated in Chapter 5.
RsaE was also found to interact with three other sRNAs; RNAIII, srn_2860 and
srn_4190. Both srn_2860 and srn_4190 were originally identified by Howden et
al, 2013, and are thought to be products of antisense transcription. As such, they
were not considered for future study. However, the interaction with RNAIII was
recovered with almost 450 unique hybrids. These sRNAs are already known to
have a common target between them, mgrA, and also have opposing roles; RsaA
promotes dormancy, while RNAIII promotes virulence (Gupta et al., 2015; Romilly
et al., 2014). Thus, due to the already recognised importance of these sRNAs, this
interaction was chosen for future study and is described further in Chapter 5.
Regarding RsaE, the most interesting candidate targets were SAA6008_09902 and
SAA6008_09903. These are α phenol-soluble modulins (PSMs), a class of virulence
factors involved in host cell lysis, biofilm remodelling and intracellular escape
(Cheung et al., 2014; Grosz Magdalena et al., 2014; Xu et al., 2017). Currently, RsaE
is known to be involved in metabolic regulation, and so this interaction suggests
a direct link between virulence and metabolism. Due to the importance of these
behaviours, the interaction between RsaE and the αPSMs is further discussed and
studied in Chapter 6.
Regarding RNAIII, this was observed to interact with four sRNAs. One, RsaA,
has been discussed above. However, it was also found to interact with srn_1070
(otherwise known as Sau-41). This transcript is highly expressed in exponential
and stationary phase, and is not present in small colony variants – a very similar
pattern of expression as seen for RNAIII (Abu-Qatouseh et al., 2010). However, it
is unclear if this is a genuine sRNA and it has been noted that it could be a 5’ UTR
of SAS014, a hypothetical protein (Felden et al., 2011). Thus, it could be an sRNA
that acts in concert with RNAIII or potentially a novel mRNA target that, judging
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from its expression pattern, may be positively regulated by RNAIII. The second
‘sRNA’ to interact with RNAIII, srn_4670 (otherwise known as RsaOT), has also been
hypothesised to be a product of 3’ end processing of its neighbouring mRNA, as
it starts a mere 6 nucleotides after the stop codon (Bohn et al., 2010). Teg4 was
identified by Howden et al, 2013, but has no meaningful information attributed to it.
As such, I subsequently focused on RNAIII’s interaction with RsaA.
RNAIII was also found to potentially interact with two virulence factors; esxA and
saeR. EsxA is a secreted peptide that regulates host cell apoptosis (Korea et al., 2014;
Sundaramoorthy et al., 2008) and it is interesting that RNAIII, a virulence-related
RNA, is found directly interacting with it. This interaction is further discussed and
validated in Chapter 5.
SaeR is the transcription factor response regulator of the sae two-component reg-
ulatory system (Giraudo et al., 1999). SaeR is activated when the sensor, SaeS,
autophosphorylates in response to certain environmental signals such as human
neutrophil peptides and calprotectin (Cho et al., 2015; Geiger et al., 2008). In turn,
SaeR activates the expression of many virulence related genes such as coa, nuc, hla,
lukE, sbi, tst and many other exotoxins. Interestingly, the agr operon has been found
to positively regulate transcription of sae P1 promoter which induces transcription
of the entire operon, including saeR (Geiger et al., 2008). Additionally, RNAIII is
required for sae transcription (Novick and Jiang, 2003). However, it has been noted
that the sae operon does not contain any AgrA binding sequences and that therefore
the effect has been hypothesised to be indirect (Liu et al., 2016). However, the
finding that RNAIII potentially interacts directly with saeR at the post-transcriptional
level may partially explain these findings; RNAIII may stabilise the saeR transcript,
allowing its translation. Although this interaction was not chosen for further study,
it would be interesting to continue this through further validation.
Thus, overall, the CLASH methodology has successfully completed its aims. Firstly,
it has proven that it can recover verified interactions. Secondly, it has successfully
recovered novel sRNA-target interactions that fit the behavioural profile of selected
sRNAs (such as RsaA’s interaction with qacAB) and also suggested novel interactions
that open up new avenues of research (e.g. linking metabolism virulence through
RsaE). These interactions have been taken forward and further studied, as described
in Chapters 5 and 6.
CRAC identifies RNA targets of RNase III and RNase Y
Another advantage to the CLASH protocol is its ability to give details on the single
RNA targets of the protein of interest. In this chapter, I have detailed these analyses
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from a global perspective. However, the CLASH data will be described further in
Chapters 5 and 6 in order to model degradation of selected target genes.
A first observation from examining the single read data obtained from RNase III
CLASH is that all classes of RNAs are recovered. This fits the known profile of RNase
III, which has already been shown to be involved in rRNA and tRNA processing,
turnover of sRNAs and mRNAs and processing of sRNA-mRNA duplexes in S. aureus
(Lioliou et al., 2012). Additionally, RNase III has been found to target untranslated
regions in Streptococcus pyogenes (Le Rhun et al., 2017) and here I also observed
binding to 5’ and 3’ UTRs of mRNAs. Regarding specific transcripts, RNase III has
also been found to bind many different sRNAs including RsaA, RsaE and RNAIII
(Lioliou et al., 2012). This is encouraging as it gives credence to the interactions I
uncovered between these sRNAs and their targets using CLASH.
RNase III has also been found to be a major regulator of antisense transcripts (Lasa et
al., 2011; Lioliou et al., 2012). Such transcripts can be generated from transcription
of the opposite strand of protein coding sequences or from overlapping long 5’ and
3’ UTRs of genes from opposite strands. This produces a noncoding transcript with
perfect complementarity to the coding sequence and can cover the 5’ or 3’ end,
coding sequence or even the entire gene (Lasa et al., 2011). RNase III has been
found to target duplexes created by the interaction between sense and antisense
transcripts (Lasa et al., 2011). Such targeting of antisense transcripts was beyond
the scope of the work presented in this thesis, but recently analyses performed by
Sander Granneman have demonstrated that these interactions are present in the
data. As such, further interrogation of the data could further add to the list of
antisense RNAs targeted by RNase III.
Examination of the target motif of RNase III revealed a preference for GA-rich
sequences. However, this was also recovered in the RNase Y data. Although these
sequences are highly enriched, it is potentially suspicious that two distinct nucleases
recovered the exact same target motifs. However, in vitro studies have shown a
preference in RNase III for G-C pairings in E. coli (Altuvia et al., 2018). It may also
be that RNase III recognises the structure of its targets more so than any specific
nucleotide tract. This fits with the known data of RNase III as it specifically targets
double-stranded RNA and in particular stem structures.
Additionally, Altuvia et al, 2018, found that RNase III is capable of cleaving in-
tramolecular stem structures formed within an individual RNA. This avenue of
research could be greatly furthered by the CLASH data, as CLASH is capable of not
only detecting intermolecular interactions (i.e. RNA1 – RNA2) but also intramolec-
ular interactions (i.e. RNA1 – RNA1). Although not presented in this thesis, the
CLASH data contains huge numbers of intramolecular interactions which could be
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the subject of further analysis to examine the structures of RNase III targets. Indeed,
a collaboration has been set up with Dr Grzegorz Kudla to further examine the struc-
tures of targeted RNAs and preliminary results indicate that RNase III targets are
generally more folded compared to other regions of the genome, contain tetraloop
structures and are depleted in long regions of unfolded nucleotides. This research
will be continued and included in any upcoming publication.
RNase Y has also been subject of some study in the Staphylococcal field. Deletion
mutants and mapping of the 5’ ends of its targets identified around 250 targets of
RNase Y, consisting of mRNAs and sRNAs (Khemici et al., 2015). Some of these
sRNAs were recovered in this study such as RsaA, SprX and RNAIII, as were members
the sae operon that have been shown to be targeted by RNase Y (Marincola Gabriella
et al., 2012). However, the authors noted that they did not identify any convincing
rRNA transcripts subject to RNase Y-mediated cleavage which disagrees with the
data presented here. The authors used a silica column-based method for their RNA
purification which is noted to select for RNAs above 200 nucleotides; as such, they
may have missed the short 5S transcript that we identify as an RNase Y target.
However, this does not explain the why I identify 23S and 16S transcripts as RNase
Y targets and they did not.
Khemici et al, 2015, also found that RNase Y does not have a strong target motif,
noting only that they consistently found a guanine nucleotide prior to any cleavage
site. They proposed that secondary structure recognition may be important for
RNase Y targeting. As such, my data could also be further analysed for secondary
structure in a similar manner to that being carried out for RNase III. However, it is
noted that in B. subtilis, RNase Y is thought to target AU-rich regions (Shahbabian et
al., 2009).
Furthermore, RNase Y is a membrane-bound RNase that is incorporated into a large
degradosome-like complex (Marincola Gabriella et al., 2012; Roux et al., 2011).
Removal of the membrane anchor results in a severe growth defect (Marincola
Gabriella et al., 2012), and so it may be that RNase Y target acquisition is mediated
through the delivery of selected RNAs to its subcellular location through degrado-
some partners. If this were the case, then this may remove the need for a consensus
RNase Y target motif and instead place this burden on the RBP partners.
Future directions
Already described above is how the single read data will be mined to examine
structural motifs targeted by RNase III and potentially RNase Y. However, the
main aim of this chapter and its constituent analyses was to identify sRNA-target
interactions for future study. This has been achieved and the interactions between
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RsaA, RNAIII and qacAB; RsaE, SAA6008_09902 and SAA6008_09902; and RNAIII
and esxA have been selected for future study. These are discussed in the upcoming
Chapter 5 and Chapter 6. However, the CLASH data as a whole will be of great
interest to the Staphylococcal field and I suspect that, when published, it will be
mined by other groups for potentially novel sRNA-target interactions. These will
undoubtedly involve known sRNAs but also novel, unidentified ones currently
annotated as intergenic regions. As such, the CLASH data presented here has great
potential in expanding the field considerably.
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5RsaA and RNAIII interact in vivo
and are targeted by RNase III
5.1 Introduction
As discussed in Chapter 1, sRNAs have already been shown to play key roles in
crucial signalling pathways including virulence and antibiotic resistance. RNAIII is
the most well characterised sRNA in S. aureus. This is a pro-virulence factor that acts
as the main effector from the quorum-sensing agr pathway (Section 1.7). It acts to
switch the cell from a state of dormancy into one of aggression. This is accomplished
through its regulation of several target mRNAs; it stimulates translation of hla and
mgrA, whilst inducing RNase III-mediated destruction of rot, spa, coa, and sbi.
As discussed in Section 1.8, RsaA is thought to be involved in the attenuation of
virulence. RsaA is known to bind to mgrA at two distinct regions; one interaction
covers the ribosomal binding site and prevents translation, while the second recruits
RNase III and induces degradation. Additionally, RsaA has been found to be involved
in regulating cell surface proteins such as ClfB, Ebh and Protein A.
The CLASH experiments revealed a large number of interactions between RsaA and
RNAIII in TSB medium. When the cells were shifted to RPMI, this interaction was
then found at a greatly reduced incidence. Additionally, the RNA-seq data showed
that RNAIII is immediately downregulated after the shift. Thus, I hypothesised that
RNAIII and RsaA are capable of interacting in vivo, that this interaction responds to
the stresses incurred, and that it may regulate the stability of RNAIII. This chapter
will detail validations of this interaction and hypothesise it helps to shape S. aureus’
adaptation.
5.2 CLASH identifies known targets of RsaA
In order to gain greater insight into the reliability of CLASH, the data was examined
to see if already known targets of RsaA could be identified. One of most well studied
targets of RsaA is the pro-virulence transcription factor, mgrA. RsaA is known to bind
to the 5’ end of mgrA to prevent the 30S ribosomal subunit from binding, and also
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to the 3’ end (Romilly et al., 2014). For JKD6008, the CLASH data obtained around
300 unique hybrids between RsaA and mgrA in RPMI and 28 in TSB; in USA300, 61
unique hybrids were identified in RPMI. All of these mapped to the 5’ end of mgrA.
As seen in Figure 5.1, the hybrids obtained through CLASH recover the entire 3’-end
interaction, including the bases covering the AUG of the start codon.
SsaA belongs to the Staphylococcal secretory antigen A family which is involved
in peptidoglycan metabolism. SsaA2_3 and SsaA_2 were identified as targets of
RsaA through MAPS, and then validated through in vitro EMSAs and toeprinting
assays (Tomasini et al., 2017). This found that RsaA binds to the RBS and prevents
translational initiation. The interaction between RsaA and Ssa2_3 was recovered
with CLASH, but only a single hybrid containing a short fragment of SsaA2_3 was
identified. The reads relating to SsaA2_3 mapped to the 5’ UTR exclusively and
did not extend into the SD sequence. Thus, the CLASH data validates the SsaA2_3
interaction with RsaA but with a slightly different binding region.
MAPS also uncovered an SH3 domain-containing protein interacting with RsaA,
named HG001_01977 in the HG001 strain (Tomasini et al., 2017). This is equivalent
to JKD6008_01954 locus in the JKD6008 strain, and this interaction was also
uncovered with CLASH. However, Tomasini et al., 2017, did not manage to identify
precisely the region of interaction. One of the advantages of CLASH over MAPS is
that CLASH gives insight into which regions of two RNAs interact together, and data
described here finds that RsaA binds to the 5’ UTR of JKD6008_01954, before the
SD sequence.
In conclusion, CLASH is able to confirm already known interactions between RsaA
and its targets. This helps to confirm the CLASH approach and gives credence to
novel interactions for RsaA.
5.3 CLASH identifies RNAIII as a target for RsaA
The most abundant interaction uncovered for RsaA was with RNAIII. This interaction
was found in both the JKD6008 and USA300 data. When summing the total number
of interactions in TSB and in RPMI, it was found that ~5X more interactions were
identified in TSB versus RPMI; 282 versus 57 respectively (Figure 5.2A). Although
CLASH is not strictly quantitative, such a large difference postulated the idea that
this interaction could respond to specific mediums. When hybrids were mapped
to the genomic locus of each gene, it was found that is the 5’ end of RsaA which
interacts with the 3’ end of RNAIII (Figure 5.2B). For RNAIII, hybrid reads involved
with base-pairing to RsaA mapped to the 8th, 9th, and 10th hairpin structures, using
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Fig. 5.1: Predicted interactions between RsaA and its known targets. RsaA is shown in grey
and the targets in black. For mgrA, the 5’ site of interaction found by Romilly
et al is highlighted in blue. Structures were generated by extracting the CLASH
read sequences as input for RNAcofold, which was used to predict the interaction
structure. For the interaction with SsaA2_3, such a short read was uncovered
(highlighted grey) that 20 nucleotides from either side of the hybrid were added
to the 5’ and 3’ end.
the nomenclature from Bronesky et al., 2016. Interestingly, this region in RNAIII is
far from the small ORF encoding for δ-haemolysin and thus I hypothesised that this
interaction regulates the activity or stability of these sRNAs, as opposed to regulating
translation of hld. Indeed, when the nucleotides involved in this interaction are
extracted and folded in silico, an extended region of interaction is observed with a
very favourable minimum folding energy of -93.30 kcal/mol.
As sequence conservation across bacterial species is indicative of a preserved func-
tionality, conservation analysis was performed on RsaA and the interacting region of
RNAIII (Figure 5.3B). RsaA does not display particularly strong conservation overall,
although there exists a ‘ACGTATATA’ motif that is somewhat preserved throughout
the examined species. Additionally, the characteristic ‘UCCC’ motif (‘TCCC’ in figure
Figure 5.2C) of the Rsa sRNAs is conserved between S. aureus, S. argenteus and
S. simiae. The interacting region of RNAIII exhibits stronger conservation, with
significant variation only observed in S. argenteus. However, this conservation could
also be related to the fact that the hairpin structures involved in interacting with
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Fig. 5.2: Proposed interaction between RsaA and RNAIII. A. Mapping the hybrids to the
genomic loci of their respective gene. B. Conservation analysis of RsaA and the
interacting region of RNAIII (with 20 flanking nucleotides on both ends). The
boxed regions indicate those which are involved in the interaction.
RsaA could also be used for interacting with other transcripts; hairpin 10 is already
known to interact with coa.
Figure 5.3 shows the regions of interaction onto the structures of the sRNAs them-
selves. This shows clearly how interacting region of RNAIII (Figure 5.3A) map to
the 8th, 9th and 10th hairpins, while for RsaA this region is found at the 3’ end and
covers the functional UCCC motif (Figure 5.3B). For in silico analyses, a portion of
RNAIII from the 7th to 11th hairpin was taken and folded with the full length RsaA.
This revealed an extended region of interaction which melts the 9th helix of RNAIII
and the UCCC-containing helix of RsaA (Figure 5.3C). The interaction also has a
favourable folding energy of -93.90 kcal/mol. Thus, overall, it is predicted that it
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is the activity of hairpin 9 of RNAIII interacting with the UCCC-containing loop of
RsaA that mediates the interaction.
Fig. 5.3: Regions of interaction for RNAIII and RsaA. A. RNAIII structure with the hybrid
reads identified in CLASH interacting with RsaA outlined in black. The nucleotides
in between the green line were taken for in silico folding analysis as shown in
C. B. RsaA structure with the hybrid reads interacting with RNAIII in black. The
UCCC motif is labelled. C. In silico predicted structure of RNAIII (7th – 11th
helices) interacting with RsaA. The nucleotides surrounded by the black border
were identified in CLASH.
5.4 RsaA and RNAIII are able to interact
specifically in vitro
In order to validate the idea that these two RNAs interact specifically through the
9th helix of RNAIII, in vitro electrophoretic mobility shift assays (EMSAs) were per-
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formed. For this, two synthetic fragments of RNAIII were generated in vitro; RNAIII
interacting, consisting of helices 7 to 11; and RNAIII non-interacting, consisting
of helices 2 to 6. This RNAIII non-interacting construct was to act as a negative
control, being specifically chosen as no reads from this region of RNAIII were found
interacting with RsaA in the CLASH data. However, folding this region with RsaA
in silico gives a similar MFE energy to RNAIII interacting domain; -72.80 kcal/mol
versus -93.90 kcal/mol respectively. Thus, I predicted that this region of RNAIII
would serve as a fair negative control to examine non-specific binding of RNAIII to
RsaA in vitro.
RNAIII interacting and RsaA were first confirmed to fold as expected through SHAPE-
based structure probing. This method uses a chemical probe, 2-methylnicotinic
acid imidazolide (NAI), that forms adducts with flexible nucleotides, which are
predominantly found in single-stranded regions such as bulges or internal loops.
These adducts can terminate reverse transcription (Deigan et al., 2009). When using
low concentrations of NAI, the location of these modification sites can be identified
by primer-extension analysis, which enabled me to detect flexible regions in the in
vitro folded RNAs.
Structure probing experiments for both RNAIII interacting and RsaA indicated that
the in vitro produced RNAs folded largely as expected as most of the NAI modification
sites mapped to regions that were predicted to be single-stranded (Kolb et al., 2000).
For RNAIII interacting, flexible nucleotides were found just before helix 7 and in
the loop region. This pattern was also observed for helices 8, 9 and 10 (Figure
5.4B). Regarding RsaA, free nucleotides were identified in bulges that formed from
imperfect base-pairing sequences, and at the first loop region, although no free
nucleotides were detected at the UCCC motif. Due to time constrains, the structure
of RNAIII non-interacting was not probed. However, overall, it was deduced that
RNAIII interacting and RsaA fold as expected. I also plan to probe the RNAIII-RsaA
duplex to see if I can validate the structure predicted by the CLASH data.
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Fig. 5.4: Structure probing of RNAIII interacting. A. Primer extension gel after NAI treat-
ment. Asterisks indicate sites of modification. B. The structure of RNAIII inter-
acting, taken from the full length structure of RNAIII as produced by (Kolb et al.,
2000), with sites of modifications marked with asterisks.
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Fig. 5.5: Structure probing of RsaA interacting. A. Primer extension gel after NAI treatment.
Asterisks indicate sites of modification. B. The structure of RsaA, as predicted by
RNAcofold, with sites of modifications marked with asterisks.
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After confirming that in vitro transcribed ‘RNAIII interacting’ fragment and RsaA
fold correctly, EMSAs were performed to examine their proposed interaction. As
shown in Figure 5.6, only RNAIII interacting is able to form a complex with RsaA and
adding increasing amounts of RNAIII interacting increases the amount of complex
produced. Quantifying this (Figure 5.6B) shows that the dynamics of this interaction
fit a classical saturation binding curve, with RNAIII able to occupy almost the entire
pool of RsaA when in 320-fold molar excess of RsaA, with around a 60-molar excess
able to bind half of the pool. Additionally, multiple bands can be observed to form
between RNAIII interacting and RsaA, and thus the duplex may exist in multiple,
slightly different conformations in vitro.
Conversely, RNAIII non-interacting is not able to form any specific interactions
with RsaA. Observed in Figure 5.6A (and quantified in Figure 5.6B) is RNAIII
non-interacting forming a duplex at a rate comparable to RsaA by itself, i.e. the
background oligomerisation of RsaA. Increasing the molar ratio of RNAIII non-
interacting does not substantially increase the formation of duplex, and thus it is
concluded that the signal observed for RNAIII non-interacting mostly relates to
negligible RsaA self-interaction. Thus, the interaction between RsaA and RNAIII
interacting is specific.
It is overall concluded that RsaA and RNAIII interact specifically through a region in
RNAIII found between helices 8 and 10, and a region containing the UCCC-motif
in RsaA. In silico predictions lead helix 9 to be the main region responsible for base
pairing with RsaA, but future experiments would be necessary to absolutely confirm
this.
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Fig. 5.6: In vitro interaction of RsaA and RNAIII. A. Left: Structure of RNAIII with the
‘RNAIII interacting’ and ‘RNAIII non-interacting’ constructs indicated. Right: EMSA
between radiolabelled RsaA and increasing molar concentrations of RNAIII inter-
acting and non-interacting B. Quantification of RsaA – RNAIII interaction. Left:
histogram showing the formation of the duplex as a percentage of the total RNA.
Right: binding curves fit to non-linear regression analysis.
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5.5 The interaction between RsaA and RNAIII
responds to stress
When I examined the CLASH data, I found that the number of interactions between
RsaA and RNAIII was much higher in the unshifted, TSB sample versus the RPMI; 282
versus 57 respectively (Figure 5.7A). Although CLASH is not a strictly quantitative
technique, this alluded to the idea that the interaction between RsaA and RNAIII
could respond to stress.
In order to explore why the number of interactions was decreasing, the expression of
RsaA and RNAIII was measured by qPCR following shift to RPMI medium. Although
this had already been obtained in the form of RNAseq (Section 4.2), it was noted
that the data for these two sRNAs was noisy and so qPCRs were predicted to give a
more reliable insight into their dynamics.
Figure 5.7B shows that when the cells are shifted back into TSB as a negative control,
their expression slowly increases over the entire time-course, although noise is
observed for the final 30-minute sample. However, when the cells are shifted to
RPMI, the expression of RNAIII immediately decreases; after just 5 minutes, its
expression is decreased by ~75%. This downregulation continues to 10 minutes
where it is downregulated ~85% before starting to slowly recover. Comparing the
expression of RNAIII in RPMI to TSB reveals that the downregulation at 5 and 10
minutes is statistically significant, although the final, 30-minute timepoint is not due
to the large degree of error for the control TSB shift.
Conversely, the expression of RsaA increases over time. After 5 minutes, RsaA is
upregulated ~1.5-fold as compared to the reference sample, and by 10 minutes this
has increased to ~2-fold. For comparison, the TSB shifted control only increases
to ~1.1-fold, although the difference between the two is not quite statistically
significant (p = 0.09) due to the degree of error.
Overall, the mirror image expression pattern of RsaA and RNAIII helps to explain why
fewer interactions are found in RPMI versus TSB. Based on these data I hypothesize
that after the shift to RPMI, RNAIII is immediately downregulated, presumably in
part through base-pairing interactions with RsaA, and only a small fraction of it
remains after just 5 minutes. Considering that CLASH was performed on cells after
15 minutes of RPMI incubation, it is predicted that only around ~20% of the original
pool of RNAIII remained, and thus there is less RNAIII for RsaA to interact with.
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Fig. 5.7: In vivo dynamics of RsaA and RNAIII A. Number of hybrids between RsaA and
RNAIII in TSB and RPMI. B. Expression of RsaA (blue) and RNAIII (orange)
after shift to TSB (dashed line) and RPMI (solid line) as measured by qPCR. The
statistics are generated from comparing the expression in RPMI at that particular
timepoint to TSB. C. Expression of RsaA and RNAIII after overexpression of the
other, as measured by qPCR. Far right panel shows the efficiency of overexpression
D. Expression of the targets of RsaA and RNA after TSB (orange) and RPMI (blue)
shift. In all panels, * = 0.05; ** = 0.01; *** = < 0.01 in Student’s unpaired t test,
and error bars relate to standard error of the mean.
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5.6 Overexpression of RsaA downregulates RNAIII
and vice versa
The fact that this interaction was discovered using RNase III as bait suggests that
RsaA binds to RNAIII and recruits this double-strand-targeting RNase in order to
degrade the duplex. Therefore, an obvious question is whether over-expression of
RNAIII results in down-regulation of RsaA and vice versa. To test this, I overexpressed
both sRNAs from a multi-copy plasmid, pRMC2 (Corrigan and Foster, 2009). The
effect of over-expression was assessed after 5 and 10 minutes after inducing sRNA
expression as I wanted to avoid any secondary effects. Moreover, I observed that
USA300 shuts down the expression of these sRNAs within 30 minutes of over-
expression (data not shown), suggesting that the expression of these sRNAs is under
tight control. While RsaA could be highly over-expressed from a plasmid (~12-fold
after just 5 minutes; Figure 5.7C far right panel), I was only able to increase RNAIII
cellular levels by ~2-fold. This is likely explained by the fact that these experiments
were carried out at OD 3, when the agr pathway is active and so RNAIII is already
a major, highly expressed transcript within the cell. Thus, the plasmid-mediated
induction does not have such a strong effect on the relative amount of RNAIII within
the cell. A possible solution to this problem would be to repeat the over-expression
experiment in an RNAIII deletion strain, which is currently being made.
When examining the expression of RNAIII after induction of RsaA, I observed a
modest, but reproducible and statistically significant, decrease in the levels of
RNAIII. In the empty control plasmid, the expression of RNAIII increases with
time. Already after 5 minutes of induction, RNAIII has increased ~1.5-fold in the
empty plasmid control. Although a large degree of error is observed, by 10 minutes
this has increased to ~2.5-fold (Figure 5.7C). Such a strong increase in RNAIII
expression after just 10 minutes once reaching OD600 3 is not observed in the TSB
to TSB shifts (Figure 5.7B) and thus it may be that the agr pathway responds to
anhydrotetracycline which is used to induce expression from the vector.
However, inducing RsaA expression leads to a small decrease in the amount of RNAIII
within the cell and prevents its future induction. After inducing RsaA, around 35%
of the original pool of RNAIII is destroyed after 5 minutes. RNAIII starts to recover
after 10 minutes, but only to ~80% of the original, and this is statistically significant
in comparison to the empty plasmid control (Figure 5.7C). Thus, overexpression
of RsaA is able to induce destruction of RNAIII and prevent its accumulation in
post-exponential phase.
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The RNA steady state levels of RsaA was then examined after induction of RNAIII.
RsaA exhibited no significant changes in expression after inducing the empty plasmid
control (~1.3-fold and ~1.1-fold for 5 and 10 minutes respectively). However, when
RNAIII was induced, a ~15% and 10% reduction in RsaA levels were observed
respectively after 5 and 10 minutes, and this was statistically significant for the
10-minute time point. Thus, although I was unable to highly over-express RNAIII in
this strain, the ~2-fold increase in RNAIII levels were sufficient to cause a small but
significant reduction in RsaA levels.
In conclusion, overexpression of RsaA and RNAIII is able to cause a statistically
significant decrease in RNA levels of the other. This data is consistent with what I
observed in the RPMI shift, when RsaA is induced and then RNAIII is subsequently
downregulated. Thus, this supports my hypothesis that RsaA is able to induce
destruction of RNAIII through recruitment of RNase III.
5.7 The induction of RsaA and destruction of
RNAIII following RPMI shift has effects on
downstream mRNAs
Once a relationship and understanding of the dynamic between RsaA and RNAIII had
been established, I next wanted to determine what are the functional consequences
of such an interaction. My assumption was that if RsaA levels increased in RPMI, the
levels of the mRNA targets that are negatively regulated by RsaA should decrease.
Vice versa, I predicted that the levels of mRNAs negatively regulated by RNAIII would
increase due to RNAIII’s destruction. To test this hypothesis, qPCR on the targets
of RNAIII and RsaA following the shift to RPMI and the TSB control samples was
performed.
RNAIII is known to regulate many mRNA targets within the cell, as described in
Section 1.7. Of particular importance is the transcription factor rot and the immune
evasive membrane protein sbi. RNAIII is known to repress the translation and induce
destruction of both of these mRNAs and so it was predicted that their levels would
increase upon RNAIII downregulation. As seen in Figure 5.7D, the expression of
both sbi and rot is upregulated following the shift to RPMI medium (and subsequent
destruction of RNAIII). However, the dynamics are different, as rot is immediately
and continuously upregulated throughout the whole time-course while sbi is only
induced at the latest 30-minute timepoint. This behaviour is in opposition to the
TSB control, where both transcripts both decrease continuously over time.
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RsaA is has been found to regulate the translational efficiency of several targets in
vitro, but in vivo data is lacking. Deletion of RsaA results in increased levels of glyS
which encodes for a tRNA synthetase, and spoVG, which encodes a sporulation factor
involved in antibiotic resistance (Romilly et al., 2014). As deletion of RsaA induces
their upregulation, their interaction with RsaA is predicted to be a negative one.
Consistent with this idea, glyS is downregulated immediately after the shift to RPMI
(Figure 5.7D), and continues to be so during the first 10 minutes (p = 0.06), and
thereafter returns to a level very similar to the control. As such, I predict that RsaA
is able to induce glyS destruction and this occurs when RsaA is upregulated in RPMI.
With regards to spoVG, this transcript is increasing over time in the TSB control but
is unable to be upregulated in the RPMI shift and instead remains at basal levels. As
such, it may be that RsaA is able to prevent spoVG induction.
I cannot rule out the possibility that the observed effect was purely due to tran-
scriptional changes but the fact that there is a negative correlation between the
sRNA levels and their respective targets suggests that sRNA-mediated degradation
at least contributes to the changes in gene expression. In fact, my current working
hypothesis is that a combination of both changed transcription of mRNAs combined
with a changing stability of the sRNAs that target these messengers has a profound
effect on the mRNA induction kinetics and results in much faster responses (also see
Discussion). To test this hypothesis, the lab has recently made a RsaA-null strain
and I will repeat the TSB-RPMI shift experiment with this mutant and quantify the
changes in RNAIII levels and its targets. The hope is that this experiment will provide
additional evidence to support my model.
In conclusion, I propose that RsaA-mediated destruction of RNAIII is able to cause
downstream effects on the targets of RNAIII. These effects are observed already after
5 minutes for rot and 30 minutes for sbi, and thus may form part of the early-stage
adaptation process that occurs when S. aureus is shifted into RPMI medium, and
ergo the host blood stream. Additionally, upregulated of RsaA appears to induce
immediate destruction of a tested tRNA synthetase, glyS, and may also play a role in
shaping the expression of spoVG. Thus, induced RsaA may downregulate its own
mRNA targets, RNAIII, and also act as an indirect activator of RNAIII targets.
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5.8 Transcription and degradation help to shape
the dynamics of RNAIII, RsaA and their target
mRNAs
As mentioned above, I can not rule out the possibility that expression of RNAIII
during the RPMI shift is also, at least in part, shaped by changes in RNA polymerase
transcription. In theory, RNAIII may have a very short half-life and the polymerase
could immediately stop transcribing it in response to RPMI, resulting in its degrada-
tion. This model would also explain its expression profile in RPMI. Thus, to test this
I would need measure transcription rates in S. aureus.In order to measure nascent
transcription, I performed CRAC on RNA polymerase before and at several timepoints
after the shift to RPMI. The assumption was that the bulk of the RNA recovered from
RNA polymerase CRAC experiments would be RNA that is actively being transcribed.
Thus, this allowed a direct read out of what RNAs in the cell are actively producing
or repressed during the stress response. To facilitate the CRAC experiments, Pedro
Arede Rei produced a USA300 strain in which the RpoC subunit was fused to an
HTF tag. Pedro then discovered that RpoC could indeed be efficiently cross-linked to
RNA and this prompted me to perform these analyses. It also reasoned that most
of the RNA recovered from RNase III CLASH experiment was RNA that was in the
process of being degraded. Hence, by comparing the RNA polymerase CRAC data
with the RNase III CLASH data, I was able to identify transcripts that were not only
repressed in RPMI (transcriptional response) but also likely degraded by RNase III
(post-transcriptional response). It is important to note that the data for RNase III
only includes a single timepoint, 15 minutes after the RPMI shift.
Following the shift to RPMI, the polymerase binding to RNAIII decreased rapidly.
Before the shift, just under 4,000 transcripts per million (TPM) encode for RNAIII and
this falls to just 125 after 5 minutes of RPMI incubation, a reduction of ~97%. This
repression is maintained throughout the whole time-course (Figure 5.6). Considering
that the expression of RNAIII decreases by ~80% at this point, there is strong
agreement between the RNA steady-state levels and the changes in the transcription
rate. When examining the RNase III binding to RNAIII, I observed a ~50% decrease
in binding 15 minutes after the shift to RPMI. This is interesting as although the
expression of RNAIII has decreased by around 80% after 15 minutes of RPMI
incubation, RNase III binding to RNAIII is still surprisingly high. This implies
that down-regulation of RNAIII is controlled both at the transcriptional and post-
transcriptional level.
To my surprise, the RpoC CRAC data suggested that transcription of RsaA actually
decreased after the shift; from ~6,000 TPM before the shift to ~3,000 after 15
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minutes (Figure 5.8). In contrast, the binding of RNase III to RsaA increased ~3-
fold after 15 minutes in RPMI. Both of these behaviours are in opposition to the
upregulation of RsaA observed after the shift to RPMI (Section 5.6). A plausible
explanation for this observation is that although RsaA transcription decreases, the
half-life of RsaA levels actually increases during the stress response. Increased RsaA
steady state levels is then expected to recruit more RNase III, which may explain the
increase in RsaA signal in the RNase III RPMI CLASH data. Alternative explanations
are provided in the Discussion section.
In Section 5.6 I showed that several RNAIII targets were increased after the shift to
RPMI. Most notably, rot increased immediately and continuously, while sbi increased
after a short delay. Examining the polymerase binding to rot reveals that its tran-
scription is actually decreased after the shift. The RNase binding data is noisy to the
point where no meaningful conclusion can be made, but it is possible that there is
little change in its binding after the shift. As RNAIII is downregulated after the shift,
rot may now be freed from its RNAIII-mediated degradation and so accumulates
despite it being transcribed at a lessened rate.
Regarding sbi, its transcription increases continuously throughout the timecourse,
from 33 TPM to 95 by 30 minutes; a ~3-fold increase. Although the stoichiometry
is not identical, this matches the expression pattern, where a ~5-fold increase is
observed. Thus, the expression pattern of sbi may be shaped by both transcription
as well as relief from RNAIII-mediated repression. RNase III binding to sbi also
increases, which could be expected since more sbi is being produced.
Less detail can be obtained regarding the targets of RsaA. The RpoC data for glyS is
too noisy for meaningful conclusions to be made regarding the first 15 minutes after
the shift. However, overall it is likely that there is no change during this time, and
so the initial decrease in glyS may be due to RsaA initiating its destruction. There
appears to be a decrease in transcription moving from 15 to 30 minutes, which does
not match the RNA steady-state levels (increasing strongly across these timepoints).
Although the RNase binding data is noisy, a decrease is observed following the
shift to RPMI. Thus, the initial decrease in glyS following the shift could be due
to RsaA-mediated destruction, which then ends after around 15 minutes, allowing
glyS to recover. Regarding spoVG, the transcription appears to be overall stable for
the first 10 minutes of the shift and is then downregulated after 15 minutes and
maintained. This fits the expression profile of spoVG, and no changes in RNase
binding are observed. Thus, the dynamics of spoVG may be shaped entirely by
transcription. Clearly some of these experiments need to be repeated, however, the
results are encouraging; as RpoC also transcribes rRNA and tRNAs, which represent
~90% of the total cellular RNA, I was unsure whether we would actually be able to
detect clear changes in mRNA transcription using RpoC CRAC. However, the results
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do indicate that for mRNAs and sRNAs that are reasonably abundant, reliable data
can be generated. We are also investigating whether different data normalization
steps can improve the results.
In conclusion, it is clear that transcription plays a major role in shaping the expres-
sion of RNAIII. As such, its interaction with RsaA may be only one facet of several
which control its expression in response to stress. The dynamics of RsaA appear more
complicated, which displays decreasing transcription, increased RNase III binding,
and yet upregulated steady-state levels. Some conclusions can be made for the
targets of RNAIII; the expression of rot may be shaped primarily by the downregula-
tion of RNAIII, while sbi undergoes both increased transcription and degradation.
Regarding RsaA’s targets, glyS appears to be shaped through RsaA-mediated recruit-
ment of RNase III, while spoVG’s dynamics may be mostly transcriptional. Thus, the
interaction of RsaA and RNAIII likely contributes to regulating the steady-state level
of RNAIII, and by extension the targets of RNAIII, but this behaviour is also coupled
to transcriptional effects.
Fig. 5.8: Nascent transcription of RNAIII, RsaA and their targets following the shift to RPMI
in USA300. Data obtained through performing CRAC on the polymerase. The
polymerase data represents two independent biological replicates, while the RNase
III data represents four.
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5.9 Identification and validation of novel targets of
RsaA and RNAIII
The CLASH data contains many potentially novel targets of RsaA and RNAIII, as
discussed in Chapter 4, Section 4.6 and Section 5. Further examination of this
reveals several potential targets of RsaA that agree with its already established
role in regulating cell membrane composition. As discussed in Section 5.2, RsaA is
already known to regulate several members of the Ssa family, which are involved
in peptidoglycan metabolism. Additionally, RsaA binds HG001_01977, which is
hypothesised to be an endopeptidase involved in breaking glycl-glycyl bridges, such
as those found in the cell wall of S. aureus. The CLASH data for USA300 uncovered 42
unique interactions between RsaA and SAUSA300_1921, a peptidoglycan hydrolase
of unknown function. Additionally, RsaA was found to bind qacAB, a peripheral
membrane protein that acts as a wide-spectrum antiseptic transporter involved
in exporting quaternary ammonium salts (e.g. cetrimide), intercalating dyes and
biguanidines (e.g. chlorhexidine) (Jaglic and Cervinkova, 2018). Considering
RsaA’s established role in regulating the composition of the cell membrane, novel
interactions between RsaA and peptidoglycan hydrolyses and transporters are worthy
of further study.
Concerning RNAIII, I was particularly interested in its interaction with esxA. EsxA
is known be involved in promoting host cell survival. Given RNAIII’s known role
in virulence, and it even encoding its own haemolysin, it was interesting to see
an interaction between two behaviours which are seemingly in opposition with
each other (Balaban and Novick, 1995; Sundaramoorthy et al., 2008). Thus, this
interaction was selected for further study.
Of additional interest is the interaction between RNAIII and saeR, as discussed in
Chapter 4, Section 5, but this interaction as only uncovered in a CLASH experiment
performed near the conclusion of this work. Thus, time did not permit further
study.
Thus, overall I chose to further elucidate the interactions between RsaA and qacAB,
and RNAIII and esxA. Although these interactions were supported by a relatively low
number of chimeras, folding of the chimeras suggested that the sRNA base-paired at
or near the SD sequence, suggesting that these could be bona fide interactions. The
interaction between RsaA and the 5’ UTR of qacAB is of high interest as it may help
us to improving the understanding antibiotic and antimicrobial resistance.
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More detailed examination of the chimeric reads revealed that the start codons
were recovered for each of the mRNAs. The qacAB fragment that was fused to RsaA
contained the ‘AU’ region that was predicted to interact with RsaA when folded in
silico with RNAcofold. Additionally, the interaction appears to start at the UCCC
motif of RsaA (Figure 5.9A). As the first two nucleotides of the start codon were
identified in the hybrid, this interaction was predicted to be a canonical example
of sRNA-mediated translational repression. Folding of the RNAIII-esxA chimeras
implied that helix 9 of RNAIII base-pairs with the esxA coding region. The start
codon, however, seems to be sequestered in an intra-molecular loop formed in the
esxA mRNA. Thus, how RNAIII would regulate esxA expression was not immediately
obvious (Figure 5.9A).
In order to deduce the role of RsaA and RNAIII on the translational efficiency of
qacAB and esxA respectively, I decided to use an in vivo GFP-reporter assay that was
recently published by the Felden group (Ivain et al., 2017). Although it is an artificial
system, it can provide a clear indication on if the interaction identified by CLASH
is also functional in vivo. The reasons for choosing this system was because of the
enormous challenges we faced when integrating DNA fragments in the S. aureus
genome. Moreover, similar reporter assays are routinely used in the Gram-negative
field (Corcoran et al., 2012). Briefly, the regions identified in CLASH were fused
in-frame to GFP and the produced fluorescence examined through FACS in the
absence or presence of sRNA overexpression (Figure 5.9B). Here, it was found that
overexpression of RsaA strongly reduces the fluorescence produced by the qacAB-GFP
reporter around 10-fold. Thus, I conclude that RsaA represses the translation of
qacAB in vivo. Interestingly, upon over-expression of RNAIII, the fluorescence of the
EsxA-GFP reporter increased ~2-fold. Thus, RNAIII is predicted to stimulate the
translation of esxA in vivo. The next goal is to use various biochemical approaches,
including RNA structure probing, to dissect the mechanism of how RNAIII enhances
EsxA translation.
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Fig. 5.9: Validation of novel targets of RsaA and RNAIII. A. Predicted secondary structures
of RsaA and qacAB, and RNAIII and esxA. The reads mapping to each RNA in the
CLASH data were extracted and folded with each other in silico. The sRNA is
shown in black and the mRNA in grey. The start codon is highlighted in blue. B.
FACS sorting showing the effect that overexpression of RsaA and RNAIII has on
qacAB and esxA respectively. * = 0.05; *** = < 0.01 in Student’s unpaired t test,
error bars relate to standard deviation.
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Other predicted RsaA-sRNA interactions
In general, the USA300 CLASH datasets contained many more interactions. In these
datasets we uncovered several sRNA fragments fused to RsaA besides RNAIII. RsaA
was found interacting with srn_2860 and RsaX28, and both of these interactions
were calculated as being statistically significant, even though only 2 and 14 chimeras
supported these interactions, respectively.
Extracting the CLASH reads and folding them in silico reveals that neither interaction
is predicted to cover the UCCC motif of RsaA (Figure 5.10). Regarding srn_2860, a
relatively long region of interaction is observed but this frequently contains unpaired
nucleotides. With regards to RsaX28, although 14 unique hybrids were identified,
only short reads were recovered. Thus, 50 nucleotides flanking the genomic region
of the read were added. Here, RsaX28 forms a perfect, 6-nucleotide pairing at the 3’
end of RsaA and another 10-nucleotide pairing with a single nucleotide bulge in the
middle of RsaA.
When examining the expression of these sRNAs after 15 minutes of RPMI shift,
neither are observed to increase significantly. Considering that RsaA is upregulated
after the shift to RPMI, these interactions may represent true sponging interactions,
as opposed to induced destruction. However, from the CLASH data it is impossible
to predict which sRNA regulates which.
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Fig. 5.10: Validation of novel targets of RsaA and RNAIII. Interaction between RsaA, and
srn_2860 and RsaX28. RsaA is shown in black, and the interacting partner in grey.
The UCCC seed motif of RsaA is highlighted in green. For RsaX28, 50 nucleotides
from either side the interacting read was added.
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5.10 Discussion
The work described in this chapter firstly illustrate CLASH’s ability to recover known
interactions of a well-understood sRNA, RsaA. This gives credence to the novel targets
that CLASH uncovers, of which several have been chosen for further validation. The
major, novel discovery of the work described here is that RsaA is able to bind RNAIII,
an sRNA intimately involved in regulating S. aureus’ transition to virulent behaviour
and that this interaction may have downstream consequences for the mRNA targets
of these sRNAs.
Other CLASH validates known targets of RsaA
Currently, detailed analyses describe how RsaA regulates the translation of mgrA, a
pro-virulence transcription factor (Romilly et al., 2014); flr, an immunomodulatory
protein involved in protection against complement and antibodies (Stemerding et
al., 2013); HG001_01977, an SH3 domain-containing protein hypothesised to act
as an endopeptidase involved in membrane modelling (Tomasini et al., 2017); and
members of the Ssa family, which are involved in peptidoglycan synthesis (Dubrac et
al., 2008; Tomasini et al., 2017). All of these interactions, except that with flr, were
recovered in CLASH, giving credence to the CLASH methodology.
RsaA is known to bind the SD sequence of mgrA in order to block ribosome binding
and repress translation (Romilly et al., 2014). This interaction was perfectly and
abundantly recovered with CLASH. However, RsaA is also thought to bind the 3’
end of mgrA and the authors were “tempted to speculate” that this interaction
site may recruit RNase III. This idea is not supported in the data presented here;
I did not detect any RsaA chimeras that had fragments of 3’ end of mgrA in the
RNase III CLASH data. However, a negative result in CLASH does not mean it does
not exist and it is certainly possible that other dsRBPs mediate or recognize this
interaction. Additionally, as different regions of RsaA bind to the 3’ and 5’ end of
mgrA respectively, it is possible that a single RsaA molecule binds both ends of mgrA,
forming a loop structure, and the double-stranded region at the 5’ end recruits RNase
III. Despite this, good agreement is found between the CLASH data and the in vitro
validation performed by Romilly et al, 2014.
There are a number of potential reasons as to why the interaction between RsaA and
flr was not identified. In their paper, Tomasini et al, 2017, expressed RsaA from a
plasmid under the agr P3 promoter, such that RsaA was expressed abundantly only
at stationary phase. This led them to performing their experiments at an OD600 of
5, while the CLASH experiments performed here were at an OD600 of 3. It may be
that RsaA only regulates flr at certain ODs or that flr may only be expressed in the
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stationary phase. Additionally, the expression of RsaA is known to increase with
OD, and so the cell will contain more RsaA at OD 5 versus OD 3. Concomitantly,
Tomasini et al found that their RsaA expressed from a plasmid was 1.7-fold more
abundant than the wild type. Thus, the amount of RsaA in the cell in the MAPS
study will be far higher than that for the experiments carried out here. flr may only
be a weak target of RsaA and so may have only been uncovered due to the potential
excess of RsaA.
A mutant RsaA-null strain was found to have increased levels of SpoVG, a protein
involved in capsule production and antibiotic resistance and also glycyl-tRNA syn-
thetase, glyS. However, no hybrids were identified between RsaA and these targets.
Similarly to flr, these interactions may not take place in the conditions here.
In conclusion, the CLASH methodology has proven itself reliable for identifying
targets of RsaA due to its recovery of several already known interacting partners.
RsaA interacts with RNAIII and potentially regulates its stability
The CLASH data also suggests new interacting partners of RsaA. The most interesting
of these is with RNAIII, an sRNA known to be involved in driving the cell into a
virulent state.
The primary evidence supporting an interaction between RsaA and RNAIII is a
considerable number of unique interactions found in CLASH and the fact that this
interaction was found both in JKD6008 and USA300. Reads mapping to helices
8, 9 and 10 of RNAIII were uncovered in CLASH, with helix 9 being predicted to
directly interact with helices 2 and 3 of RsaA, covering the UCCC motif. The fact
that this seed region of RsaA is recovered in the interaction is also good evidence of
the interaction being genuine.
Additionally, the interaction was recapitulated in vitro, where in vitro transcribed
RNAs were shown to interact with each other. Importantly, this interaction was
proven to be specific, as RsaA was only able to interact with a selected portion of
RNAIII, chosen due to its presence in the CLASH data. Conversely, RsaA was not able
to interact with a second, control region of RNAIII. Thus, the interaction between
RsaA and RNAIII is specific and occurs only with a particular region of RNAIII.
Interestingly, there were 5-fold more interactions between RsaA and RNAIII in TSB
medium versus RPMI. This leads me to propose that this interaction responds to
nutrient stress. Delving further into the dynamics of these two sRNAs revealed
that after the shift to RPMI medium, RNAIII is immediately downregulated and
the pool is destroyed. On the basis that RPMI has been shown to mimic human
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blood plasma (Mäder et al., 2016), this finding matches already published data
where transcriptomic analysis of S. aureus that had been incubated in human blood
revealed that the agr locus was completely shut down, even at high cell densities
(James et al., 2013; Malachowa et al., 2011). Part of the reason for this is thought
to be due to host apolipoprotein B, which is able to sequester the agr signalling
molecule, AIP (Peterson et al., 2008). However, as there is no apolipoprotein B in
RPMI medium, this suggests that there is another reason for the decrease in RNAIII
expression. One explanation is that the agr pathway is turned off in the face of
stress and this connection has already been made with antibiotic stress, both for
vancomycin and methicillin resistance (Howden et al., 2008; Moise et al., 2010;
Pozzi et al., 2012; Sakoulas et al., 2002). Thus, the stress encountered in RPMI
medium, such as iron depletion, may induce agr suppression.
With regards to the data discussed here, the key questions are therefore; What role
does RsaA have in this downregulation of RNAIII? What is the functional outcome
of this interaction?
Overexpression of RsaA was found to cause a modest, but reproducible, decrease in
the amount of RNAIII within the cell. This over-expression also prevented RNAIII
from being induced as was seen in the control. This finding fits well with the expres-
sion patterns of these two sRNAs after shifting to RPMI, when RsaA is upregulated
and RNAIII is downregulated. Overall, this leads to the idea that RsaA is able to
induce the degradation of RNAIII and prevent it from accumulating within the cell.
However, it is important to note the stoichiometry. Overexpression of RsaA leads
to a 10-fold increase in the amount of RsaA and a 23% decrease in the amount of
RNAIII after 10 minutes. On the other hand, the shift to RPMI induces just under a
2-fold increase in RsaA, yet an 85% decrease in RNAIII levels. Thus, it is likely that
the behaviour of RNAIII can not only be explained through the action of RsaA.
It is clear that transcription also plays a role in shaping the expression of RNAIII.
Following the shift to RPMI, the polymerase immediately stops transcribing RNAIII
and this remains throughout the time course, which matches the expression profile.
Thus, it may be that the bulk degradation of RNAIII immediately after the shift
to RPMI is due to RsaA-mediated destruction, but the long-term dynamics are
shaped by transcription. Despite the significant decrease in transcription and drop
RNAIII steady-state levels, a relatively large number of interactions between RsaA
and RNAIII are still able to be captured using RNase III after 15 minutes of RPMI
exposure. It may be that any residual RNAIII or newly transcribed RNAIII is still
preferentially destroyed by the cell under RPMI stress. This could be a result of its
interaction with RsaA.
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For most mRNAs that I analysed in the RpoC CRAC data, I detected what appeared
to be a decrease in polymerase transcription, whereas few mRNAs showed increased
transcription. This is a suspicious and so the lab is now investigating the possibility
that the observed decrease in many RNA levels could be explained by issues with
the normalization of the CRAC sequencing data. One possibility is that during stress
the levels of most RNAs strongly decreases and standard normalization methods for
library depth (such as TPM normalization) do not perform well on datasets where
there are substantial changes in RNA levels. To solve this problem, we are currently
testing other normalization methods. From experience with yeast and human cells
we learned that rRNAs that often contaminate CRAC datasets can be reliably used
for data normalization. Moreover, we are in the process of designing a modified
CRAC protocol that allows us to use spike-ins.
The fact that RsaA is known to be involved in attenuating virulence puts it in
direct opposition of RNAIII. Deletion of RsaA in S. aureus was found to induce
a hypervirulent phenotype in a mouse sepsis model, with increased invasiveness
observed. RsaA is known to promote dormancy, biofilm formation, and potentially
favours chronic infections in vivo (Romilly et al., 2014). In addition, Romilly et al,
2014, postulated that RsaA may act as a suppressor of virulence, noting that RsaA
has been found to be actively expressed in commensal S. aureus infections, such as
those in nasal passages (Song et al., 2012). Their opinion was based on the idea
that as S. aureus exists primarily as a commensal bacterium, i.e. one that does not
cause damage to the host, it must have a means of halting its virulent behaviour
in order not to cause excessive damage to the host. Indeed, non-coding RNAs that
act to repress virulence have already been identified in S. typhimurium, where an
antisense sRNA negatively regulates the mgtC virulence factor and deletion of the
asRNA induces a hypervirulent phenotype (Lee and Groisman, 2010) . However,
the data described here suggests that RsaA may be used as a very general means to
rapidly shut down virulent behaviour whenever necessary, such as in the stressful
conditions encountered in RPMI medium. Here, it may be of benefit to S. aureus
to stop committing resources to virulent behaviours and instead focus on making
the necessary metabolic remodelling in order to survive. Thus, RsaA may play a
leading role in this state change through accelerating the downregulation of RNAIII
and therefore attenuating virulence until the stress is survived.
However, this model still needs to explain why a large number of RsaA – RNAIII
interactions were found in TSB, before the imposition of stress. It may be that RsaA
is able to interact with RNAIII under these conditions, but RNase III does not induce
any degradation. Alternatively, RsaA may continuously induce RNAIII degradation,
but this is offset by very high rates of RNAIII transcription. Both of these models
would suggest that the cell is permanently ‘primed’ to induce degradation of RNAIII
in order to shut down virulence in times of stress, allowing rapid adaptation.
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A potentially interesting alternative interpretation of the interaction between RsaA
and RNAIII is that the interaction is bi-directional. That is, RNAIII would also able
to regulate the activity of RsaA. A small piece of evidence currently supports this
model. Overexpression of RNAIII was found to induce a small but reproducible and
statistically-significant downregulation of RsaA. One reason why this downregulation
was so small could be that RNAIII is such an abundant transcript within the cell at the
optical density the experiment was performed at, that the degree of overexpression
was not strong enough to cause significant effects within the cell. Indeed, plasmid-
induced expression of RNAIII only caused a 2.5-fold upregulation of RNAIII by 10
minutes. It would be important to repeat this experiment in an RNAIII knock-out
strain.
In the CLASH experiments performed here, cells were grown to late-exponential
phase. Here, the agr pathway in S. aureus has become active, RNAIII is being
increasingly transcribed and the cell is committing to a more virulent state. It may
be that at OD600 3 in TSB medium, RNAIII is actually binding to RsaA to mediate
its inactivation or destruction. Both RsaA and RNAIII regulate the pro-virulence
transcription factor mgrA in opposite fashions, with RsaA repressing and RNAIII
stimulating its translation. Thus, RNAIII could increasingly bind RsaA as RNAIII
expression increases with time, in order to halt RsaA’s promotion of dormancy and
repression of virulence. Thus, when CLASH was performed in TSB, interactions
representing RNAIII repressing RsaA were captured. Upon the shift to RPMI, RNAIII
is downregulated through the combined action of its decreased transcription and
also through RsaA now acting as the regulator and inducing RNAIII destruction. This
model also fits the observation that only a small number of RsaA-RNAIII interactions
were found in RPMI.
This model fits the idea of a feed forward loop. RNAIII’s potential mediation in the
destruction of RsaA, an inhibitor of mgrA translation, would mean that it encourages
the translation of mgrA both directly and indirectly (through destruction of an mgrA
inhibitor). Additionally, if the cell intends to promote dormancy following the shift
to RPMI through upregulation of RsaA, then RsaA’s promotion of RNAIII destruction
would also represent a feed forward loop as RsaA would be concomitantly shutting
down an opposing virulence pathway.
The idea that RsaA is connected to the agr pathway, and therefore RNAIII, has been
suggested before. RsaA is positively regulated by σB, and strains that have a fully
functional σB express lower levels of RNAIII (Bischoff et al., 2004). mgrA is also
positively controlled by σB, and thus RsaA acts in an incoherent feed-forward loop
with MgrA. Additionally, MgrA is connected to the agr locus; mutations in MgrA
reduce the levels of RNAIII, and MgrA also has several targets in common with
RNAIII such as hla and sbi (Ingavale et al., 2005; Luong et al., 2006; Romilly et al.,
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2014). Additionally, an entirely in silico analysis predicted that RsaA interacts with
agrC (Subramanian et al., 2018).
RsaA may thus have several links to the agr system. However, the data described
here is the first instance of a direct, in vivo connection between the two.
One crucial experiment in order to further validate this interaction would be to shift
an RsaA deletion strain into RPMI medium and monitor the expression of RNAIII.
If this model proposed here is correct, then kinetics of RNAIII reduction should
change as it will largely be dependent on the sRNAs own half-life and its decrease in
transcription.
Now that the USA300 RsaA knock-out strain available, I will also be able to perform
cell survival studies to demonstrate the importance of RsaA shutting down RNAIII.
For example, wild type and the RsaA deletion mutant could be shifted to RPMI
medium and then have their growth measured in a plate reader in order to monitor
their response to the stress. One hypothesis would be that only wild type cells are
able to adapt and then survive in order to grow, while the RsaA mutant would be
unable to turn off virulent gene expression and then fail to adapt to the nutrient
stress. This experiment could be combined with staining in order to visualise cell
death after the shift.
In order to explore the idea of a bi-directional interaction, the expression of RsaA in
an agr knockout strain could be compared to wild type. Additionally, RNAIII could
be overexpressed in the same strain through a plasmid, or at a low optical density
before the agr pathway is activated. Both of these would allow a huge induction of
RNAIII relative to that within the cell at the time of experimentation, and this may
be enough to induce strong effects on RsaA.
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Fig. 5.11: The interaction between RsaA and RNAIII responds to stress. During unstressed
conditions, e.g. in TSB, RNAIII and RsaA interact but the consequences of this are
unknown. As cells grow and increase in density, the level of RNAIII increases (red
arrow) and this drives virulent behaviour. This is in part due to the repression
of sbi and rot. After the imposition of stress, it is theorised that RsaA inhibits
RNAIII activity and recruits RNase III, which induces RNAIII destruction. This,
in combination with decreased RNAIII transcription, causes RNAIII levels to fall
(blue arrow). Additionally, RsaA is upregulated, theorised due to an increase
in stability (red arrow). The destruction of RNAIII leads to its target transcripts
being relieved of their repression, while targets of RsaA are now subject to
regulation.
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Novel mRNA targets validated for RsaA and RNAIII
RsaA is already known to be involved in regulating the composition of the cell wall
and inhibiting capsule formation (Romilly et al., 2014; Tomasini et al., 2017). I
also found RsaA binding to the 5’UTR of qacAB, which encodes for a wide-spectrum
antiseptic transporter. This was chosen for further validation due to the current
interest in understanding antiseptic and antibiotic resistance. In vivo GFP reporter
assays suggest that RsaA is able to significantly downregulate the translation of
qacAB. This interaction fits with the proposed, although not validated, interaction
between RsaA and spoVG. RsaA was proposed to negatively regulate the translation
of SpoVG due to its upregulation in an RsaA-null strain (Romilly et al., 2014). SpoVG
is known to mediate methicillin and glycopeptide resistance (Eyraud et al., 2014),
thus RsaA’s inhibition of qacAB would fit an idea of it negatively repressing proteins
involved in antibiotic resistance.
In order to further validate this interaction, it must be further probed. One means to
do would be to generate an RsaA ‘seed mutant’, where the UCCC motif is mutated
and thus the binding should be abrogated, and the regulation of qacAB-GFP removed.
This could then be further strengthened by creating a compensatory mutation in the
qacAB-GFP construct such that binding and regulation is restored. Alternatively, in
vitro methods such as EMSAs, toeprinting assays and structure probing could delve
into the binding dynamics.
I found that RNAIII positively regulates the translation of a virulence factor, EsxA.
This is a surprising finding since the interaction was recovered with the nuclease
RNase III. It is possible that RNase III cleavage of the duplex does not lead to
degradation of the esxA mRNA and instead this processing event that alters the
structure of the 5’ UTR. This may then lead to freeing of the start codon from the
stem structure. It was previously shown that RNase III processing of σB in E. coli
can stimulate the translation of the mRNA (Freire et al., 2006).
Besides EsxA, RNAIII also enhances the translation of hla, a haemolysin implicated
in inducing host cell lysis (Menzies and Kourteva, 2000). Furthermore, RNAIII itself
also encodes for a small, cytolytic peptide, δ-haemolysin that is also involved in
intracellular escape (Balaban and Novick, 1995; Giese et al., 2011). The positive
regulation of esxA, a protein involved in host cell survival, and hla, a protein involved
in host cell lysis, are seemingly at odds. It may be that temporal changes, such as
in the timing of esxA and hla expression, dictate which behaviour RNAIII drives.
Overall, this potentially puts RNAIII in the unique position of regulating both host
cell death and host cell survival (Figure 5.12A).
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An alternate hypothesis is that esxA and hla may be produced and secreted together.
Indeed, it has been observed that Helicobacter pylori injects an anti-apoptotic protein,
CagA, to offset the cytotoxic activity of a main virulence factor, VacA (Oldani et
al., 2009). Thus, hla may be translated and secreted to e.g. allow escape from
a phagolysosome, but esxA is also produced concurrently in order to ensure the
cell as a whole is kept alive. This would help S. aureus to escape a perilous local
environment within the cell but maintain itself within safety overall (Figure 5.12B).
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Fig. 5.12: Hypothesised dual role of RNAIII in regulating host cell survival and lysis. A.
During the early infection stage of a host non-immune cell (e.g. an endothelial
cell), RNAIII promotes the translation of esxA, which is then secreted into the
host cell. EsxA then promotes host cell survival, facilitating S. aureus replication
in a safe, nutrient-rich environment. After division, RNAIII then switches to
promoting hla translation, which then integrates into the host cell membrane
and induces lysis, facilitating S. aureus escape. B. Following internalisation by a
host phagocyte, S. aureus may use hla in order to escape from the lysosome. At
the same time, EsxA is secreted in order to offset any cytotoxic effects of bursting
the lysosome due to its promotion of host cell survival. This potentially allows S.
aureus to stay within a favourable environment.
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RsaA may have other sRNA targets
In addition to RNAIII, RsaA was also found interacting with two other sRNAs;
srn_2680 and RsaX28. Both of these interactions were found in USA300 after the
RPMI shift.
All that is known about srn_2680 is that it is encoded antisense to MsrR, a membrane-
associated transcriptional attenuator (Howden et al., 2013; Rossi et al., 2003).
Interestingly, mutants for MsrR express higher levels of RNAIII, and thus MsrR could
be a negative regulator of RNAIII (Rossi et al., 2003). Although highly speculative,
srn_2680 may act as an antisense, cis-encoded sRNA to repress the transcription
or translation of MsrR. Upon the shift to RPMI, RsaA may then sponge srn_2680
activity to allow MsrR to be transcribed and translated, and this may then have a
role in shutting down RNAIII production.
RsaX28 is a trans acting, bona fide sRNA that has its own promoter, terminator, and
does not overlap any other coding regions (Liu et al., 2018). It has been recorded as
displaying different lengths in different S. aureus strains but appears to be around
1200 nucleotides long on average. Interestingly, it is known to upregulated after
exposure to sub-inhibitory concentrations of antibiotics and is involved in virulence
(Horn et al., 2018, p. 42). S. aureus RsaX28 mutant strains have a decreased ability
to lyse red blood cells be due to an inability to transcribe hla (Horn et al., 2018).
Thus, RsaX28 acts as a positive regulator of hla, but the mechanism behind this
remains unexplained.
This chapter has proposed that RsaA plays a role in downregulating virulence by
aiding the destruction of RNAIII. Incidentally, RNAIII also stimulates hla expression
by encouraging its translation. Thus, hla is subject to regulation by both RNAIII
and RsaX28. Each of these is potentially regulated by RsaA in times of nutrient
stress, and so these interactions may represent RsaA attenuating hla expression, and
virulence as a general concept, from several different angles. This idea could be
further explored by confirming the interaction between RsaX28 and RsaA in vitro,
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6RsaOG sponges RsaE in times of
nutrient stress
6.1 Introduction
Virulence is a costly exercise and is thus intertwined with metabolism. The avail-
ability of energy and carbon resources dictate the expression of virulence genes. In
support of this idea, it has been found that RNAIII is produced only in the absence
of glucose and this repression was found to lead to elevated levels of spa (Seidl et
al., 2006). Additionally, deletion of ccpA, a transcriptional regulator involved in
metabolic regulation, also lowers RNAIII levels (Seidl et al., 2008), and was found
to control the expression of toxic shock syndrome toxin 1, a major Staphylococcal
virulence factor (Seidl et al., 2008). Finally, inactivation of the TCA cycle reduces
the production of secreted virulence factors in S. aureus (Somerville et al., 2003,
2002).
Studies on CodY further demonstrating the link between virulence and metabolism.
CodY is a carbon and nitrogen source sensor through its recognition of branched
chain amino acids and is known to repress genes involved in amino acid transport,
catabolism and biosynthesis (Sonenshein, 2005). CodY has also been implicated in
regulating virulence factor synthesis in Clostridium difficile, Listeria monocytogenes,
Streptococcus pneumoniae and S. aureus (Somerville and Proctor, 2009). Additionally,
deletion of the codY locus in clinical isolates has been found to result in elevated
agr activity and hla, and this in turn lead to increased haemolytic activity towards
erythrocytes and increased biofilm formation (Majerczyk et al., 2008).
Additionally, MgrA, a pro-virulence transcription factor, responds to the intracellular
redox conditions. It can be oxidised by TCA cycle-generated superoxide anions,
which decreases its DNA binding potential and increases the expression of autolysin
genes and the rate of cellular autolysis (Luong et al., 2006). When the TCA cycle in
inactive, this autolysis is prevented.
It is important to note that the above descriptions are not exhaustive in describing
the established link between S. aureus metabolism and virulence. For example,
redox-responsive regulators, oxygen sensors and metal ion-responsive regulators
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have also been linked to virulence factor production (reviewed by Somerville and
Proctor, 2009).
Transcription factors are not alone in regulating the metabolic demands of the cell. It
is becoming clear that post-transcriptional regulation is also important in regulating
gene expression and coordinating adaptive responses. In S. aureus, the sRNA RsaE
is believed to play a central role in regulating oligonucleotide transport, folate
metabolism, arginine degradation and the TCA cycle. RsaE appears to be primarily
expressed in the late-exponential stage, and is then downregulated in stationary
(Bohn et al., 2010; Geissmann et al., 2009). However, it should be noted that the
degree of change in expression between the exponential and the stationary phase
varies between different S. aureus strains. Overall, it has been proposed that RsaE
helps to coordinate the required metabolic remodelling for transitioning between
these growth states.
RsaE is strongly conserved throughout the Bacillales order and has also been found
to contribute to cellular NAD+/NADH balance in B. subtilis (Durand et al., 2015;
Rochat et al., 2018). In S. aureus, RsaE has been shown to block the ribosomal
binding site of its targets via its UCCC motif, triggering RNase III-mediated cleavage
(Felden et al., 2011). In particular, RsaE is thought to downregulate the TCA cycle
and purine biosynthesis upon the entry to stationary phase, when carbon sources
become scarce.
The regulation of the TCA cycle by RsaE is exerted through its base-pairing with
mRNA encoding succinyl-CoA synthetases (sucC and sucD), aconitase (citB) citrate
synthase (citZ) and isocitrate dehydrogenase (citC). Additionally, it is also able to
regulate fhs mRNA stability, which is involved in purine biosynthesis (Bohn et al.,
2010; Geissmann et al., 2009). RsaE is also intimately involved in cellular amino
acid availability through regulation of the oligopeptide transporter operon opp-3,
and operons involved in valine, leucine, and isoleucine metabolism (Bohn et al.,
2010).
Other targets of RsaE were identified through a technique called Hybrid-trap-seq
(Rochat et al., 2018). This technique is similar to the aforementioned MAPS, however,
it is entirely based on in vitro assembled interactions. In short, in vitro transcribed
RsaE was produced, biotinylated, and then fixed onto magnetic streptavidin beads.
These beads were then incubated in total cellular RNA extracts, washed, and then
the RsaE binding partners were eluted and sequenced. In order to increase the
confidence of found interactions, the expression of putative RsaE targets were
investigated in a ∆rsaE strain, compared to both a wild type and a ∆rsaE strain
where RsaE expression was induced through a plasmid. These analyses predicted
direct interactions between RsaE and rocF, rocD, ndh2 and icaR. These interactions
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are thought to not only regulate translational efficiency but also mRNA stability
as well. RocF and RocD are involved in the conversion of arginine to ornithine
and then to glutamate semialdehyde respectively, and the authors also showed that
a ∆rsaE strain grew faster in Complete Defined Medium where the only carbon
source is amino acids (Rochat et al., 2018). Finally, the authors reported that RsaE
contains two distinct UCCC motifs that function independently of each other in their
regulation of rocD and rocF (Rochat et al., 2018). Regarding RsaE’s regulation of
icaR, this interaction was proposed to explain RsaE’s promotion of biofilm production
in S. epidermidis (Schoenfelder et al., 2019).
As RsaE is known to be involved in regulating cellular metabolism, I hypothesised
that it could also be involved in regulating the virulent state of the cell. The CLASH
data described here included interactions between RsaE and several α phenol soluble
modulin (PSM) mRNAs. PSMs are small, secreted peptides that cause disruption
of membranes through insertion via amphipathic helices, inducing pore formation
(Cheung et al., 2014). PSMs make up around 60% of the total secreted peptides of
S. aureus, indicating that these are critical factors in S. aureus biology (Wang et al.,
2007).
All PSMs within S. aureus are produced from two operons, the α and the β. The
αPSMs range from 20-25 amino acids in length, while the β are between 43 and 45
amino acids long (Cheung et al., 2014). The PSM operons are regulated directly by
AgrA binding to their promoters and thus they are increasingly expressed as cellular
density increases (Xu et al., 2017). Interestingly, PSMs have already been shown to
be subject to regulation by sRNAs, with Teg41 positively regulating the production
of αPSMs, and deletion of the crucial regulatory seed sequence of Teg41 attenuated
virulence in a murine model of infection (Zapf et al., 2019).
Within the local S. aureus community, PSMs can be secreted to induce biofilm re-
modelling in order to enable cellular dissemination (García-Betancur et al., 2017).
Additionally, they are able to act as critical virulence factors through their cytotoxic
activity, and have been shown to induce lysis of osteoblasts, endothelial cells, ep-
ithelial cells, monocytes, erythrocytes and neutrophils (Cheung et al., 2014). The
αPSMs also overall displaying increased lytic activity as compared to the βPSM class
(Cheung et al., 2014; Wang et al., 2007). Finally, αPSMs have been shown to be
crucial in S. aureus escape from phagosomes in both non-professional phagocytes
(such as epithelial cells), and also from monocytes (Grosz Magdalena et al., 2014).
Demonstrating the overall crucial nature of αPSMs in virulence, their deletion re-
sults in decreased skin legions and morbidity in a murine model of infection, and
also decreased cortical bone destruction in a murine model of S. aureus-mediated
osteomyelitis (Cassat et al., 2013; Wang et al., 2007).
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Interestingly, Hybrid-trap-seq and MAPS also identified another sRNA, RsaOG, as a
target of RsaE (Bronesky et al., 2019; Rochat et al., 2018). However, Bronesky et
al were unable to recapitulate this interaction in vitro, and no further validations
were attempted by Rochat et al. RsaOG (also known as RsaI) is highly conserved in
Staphylococcacea and is involved in a signalling pathway which responds to glucose
availability (Bronesky et al., 2019; Geissmann et al., 2009). In rich medium, RsaOG
is known to be repressed by CcpA when glucose is present, but becomes induced in
its absence (Bronesky et al., 2019). Using MAPS, the authors managed to identify
several targets of RsaOG and proposed that RsaOG functions to switch the cell
away from glucose utilisation. Of these targets, two were validated as causing
translational repression; glcU_2, a glucose permease, and fructosamine-3-kinase.
Additional targets involved in glucose catabolism were identified through MAPS,
such as treB, fba, gnd and tkt. Interestingly, icaR was also identified as a target of
RsaOG, and thus icaR may be subject to regulation from both RsaE and RsaOG.
Alongside these mRNAs and RsaE, RsaOG was also found to bind RsaG and RsaD
through both MAPS and in vitro EMSAs (Bronesky et al., 2019). The functional
consequences of these sRNA – sRNA interactions are unknown but were speculated
to be involved in RsaOG’s promotion of nitric oxide (NO) detoxification. From
an infection perspective, RsaOG’s promotion of NO resistance and regulation of
metabolic rewiring was hypothesised to place it as a potential player in S. aureus
survival within host cell phagocytes.
The interaction between RsaOG and RsaE, RsaG and RsaD links to the idea of sRNA
sponging. As discussed in Section 1.11, sRNA sponging has been observed in the
bacterial species S. typhimurium and E. coli, but has not been demonstrated in S.
aureus. Although no biological significance has been attributed to the interaction
between RsaOG and RsaE, RsaG or RsaD, it is very likely that sRNA sponging will
be an important regulatory mechanism in S. aureus biology. This is because sRNA
sponging allows responses to occur on rapid timescales and allows co-regulation of
different adaptive responses (as described in Section 1.11).
As discussed in Chapter 3, CLASH identified a large number of RsaE and RsaOG
interactions in RPMI medium. This was hypothesised to be a sponging interaction,
as the expression of RsaOG was immediately upregulated in RPMI, but the stability
of RsaE remained constant. This chapter will discuss the validation of this inter-
action and the findings that attribute biological functionality to it. Finally, in vitro
validations of RsaE and phenol soluble modulins will be described.
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6.2 CLASH identifies known mRNA targets of
RsaE
I first asked how many of the known RsaE interactions were recovered from CLASH
in order to increase the confidence in my data, similarly to what was described in
Section 5.2. Through microarray analysis, purK was identified as being upregulated
following RsaE deletion (Geissmann et al., 2009). Although this interaction was
not further validated, the CLASH experiments performed here identified 4 unique
interactions between RsaE and purK, occurring in the 5’ UTR of purK at a region that
could be a SD sequence (‘AGGG’), pairing with the distinctive UCCC motif of RsaE
(Figure 6.1). As described in Section 6.1, the opp-3 operon is another target of RsaE,
identified via microarray analysis and validated through EMSAs and toeprinting.
Here, hybrids between RsaE and opp-3B were identified that covered the start codon
and SD sequence, again through the UCCC motif of RsaE. Finally, a similar finding
was observed for sucD, although the in silico structural prediction did not pair the
start codon with RsaE.
The interaction between purH and RsaE was previously found in Hybrid-trap-seq
(Rochat et al., 2018) and RsaE has already been implicated in the regulation of
another member of the pur operon, purK (Geissmann et al., 2009). Here 14 in-
teractions were found between purH and RsaE, however, this was found to occur
within the coding region of purH. Additionally, when in silico structural predictions
were made, the UCCC motif of RsaE was only very tenuously base-paired with purH,
although an extended basepairing interaction is seen downstream. Given that this
interaction does not mimic in the canonical mode of RsaE regulation, i.e. it does
not occur at the 5’ UTR and SD sequence/start codon region and does not utilising
RsaE’s UCCC motifs, this interaction requires further investigation before significant
meaning is attributed to it.
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Fig. 6.1: Predicted interactions between RsaE and its known targets. RsaE is shown in
grey and the mRNA targets in black. Structures were generated by extracting the
CLASH read sequences as input for RNAcofold, which was used to predict the
interaction structure. Due to the fact that short read fragments were recovered for
purK, opp3-B and sucD, 20 nucleotides from either side of the hybrid were added
to the 5’ and 3’ end.
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6.3 The expression of RsaOG responds to RPMI
stress, while RsaE does not
Reviewing the RNAseq data reveals that upon the shift to RPMI medium, RsaOG is
immediately upregulated 6-fold by 5 minutes (Figure 6.2A). This is maintained until
after 10 minutes, when steady state levels decrease rapidly, and RNA levels return
to basal levels by 30 minutes. This is in contrast to the control TSB shift, where
the expression of RsaOG remains virtually constant, perhaps decreasing slightly.
Examining the RNA polymerase and RNase III binding to RsaOG explains how this
trend is shaped. The shape of the RNA polymerase binding profile matches that
of the RNA steady state levels where a sharp increase is observed after 5 minutes,
which then decreases afterwards (Figure 6.2, middle row). However, it should be
noted that the stoichiometry is not the same, with only a 2-fold increase in RNA
polymerase RsaOG binding, as compared to a 6-fold increase in the expression levels.
As such, the increase in RsaOG levels may reflect an increase in transcription and
an increase in RNA stability. The RNase III data is also in agreement, as it can be
seen that there in increased RNase III binding to RsaOG after 15 minutes of RPMI
shift, which is when the RNA steady state levels start to decrease. Thus, it can be
concluded that the expression of RsaOG responds positively to the shift to RPMI,
and that the dynamics of this are shaped by RNase III and the RNA polymerase.
In contrast to this, the expression of RsaE remains basal through both the TSB and
RPMI shifts, indicating that RsaE does not respond to the stresses imposed (Fig
6.2A). The RNA polymerase binding to RsaE actually decreases throughout the time
course, however the RNase III data is noisy to the degree where no conclusions can
be made. It may be that although the RNA polymerase decreases the rate of RsaE
transcription, the cellular pool already existing is not targeted by RNase III to a
degree that would change the steady state levels.
In order to explain the dramatic change in the RNA levels of RsaOG, it is important
to consider the growth conditions at the time of the shift. TSB contains 0.2% glucose,
the same as RPMI. At the late-exponential phase in TSB, I predict that the cells
have depleted most, and if not then all, of the available glucose. Thus, the shift to
RPMI actually induces a glucose replenishment. As RsaOG is known to be positively
regulated by CcpA, its upregulation indicates that CcpA is activated after the RPMI
shift (Mäder et al., 2016, Bronesky et al., 2019). This makes sense as CcpA is known
to promote glycolysis and shut down the TCA cycle, which would be expected under
conditions in which glucose is present (Seidl et al, 2009). Thus, I predict that the
upregulation of RsaOG is mediated by the response of CcpA to glucose.
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Fig. 6.2: Shaping the expression profile of RsaOG and RsaE. Top panels: RNA steady state
levels of RsaOG and RsaE after the shift to RPMI, and a control TSB shift as
measured by RNAseq. Middle: RNA polymerase binding to RsaOG and RsaE
throughout the shift. Bottom: RNase III binding to RsaOG and RsaE in TSB and
after 15 minutes of RPMI shift
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6.4 RsaOG and RsaE interact in vitro through both
of RsaE’s UCCC motifs
Examination of the CLASH data revealed reasonably long interacting reads for both
RsaE and RsaOG, and it was noted that both of the UCCC motifs of RsaE were
included. Through in silico folding, it was predicted that only the 3’ UCCC motif
interacted with a GGG trimer in RsaOG (Figure 6.3A).
In order to examine this hypothesis, two mutant versions of RsaE were produced in
vitro; one in which the 5’ UCCC mutant was mutated to AGGG, and another mutant
in which both the 5’ and the 3’ UCCC double motifs were mutated. EMSAs were
then performed with radiolabelled RsaOG, as compared to wild type RsaE. As shown
in Figure 6.3B, a strong band shift was observed when incubating RsaOG with RsaE.
In order to quantify this, the amount of dimer (indicated with the chevron) was
compared to the total amount of signal relating to the monomer plus the dimer.
Although another band is observed above the proposed dimer band, this band is also
observed when only RsaOG is present without RsaE. Thus, it may be that RsaOG is
able to oligomerise, potentially into a trimer. In an attempt to examine formation of
just an RsaOG – RsaE interaction, only the dimer band was examined as this is not
observed when RsaOG is alone. Interestingly, the maximum occupancy was observed
when RsaOG was incubated with just a 5-fold molar excess of RsaE, giving a binding
of 60% of the total examined pool. Increasing the amount of RsaOG, even up to
320-fold excess, did not increase this binding.
Why RsaE binding does not increase in the presence of increasing amounts of RsaOG
is not clear, however, the following experiments suggest that the interaction is
specific. Binding to RsaOG is significantly disrupted upon mutation of one of RsaE’s
UCCC motifs. The maximum occupancy is reduced to around 25%, and this also
only occurs at a higher molar excess of 20. Interestingly, increasing the molar excess
does not change this, despite the fact that more UCCC motifs are being added
to the reaction that could, in theory, compensate for the mutation. Once both of
RsaE’s UCCC motifs are removed, binding is completely abrogated, and dimer bands
are no longer visibly observed. Thus, it is overall concluded that RsaE is able to
interact with RsaOG using both of its UCCC motifs, and that these are able to bind
RsaOG independently of each other, but that maximum RsaOG binding relies on
their cooperative action. I am currently making compensatory mutations in RsaOG
to determine if I can restore the interaction with the RsaE UCCC double mutant.
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Fig. 6.3: In vitro interaction between RsaOG and RsaE. A. In silico predicted structure of the
RsaE – RsaOG interaction. RsaE is shown in grey and RsaOG in black. Structures
were generated by extracting the CLASH read sequences as input for RNAcofold,
which was used to predict the interaction structure. The two UCCC motifs are
highlighted. B. EMSA of radiolabelled RsaOG with RsaE WT, the single RsaE UCCC
mutant, and the double mutant. Asterisk (*) indicates the proposed trimer, while
the chevron (>) indicates the proposed dimer. Quantifications are shown below
the gel, in which the amount of dimer was compared to the total monomer plus
dimer signal.
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6.5 RsaOG may bind RsaE in a sponging
interaction that responds to RPMI
Examining the number of interactions found by CLASH between RsaOG and RsaE
reveals a sharp increase upon the shift to RPMI medium. In TSB, 12 interactions
were found while 63 were observed in RPMI (Figure 6.4A). Although CLASH is
not considered a quantitative approach, the observed increase in RsaOG expression
suggests that the newly transcribed RsaOG molecules are able to increasingly target
RsaE. Given that RsaE steady state levels did not significantly change during the
timecourse, this begs the question whether RsaOG is able to bind to RsaE but not
induce its degradation, even though this interaction is recognized by RNase III.
I hypothesize that RsaOG is a bona fide sRNA sponge that, by base-pairing with
RsaE, sequesters RsaE away from its targets. To test this hypothesis, I examined the
expression of several RsaE targets in the TSB-RPMI timecourse by qPCR. I reasoned
that if RsaOG indeed sponges RsaE, then the targets that are normally negatively
regulated by RsaE should now be upregulated or at least be stabilized. I chose rocA,
fumC and citB for these analyses as they were identified as potential targets of RsaE
through transcriptome analysis of an RsaE deletion strain (Rochat et al., 2018).
Firstly, consistent with my RNA-seq data, the qPCR data showed that RsaOG was
significantly upregulated shortly after the shift to RPMI (Figure 6.4B, upper left
panel). RsaOG was 6-fold upregulated after 5 minutes and these high levels were
maintained until 10 minutes, after which they went back down to basal levels after
30 minutes. A similar expression pattern was observed for RsaE targets (Figure 6.4B).
All of rocA, fumC and citB showed an immediate upregulation in response to the
RPMI shift, albeit to varying degrees. rocA underwent the most significant increase,
with around a 10-fold expression increase after just 5 minutes and decreased down
to basal levels by 30 minutes in an expression profile shape identical to that of
RsaOG. Regarding fumC, its expression is only increased to a maximum of around
1.75-fold by 10 minutes, before it starts to decrease afterwards. The citB and rocA
mRNAs showed a similar profile as RsaOG, although the data for the latter contained
noise. Overall, the targets of RsaE are immediately upregulated after the shift to
RPMI which provides further evidence for a sponging interaction between RsaOG
and RsaE.
It is important to note that citB and rocA have been shown to be repressed by
CcpA (Seidl et al, 2009). However, their upregulation is in opposition to the
hypothesis already discussed in which CcpA is activated after the shift to RPMI in
order to shut down the TCA cycle and amino acid metabolism following glucose
replenishment. Considering that CitB and RocA are members of these respective
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metabolic processes, this overall implies that there are other transcription factors
potentially competing with CcpA. As such, the expression of these genes likely
involves multiple transcription factors.
In order to differentiate between post-transcriptional and transcriptional effects, the
RNA polymerase binding to rocA, fumC, and citB was examined (Figure 6.4C). citB
offers the clearest data, with the distinctive immediate upregulation observed, which
is maintained until 10 minutes and starts to decrease afterwards. Although the data
for fumC is noisier, it can be said that fumC also displays a sharp increase after 5
minutes, which returns to basal by the end of the time course.
Unfortunately, the t0 sample for rocA displays significant error which makes conclu-
sions about the overall nature of the profile difficult. However, again it is observed
that expression remains constant between 5 and 10 minutes and decreases after-
wards.
Thus, I conclude that the RNA polymerase helps to shape the expression of these
rocA, fumC and citB, as the profile of their RNA steady state levels matches the RNA
polymerase binding. As such, the data strongly suggest that both transcriptional
and post-transcriptional regulatory mechanisms act cooperatively to shape the gene
expression pattern.
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Fig. 6.4: The interaction between RsaE and RsaOG responds to RPMI stress and may dictate
the fate of RsaE’s targets. A. Number of interactions found between RsaE and
RsaOG in TSB and after 15 minutes in RPMI. B. Expression of RsaOG, rocA, fumC
and citB after the shift to RPMI, as measured by qPCR. Statistical significance was
calculated through comparing the expression value in RPMI versus TSB. p values:
* = 0.05, ** = 0.01, *** = <0.01 C. RNA polymerase binding to citB, fumC, and
rocA following the shift.
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Thus, the expression of RsaOG responds to the stresses induced by RPMI, which
results in its rapid but transient upregulation. In these stressful conditions, an
increased number of interactions were observed between RsaOG and RsaE, and this
interaction was recapitulated in vitro and proven to be specific. Finally, through
examination of the expression patterns of the targets of RsaE, it is hypothesised that
this sponging of RsaE results in its targets being relieved of their previous repression,
allowing them to be upregulated. However, transcriptional effects are likely to play
a role in this dynamic as well.
6.6 RsaE binds phenol-soluble modulins in vivo
and this can be recapitulated in vitro
Interestingly, my CLASH data revealed interactions between RsaE and PSMα2 plus
PSMα3. All of these were identified in the TSB data, with 15 unique interactions
between PSMα2 and 10 between PSMα3 found. In silico structure predictions of the
CLASH reads show that it is the 3’ UCCC motif of RsaE that is predicted to interact
with a SD-like sequence of both of these PSMs (Figure 6.5 A and B, top panel).
In order to confirm these interactions, in vivo GFP reporter assays, like those de-
scribed in Section 5.8 for RsaA with qacAB and RNAIII with esxA, were attempted
by Jai Tree and Julia Wong in Sydney. Unfortunately, the PSM-GFP fusions did
not exhibit sufficient fluorescence for meaningful interpretation to be made. It is
conceivable that the PSM-GFP fusions were unstable or toxic to the cell. As an
alternative approach to demonstrate the interaction between these RNA molecules, I
performed in vitro EMSAs. As observed in Figure 6.5A and B, bottom panel, a specific
band relating to duplex between RsaE and each PSM was observed (indicated by
the chevron). When even a single UCCC motif was mutated, this interaction was
completely abolished. It is also clear that the interaction between RsaE and PSMα3
is stronger than that between PSMα2, as specific signal is observed at lower molar
ratios of RsaE. Thus, I conclude that RsaE interacts with these PSM transcripts in
vitro, although I point out that a vast excess of RsaE is required (320 molar excess) to
see a significant shift. Nevertheless, the data suggest that this interaction is specific
and that only a single UCCC motif in RsaE is sufficient to support this interaction in
vitro, in opposition to that observed for RsaOG.
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Fig. 6.5: Interaction between RsaE and PSMα3 (A.) and PSMα2 (B.). Top: predicted
interactions between RsaE and the respective PSMs. RsaE is shown in grey and
the PSMs in black. Structures were generated by extracting the CLASH read
sequences as input for RNAcofold, which was used to predict the interaction
structure. The two UCCC motifs are highlighted. Bottom: EMSA between the
respective radiolabelled PSMs with RsaE WT, the single RsaE UCCC mutant, and
the double mutant. The chevron (>) indicates the proposed dimer.
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6.7 CLASH reveals novel RsaE targets
The CLASH data also uncovered other novel targets of RsaE which were manually
inspected after filtering for statistical significance. I asked whether or not the
interaction was found in multiple datasets, whether the interaction was discovered
in both orientations (RNA1-RNA2, RNA2-RNA1), and whether or not they fitted the
already known role for RsaE in regulating metabolic processes, and by extension
virulence. This final proposed functionality of RsaE has been extended through the
previously discussed interaction between RsaE and the αPSMs. This filtering left
two proposed candidates; glutamine synthase, glnA, and an integrase of unknown
function encoded in a pathogenicity island, SAA6008_00346. The interaction with
glnA covers two nucleotides of the start codon and extends downstream of it and so
is likely to represent a canonical repressive action. Glutamine synthase is part of the
nitrogen metabolism pathway, and it catalyses the production of glutamine using
glutamate and ammonia as precursors (Joo et al., 2018). This proposed interaction
between RsaE and glnA fits with RsaE’s proposed regulation of rocD and rocF, as
described in Section 6.1, which are also involved in glutamine synthesis (Rochat et
al., 2018). Thus, RsaE may have a more intimate role in nitrogen metabolism, and
therefore amino acid anabolism and purine/pyrimidine synthesis, than previously
thought.
The interaction between RsaE and SAA6008_00346 was found in every CLASH
dataset obtained. Examining the CLASH reads show that the start codon of SAA6008_00346
was identified, an in silico folding predicts that the 3’ UCCC double motif exhibits
perfect base pairing with a downstream SD sequence. However, very little is known
about SAA6008_00346 and what is available comes from bioinformatic predicitons.
SAA6008_00346 is encoded in a pathogenicity island and is a proposed integrase
with similarity to the ICEB1 class. If true, this would make SAA6008_00346 a
recombinase that is part of a mobile genetic element (Johnson and Grossman, 2015).
Such mobile genetic elements are known to be activated in times of DNA damage,
and although it is possible that the shift to RPMI medium induces such stress (either
directly or indirectly), it may that the UV cross-linking used in CLASH activated this
element’s expression. Although previous studies have shown that the crosslinker
used here greatly reduces contaminating signal from UV-mediated DNA damage, this
still inevitably occurs (Nues et al., 2017). Regardless, it is interesting that RsaE is
able to interact with this mRNA in vivo, and if this interaction were true then it may
open up a new role for RsaE in regulating mobile genetic elements.
Thus, two mRNAs have been proposed as novel RsaE targets worthy of further
exploration, glnA and SAA6008_00346. If these interactions were to pass future
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validation, then this would further associate RsaE with nitrogen metabolism but also
add a role in regulating genome integrity.
Fig. 6.6: Predicted interactions between RsaE and novel targets as predicted by CLASH.
RsaE is shown in grey and the mRNA targets in black. Structures were generated
by extracting the CLASH read sequences as input for RNAcofold, which was used
to predict the interaction structure.
6.8 Discussion
The work described in this chapter further demonstrates that CLASH is able to
recover known interactions of well-studied sRNAs, in this case RsaE. One of these
targets is the sRNA RsaOG. Although this has already been described, its validation
and the understanding of this interaction has remained elusive. This chapter has
managed to demonstrate the specificity of this interaction and has started to attribute
biological significance. Furthermore, CLASH was able to identify novel targets of
RsaE from the phenol soluble modulin class, and these were further validated in
vitro.
CLASH uncovers known RsaE target interactions
Through overexpression and microarray plus RT-qPCR analysis, RsaE was predicted
to downregulate gcvP and gcvT; fhs; sucC and sucD; citB, citC and citZ; opp3A and
opp3B; and opp4A and opp4B (Bohn et al., 2010). However, it should be noted that
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in vitro EMSAs aimed at validating several of these interactions failed, with the sole
exception of opp3A (Bohn et al., 2010). Additionally, RsaE deletion and microarray
analysis found upregulation of purK (Geissmann et al., 2009), and Hybrid-trap-seq
principally identified purH, fumC, RsaOG, rocA, rocD and rocF (Rochat et al., 2018).
From the known bank of interactions, CLASH managed to recover the interactions
with opp3-B, sucD, purK and RsaOG (Figure 6.7). It should be noted that CLASH
is not necessarily an exhaustive technique due to its reliance on the stochastic
RNA ligation step. As such, I do not expect to recover every known interaction.
Additionally, the previous in vivo studies that overexpressed RsaE were performed
at OD600 values of 0.6 and 0.5 respectively, while the CLASH experiments were
performed at an OD600 of 3. Thus, these interactions may not occur at the tested
density.
The RsaE – RsaOG interaction responds to stress
RsaOG has already been hypothesised to be a binding partner of RsaE through
Hybrid-trap-seq, but attempts to validate this interaction through in vitro EMSAs
failed (Rochat et al., 2018). Here, 75 unique interactions between RsaOG and RsaE
were identified and validation through EMSAs was performed. These EMSAs proved
that the interaction is specific and occurs through both of RsaE’s UCCC motifs.
It is not easy to explain why the interaction between RsaE and RsaOG was able to
be recapitulated in vitro in this study and not by Rochat et al, 2018. Examination
of the materials and methods reveal similar buffer compositions and molar ratios.
However, there may have been some difference in the sample preparation and RNA
refolding (personal communications).
The vast majority of RsaE – RsaOG interactions were found after the shift to RPMI.
This was accompanied by a significant upregulation in the RNA steady state levels
of RsaOG during the first 10 minutes of the shift, after which the levels return to
basal by 30 minutes. This pattern of expression is also recapitulated into the RNA
polymerase binding of its RNA, indicating that transcription is shaping the expression
profile. However, although the duplex between RsaOG and RsaE is recovered using
RNase III, the stability of RsaE remains constant throughout the time course. Thus, it
may be that RNase III binds but does not degrade the duplex, or that any degradation
is compensated by transcription. Such binding with a lack of degradation has been
shown to occur in E. coli, where RNase III binds to but does not degrade the cIII
gene of bacteriophage lambda (Altuvia et al., 1987). Additionally, RNase III is able
to cleave just one strand of a double-stranded target (e.g. an sRNA-sRNA duplex),
and so perhaps only RsaOG from the interaction is cleaved (Court et al., 2013).
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Fig. 6.7: Targetome of RsaE. Targets found in previous studies (Geissman et al, 2009;
Rochat et al, 2018 and Bronesky et al, 2019) are shown alongside the newly
proposed interaction with the αPSMs (blue circle). Known interactions which
were recovered in this study are circled in green.
This leads to the model that upon the shift to RPMI, RsaOG is upregulated through
increased transcription. The newly transcribed RsaOG molecules are then able
to bind to RsaE, drawing it away from its targets, but do not induce significant
downregulation (a so-called sponging interaction). The mRNAs that RsaE was
previously targeting for degradation, such as rocA, citB and fumC, are now freed
of their repression. As such, this model predicts that they would be upregulated
after the shift for a period (Figure 6.8). Once RsaOG levels decrease as a result of
decreased transcription and potentially degradation, RsaE is able to return to its
original activity and repress its targets once more.
Examining the expression of the RsaE targets, such as rocA, fumC and citB gives cre-
dence to this model. After the shift to RPMI, these mRNAs were seen to immediately
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Fig. 6.8: RsaOG sponges RsaE in times of RPMI stress. A. Under favourable conditions,
RsaE targets transcripts such as citB, rocA and fumC for degradation. B. Upon
the imposition of stresses, such as those imposed upon the shift to RPMI medium,
RsaOG is upregulated through increased transcription. C. The newly transcribed
RsaOG molecules bind to RsaE. For simplicity, only the first 3’ UCCC motif (blue)
is shown to bind a G-rich sequence (green) in RsaOG, as this was uncovered
in CLASH. This duplex is then targeted by RNase III, although no significant
degradation occurs. The primary outcome of this interaction is that the mRNAs
previously being repressed by RsaE are now relieved, and able to be upregulated
and predicted to be translated afterwards (indicated by red arrows).
increase in stability before decreasing back down to basal levels by the end of the
time course. Although citB and fumC also exhibit increased rates of transcription, this
is not unexpected; transcription and post-transcriptional regulation act in tandem to
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shape a response, and commitment to a survival pathway is likely to involve both as
avenues of adaptation.
My current working hypothesis is that RsaOG is part of a coherent feed forward loop
that enables rapid accumulation of RsaE mRNA targets by inhibiting RsaE activity.
Thus, my prediction is that RsaOG expression should have a significant positive
impact on the gene expression induction kinetics of RsaE targets. In order to test this
model, two key experiments are currently underway. Firstly, a ∆rsaOG mutant must
be shifted to RPMI medium and then the expression of RsaE targets determined by
RT-qPCR. If RsaOG does indeed sponge RsaE away, the lack of RsaOG in this mutant
should mean that the targets of RsaE should remain constant or upregulated after
the shift to a much lesser degree. The required mutant strain has now been made
and this experiment will be performed imminently.
Secondly, in order to examine if this relieving of RsaE-mediated regulation on its
targets actually affects protein levels, mass spectroscopy on total cell lysates will
be performed after the shift to RPMI. Investigating if proteins such as CitB are
upregulated would help to demonstrate that this interaction does indeed dictates
changes in the proteome, and this experiment could also be performed on a ∆rsaOG
mutant to further prove that the sponging interaction is crucial for this.
RsaE regulates αPSM transcripts
S. aureus utilises the glycolytic, TCA cycle and pentose phosphate pathways in order
to derive their required macronutrients (Somerville and Proctor, 2009). In rich
medium conditions, the TCA cycle is typically repressed as the cells enter logarithmic
growth and glycolysis is utilised as the primary mode of ATP generation (Collins and
Lascelles, 1962; Strasters and Winkler, 1963). However, once S. aureus has depleted
the pool of preferential carbon sources, such as glucose, then the TCA cycle becomes
active and upregulated (Somerville et al., 2003).
RsaE is so far the only sRNA known in S. aureus to have an intimate relationship
with metabolism. As described in Section 6.1, it regulates the TCA cycle purine
biosynthesis and amino acid transport and metabolism. This chapter has proposed a
novel class of targets for RsaE, the αPSMs. These are critical virulence factors which
make up the majority of the secretome of S. aureus, and are involved in host cell
escape and lysis, and biofilm restructuring. As such, these interactions place RsaE as
a core link between metabolism and virulence.
The interaction between RsaE and the two αPSMs was found to require both of
RsaE’s UCCC motifs. Deletion of just the 5’ UCCC motif completely abolished the
interaction, despite the fact that all interactions found through CLASH occurred
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within the 3’ UCCC motif. It may be that the 5’ motif is crucial for the initial binding
or inducing structural rearrangements within RsaE. This behaviour is in opposition
to that observed for the interaction with RsaOG, where deletion of the 5’ UCCC motif
reduced the binding capacity of RsaE but did not abolish it entirely. This shows that
RsaE has different interaction kinetics for its different targets.
It is also observed that the interactions between RsaE and the αPSMs do not appear
to be particularly strong in vitro, with significant shifts only observed upon addition
of a 320-fold excess of RsaE. However, these experiments were performed only with
the RNAs. It may be that these interactions require a chaperone in vivo to efficiently
base pair. In Gram-negative species, the protein Hfq is the major RNA chaperone
and is thought to impact the expression of more than 20% of the genome in E. coli
and S. enterica (Chao et al., 2012; Tree et al., 2014). However, the role of Hfq in S.
aureus is unclear, as discussed in Section 1.9. Another important RNA chaperone in
Gram-negative species is ProQ, although a functional counterpart of ProQ does not
appear to exist in S. aureus (Smirnov et al., 2017). However, this does not eliminate
the idea that Hfq could be important in regulating an interaction between RsaE and
αPSMs, or that another, unidentified chaperone could play a role.
All of the interactions between RsaE and the αPSMs were discovered in TSB. Thus, it
may be that RsaE represses the translation of αPSMs in TSB, a nutrient-rich medium
which contains all of its required cofactors. The fact that no interactions were
observed in RPMI may hint that the αPSMs are relieved of their repression in this
medium, resulting in their translation and secretion. This may be a means of S.
aureus acquiring nutrients through lysis of surrounding cells.
RPMI and TSB have a similar glucose composition (2 g/L and 2.5 g/L respectively),
and the shift was performed at the post-exponential phase when S. aureus will have
depleted the preferential carbon sources such as glucose. Thus, it is not hypothesised
that carbon is the limiting factor in RPMI medium. It may be alternative stresses
imposed by the RPMI medium, such as a lack of iron, that induce S. aureus to secrete
αPSMs in an attempt to lyse nearby cells and scavenge essential metal cofactors.
However, this observation does potentially link the translation of virulence factors to
the metabolic state of the cell via an sRNA.
In order to further validate this interaction, a collaboration has been set up with
Ronan Carroll, where he will test the protein levels of the αPSMs in a ∆rsaE mutant
and after overexpression of RsaE. This experiment is also being combined with
haemolysis assays to monitor the ability of these strains to induce red blood cell lysis,
presumably mediated through PSM activity.
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However, other experiments could be performed to further verify the interaction in
vivo, such as a MAPS-based approach. Although MAPS has already been performed
on RsaE, this was carried out at an OD600 of 0.5, as opposed to the value of 3
used here. This may explain why the interaction with the αPSMs was not found.
Additionally, MAPS could be used to enrich for proteins that bind to RsaE, and mass
spectroscopy could identify a potential chaperone.
Another in vivo method that could be used is ribosome profiling. This method
captures translating ribosomes in vivo, and then examines which RNAs are bound.
As such, it provides a direct read out of translation in vivo. Ribosomal profiling could
be performed after overexpression or deletion of RsaE, and thus investigate if RsaE
is able to control translation of the αPSMs as expected. Finally, overexpression of
RsaE could be combined with RNAseq in order to investigate if this induces αPSM
downregulation, which would imply that RsaE is able to recruit RNase III in order
to destroy these mRNAs (RT-qPCR is challenging due to the short length of the
PSMs). Overall, these proposed experiments would further solidify the link between
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7Concluding remarks
The advent of next generation sequencing has revolutionised the field of post-
transcriptional regulation. Originally, studies were carried out on a gene-by-gene
basis and often required prior knowledge about the biological system of interest. For
example, the elucidation of RNAIII as a post-transcriptional regulator in S. aureus
relied on knowledge of the quorum sensing pathway, detailed structure of the agr
locus and of its promoters (Novick et al., 1993; Peng et al., 1988; Recsei et al.,
1986).
However, immunoprecipitation-based methods now allow us to capture interactomes
with relative ease. Proximity-based ligation methods, such as CLASH and related
methods (e.g. RIL-seq) are now being increasingly applied to a wider and wider
variety of organisms. Such methods were originally applied to human and yeast
cells (Helwak et al., 2013, Kudla et al., 2011) but have now been applied to Gram-
negative bacteria such as E. coli (Iosub et al., 2018; Melamed et al., 2016; Waters
et al., 2017). This thesis details the application and optimisation of CLASH to the
Gram-positive bacterium S. aureus.
It is also noteworthy that interactome-capture methods which forego immunopre-
cipitation have now been developed and may help to circumvent the main issue
of previous techniques; identifying a suitable RBP. These include methods such as
SPLASH, PARIS and MARIO (Aw et al., 2016; Lu et al., 2018; Nguyen et al., 2016).
Overall, these methods crosslink RNA duplexes together and then capture these on a
global scale through bead-based purification or 2-dimensional gel electrophoresis.
As such, they eliminate the need for a known RBP. However, one of the main reasons
I chose CLASH over these methods is that utilising an RBP allows one to enrich for
a specific class of RNA interaction, such as the sRNA-target interactions that were
my focus here. Even so, these methods have still proven themselves to be powerful
tools in further elucidating RNA interactions on a global scale and offer a different
approach in future research.
I suspect that the produced interactomes from this study will have wide-reaching
implications for the Staphylococcal field. Firstly, they confirm a number of already
known interactions and therefore increase our confidence in their veracity. Secondly,
many novel interactions have been found and a selection of these validated. Fi-
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nally, the data may give leads into identifying novel sRNAs from regions previously
annotated as intergenic or UTRs.
In this thesis I have identified and verified several novel interactions between sRNAs
and mRNAs. This has increased the depth of our understanding of how particular
sRNAs regulates a certain aspect of S. aureus biology, such as RsaA and membrane
homeostasis. However, it has also directly linked distinct behaviours such as virulence
and metabolism, such as via RsaE.
However, the most unique element of the work described here relates to the experi-
ments detailing interactions between sRNAs. These have added to the knowledge of
how sRNAs are able to coordinate a multitude of responses through a single binding
interaction, inducing myriad downstream repercussions. Additionally, although
requiring further verification, this work has hypothesised how these interactions
can lead to the destruction of an sRNA population on exquisitely short timescales,
such as that seen for RNAIII with RsaA. These experiments are ongoing and will be
included in an upcoming publication.
Summary of the main findings and broader implications
The first aim of this work was to optimise CLASH for use in S. aureus, which was by
no means facile (Chapter 3). Ultimately, most progress was found in reducing the
contact time between the immunoprecipitated RNP complex and the cell lysate, thus
minimising RNA degradation from cellular RNases. Additionally, when using RNases
as bait proteins, this reduction in contact time is likely to have the extra benefit of
bringing the experiment into the denaturing conditions of the secondary purifica-
tion as fast as possible. This subsequently inactivates the RNase and presumably
minimises degradation. The produced protocol allowed CLASH to be performed on
two RNases; RNase III and RNase Y. Analyses detailed in Chapter 4 showed that this
resulted in successful libraries which confirmed many sRNA-target interactions but
also discovered novel ones, particularly observed for RNase III. As such, I hypothesise
that this optimised CLASH methodology will of great interest to the field and indeed
be applicable to any RBP – research in Sander Granneman’s lab has already started
to apply this protocol to other RNases, metabolic enzymes and RNA modifying
enzymes.
I next focused on several validated sRNAs; RsaA, RsaE and RNAIII. This allowed me
the luxury of being able to work in relatively well-understood research area which
was of great benefit, and I thank the scientists whose previous hard work has greatly
aided my own research.
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Regarding RsaA and RNAIII, my work has suggesting a balance between these
two sRNAs. I hypothesise that these sRNAs interact in the late-exponential phase
of growth, where RNAIII may downregulate RsaA’s activity as part of its virulent
post-transcriptional program. However, this interaction responds to stress and I
hypothesise that RsaA is then able to rapidly induce RNAIII destruction. Such a
finding is novel for several reasons. First, it may suggest that the cell maintains a
pool of RsaA just in case it needs to shut-down RNAIII in response to stress. Secondly,
it may show how sRNAs can be the foundation of complex cell behaviours and how
their regulation has wide-reaching implications. Finally, it is another example of
how bacteria are able to rapidly change their gene expression profiles in response to
stress.
My work on RsaA and RNAIII also elucidated novel mRNA targets for both of these
sRNAs. Thus, despite their study of many years, it is likely that study of these sRNAs
has not been exhausted. Additionally, the discovery that RNAIII (typically associated
with inducing host cell lysis and tissue destruction) positives regulates esxA, a protein
involved in host cell survival, shows how a single RNA can encode for seemingly
contradictory behaviours. As such, a gap in our understanding clearly exists and
more knowledge on the temporal control of sRNA-mediated regulation may aid in
bridging this.
I next detailed the interaction between RsaE and RsaOG. This work adds to the
knowledge of sRNA sponging and differs from the interaction between RsaA and
RNAIII as it does not involve degradation. As such, this may represent an sRNA-sRNA
interaction that the cell expects to be temporary, and so does not induce destruction
of any partner.
I also uncovered an interaction between RsaE and several mRNAs encoding for
toxins. This is of particular import as it adds to the growing connection between
virulence and metabolism and is a direct representation of the link between these
two cell pathways. It is unlikely that RsaE will be the only sRNA within S. aureus
to link these two together and so I expect further study in the field to further this
hypothesis.
This study also shows the power of merging different global analysis methods.
Here, I used CRAC on RNA polymerase to model nascent transcription, RNA-seq to
calculate RNA steady-state levels and CLASH on RNase III to model RNA degradation
and detect RNA-RNA interactions. I also intend to augment these analyses with
mass spectroscopy at a later date in order to calculate protein expression. As such,
combining all of these methods allows one to examine a response to stress on
several levels; RNA production, RNA interactions, RNA decay and the cumulative
effect of all on the proteome. Such holistic analyses allow us to gain intimate
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insight into how cells adapt to their changing environments. However, even this
is not exhaustive; techniques such as ribosome profiling are also integrable into
these datasets to examine the translatome and CHIP-seq could be used to examine
how transcription factors shape the transcriptional response. As such, all the tools
required for understanding how cells adapt to change now seem to be available. Our
main limiting factors therefore appear to be predictable ones; time and money.
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1.1 Transcriptional initiation in Gram-positive bacteria. The σ factor directs
RNA polymerase, composed of its core α2ωββ’ subunits, to its target
promoter sites. Transcriptional factors (TFs) can also further modulate
the activity of RNAP by interacting with the holoenzyme. . . . . . . . . 8
1.2 The canonical mechanisms of post-transcriptional regulation. A.The cen-
tral dogma of biology, with the region under which post-transcriptional
regulation exerts its control highlighted. B. The typical mode of mRNA
translational repression by an sRNA. The Shine-Dalgarno sequence
(SD) is occluded through sRNA binding, preventing ribosome assem-
bly. Furthermore, a nuclease can be recruited in order to degrade the
sRNA-mRNA duplex. C. An example of target upregulation by an sRNA.
An autoinhibitory loop on the mRNA which would otherwise occlude
the SD sequence is melted by an sRNA and then a recruited nuclease
cleaves the duplex in order to remove the inhibitory region. . . . . . . 13
1.3 The architecture of cis- and trans-encoded sRNAs. Cis-encoded sRNAs
are encoded on the opposite strand of their target and exhibit perfect
complementarity. Trans-encoded sRNAs are encoded at a distant ge-
nomic locus, and thus exhibit only partial complementarity to their
targets. Figure adapted and redrawn from Prasse et al., 2013. . . . . . 14
1.4 The structure and mechanics of the quorum sensing system in S. aureus.
AgrD is processed into autoinducing peptide (AIP) through the action
of the transmembrane protein AgrB. AIP is then secreted and binds the
transmembrane kinase receptor AgrC, which then autophosphorylates
and activates AgrA through phosphorylation. AgrA then drives expres-
sion from the P2 promoter to upregulate the agr operon, and also the
P3 promoter to drive RNAIII expression. RNAIII then drives virulent
gene expression. Adapted and redrawn from Painter et al, 2014. . . . 17
1.5 The targets and regulatory mechanisms of RNAIII. RNAIII negatively
regulates spa, coa, sbi and rot through classical RBS occlusion. In the
cases of spa, coa and rot, this is accompanied by RNase III recruitment
and transcript degradation. Conversely, RNAIII is able to stimulate
translation of hla and mgrA through transcript stabilisation and libera-
tion of the SD from autoinhibitory loops. This image was taken from
Bronesky et al, 2016. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
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1.6 The degradosome of E. coli and proposed degradosome of S. aureus.
A. E. coli degradosome is built upon a tetramer RNase E, which acts
as a central scaffold for PNPase, Enolase and RhlB via its unstructured
C-terminal domains. In addition to this, RNase E initiates bulk mRNA
decay. B. The S. aureus degradosome is not as well understood as that
in E. coli. It is potentially based built upon the membrane-bound RNase
Y, which can then interact with Enolase and CshA. Enolase can then
recruit PNPase, which in turn recruits the RNase J1 and J2 heteromer.
CshA can interact with both Pfk and RnpA. Data based off of (Khemici
et al., 2015; Roux et al., 2011). . . . . . . . . . . . . . . . . . . . . . . 31
1.7 The architecture of single input modules (SIMs) and negative feedback
loops (NFLs) utilising sRNAs. A. SIMs consist of a single transcription
factor that drives expression of an sRNA, which then regulates its targets
directly. B. In an NFL, the sRNA then represses the translation of its
own inducing transcription factor. Modified from Beisel and Storz, 2010. 33
1.8 The architecture of dense overlapping regulons (DORs) and feedfor-
ward loops (FFLs). A. DORs consist of several individual SIMs which
converge on common targets. This allows different signalling pathways
to act in concert or to buffer them against each other. B. FFLs are
separated into coherent and incoherent architectures. Coherent loops
drive repression or stimulation from both a transcriptional level and
translational level, while incoherent loops contain properties of both
repression and stimulation. Modified from Beisel and Storz, 2010. . . . 35
1.9 The role of sRNA sponges in shaping gene expression profiles. A. sRNA
sponges can act to buffer transcriptional noise of an sRNA, preventing
unwanted repercussions and ensuring that responses only occur upon
a strong stimulus. B. sRNA sponges can act to repress sRNA activity,
leading to either rapid inactivation (left hand side) or a timed response
(right hand side). Figure A adapted from Lalaouna et al, 2015, and B
and C from Ebert and Sharp, 2010. . . . . . . . . . . . . . . . . . . . . 38
1.10 The CRAC and CLASH methodologies. Both utilise an HTF-tagged RBP
as bait, which is cross-linked to its bound RNAs through UV irradiation.
The RBP is then captured under highly denaturing conditions following
lysis. In CRAC, sequencing adaptors are ligated onto the bound RNAs,
which are then isolated, reverse transcribed, and sequenced. This
produces ‘single read’ data, where the RNAs bound to the RBP are
identified. CLASH utilises the same methodologies, but includes a
ligation step where RNA duplexes, such as sRNA-target interactions, are
joined to create a single entity. Thus, CLASH produces chimeric reads,
which can identify RNA interacting partners. . . . . . . . . . . . . . . . 41
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3.1 Optimisation of the CLASH protocol. A. Initial CLASH experiment using
published protocols. The very long autoradiogram exposure represents
poor efficiency of RNA recovery. B. Testing the effect of different
crosslinking times (13, 30, 60 and 90 seconds) and also the addition
of a lysostaphin treatment and EDTA to the primary capture buffer on
recovery of crosslinked RNAs. RNase III was used as the bait. C. Testing
the effect of different RNase-IT concentrations (untreated, 1/25, 1/50,
1/100, 1/250, 1/500), and also a two hour FLAG capture, on recovery
of crosslinked RNAs. RNase III was used as the bait. D. Testing the
effect of Triton X-100 on recovery of crosslinked RNAs with RNase Y and
RNase III. E. Autoradiogram and cDNA library of a successful CLASH
experiment on RNase Y and RNase III, obtained from cells grown in
TSB and also from cells shifted from TSB to RPMI for 15 minutes. . . . 96
4.1 Experimental set up for global analyses. Cells were grown in TSB until
OD600=3, and then a reference sample was taken. The cells were then
harvested through vacuum filtration and resuspended in RPMI medium
A. For CLASH, a sample was taken after 15 minutes and subsequently
crosslinked. For RNAseq, samples were taken after 5, 10, 15 and 30
minutes. As a control for the RNAseq data, cells were shifted back into
the original medium (B.) and samples were taken after 5, 10, 15 and
30 minutes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.2 Optical density measurements following the shift to RPMI as compared
to an unshifted control. . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.3 sRNA expression in response to RPMI stress. A. Heatmap showing sR-
NAs with statistically significant changed expression after 30 minutes of
RPMI exposure, as compared to the control. sRNAs have been clustered
into patterns of similar behaviour, as calculated by STEM (Ernst and
Bar-Joseph, 2006). Bone fide, trans-acting sRNAs are labelled (Liu et
al., 2018). The expression of RsaOG and RsaH has been also added,
both of which exhibit statistically significantly changed expression after
15 minutes but then recover by 30 minutes. B. Line graphs showing
chosen expression clusters. . . . . . . . . . . . . . . . . . . . . . . . . . 105
4.4 Expression of bona fide, trans-acting sRNAs that exhibit significantly
changed expression after either 15 or 30 minutes of RPMI exposure. . 106
4.5 Transcriptome-wide changes in response to RPMI. A. Left: heatmap
showing genes with statistically significant changed expression after
30 minutes of RPMI exposure, as compared to the control. Genes have
been clustered into patterns of similar behaviour as calculated by STEM.
Right: heatmap showing genes with significantly changed expression
after 30 minute of TSB shift B. Line graphs showing chosen expression
clusters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
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4.6 Differential gene expression following RPMI shift. Expression 30 min-
utes after RPMI shift was compared to the reference, unshifted sample. 110
4.7 CLASH hybrid incidence and composition. A. The incidence of hybrid
reads in CLASH for RNase III, RNase Y and the parental strains. Both
JKD6008 and USA300 data have been merged for the RNase III and
the parental strain data, while RNase Y CLASH was only carried out
in JKD6008. B. and C. Hybrid composition for RNase III and RNase
Y in USA300 and JKD6008, alongside the respective parental strain.
Left hand panel shows the total number of hybrids involving each RNA
class and this data is presented as a percentage in the right hand panel.
Interactions between rRNAs and tRNAs were removed from the data
and the parental strain data (USA300 and JKD6008) were merged.
Note that for the purpose of this analysis, reads mapping to 5’ UTR,
CDS and 3’ UTR were merged into the umbrella term of ‘mRNA’. D.
Total number of each interaction type for RNase III and RNase Y in TSB
and RPMI. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
4.8 Intermolecular RNA transcript combinations as detected by RNase III
and RNase Y CLASH. Interactions were first filtered for statistical signifi-
cance and then interactions containing rRNAs and tRNAs were removed.
Interaction types of interest are annotated, and ‘Other combinations’
represents merged lowly abundant combinations. Each RNA interaction
was then plotted as a percentage of the total. Note, a single interaction
can be represented by many individual hybrids. . . . . . . . . . . . . . 115
4.9 RNase III CLASH identifies canonical sRNA – mRNA interactions. A.
The reads mapping to mRNAs involved in sRNA – mRNA interactions
were plotted relative to the starter codon. B. The same reads were
plotted across the mRNA genomic sequence, split into 100 equally sized
bins. C. All of the sRNAs involved in sRNA-mRNA interactions in both
USA300 and JKD6008 were extracted and the overlap between them
was plotted as a Venn diagram. Additionally, in order to see how many
of these sRNAs are highly verified, the curated list of ‘bona fide’ sRNAs
as described by Liu et al., 2018, was integrated into this Venn diagram. 117
4.10 Examples of known targets identified through CLASH; SprX-spoVG (A.),
SprF1-sprG1 (B.) and sprA1-SprA1AS (C.). Structures were generated
by extracting the CLASH read sequences as input for RNAcofold, which
was used to predict the interaction structure. For SprA1AS - sprA1,
computational predictions of the interaction were made by the authors
and are highlighted in blue (Sayed et al., 2012). For SprX-spoVG, the
structure of this interaction has been validated previously through in
vitro structure probing, and the regions of spoVG known to be targeted
by SprX are highlighted in blue (Eyraud et al., 2014). . . . . . . . . . . 119
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4.11 Examples of interactomes obtained from CLASH. A. Individual interac-
tomes of RsaA, RsaE and RNAIII from merging all the RNase III and
RNase Y CLASH datasets. Interactions that have already been reported
are highlighted in blue. These data have been filtered for statistical
significance and any interactions with rRNAs and tRNAs have been
removed. The edge weight indicates the number of unique interactions
obtained. B. Overall interactome obtained from CLASH on RNase III
in USA300. The most abundant interaction, that between sprA1 and
SprA1AS is highlighted. Additionally, the locations of RsaA, RNAIII and
RsaE are shown. These data have been filtered for statistical significance
and any interactions with rRNAs and tRNAs have been removed. The
edge weight indicates the number of unique interactions obtained. . . 120
4.12 RNase III and RNase Y target composition. Each panel shows the target
classes of RNase III (A.) and RNase Y (B.) as raw counts (left) and as a
percentage of the total (right). . . . . . . . . . . . . . . . . . . . . . . . 122
5.1 Predicted interactions between RsaA and its known targets. RsaA
is shown in grey and the targets in black. For mgrA, the 5’ site of
interaction found by Romilly et al is highlighted in blue. Structures
were generated by extracting the CLASH read sequences as input for
RNAcofold, which was used to predict the interaction structure. For the
interaction with SsaA2_3, such a short read was uncovered (highlighted
grey) that 20 nucleotides from either side of the hybrid were added to
the 5’ and 3’ end. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
5.2 Proposed interaction between RsaA and RNAIII. A. Mapping the hybrids
to the genomic loci of their respective gene. B. Conservation analysis of
RsaA and the interacting region of RNAIII (with 20 flanking nucleotides
on both ends). The boxed regions indicate those which are involved in
the interaction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
5.3 Regions of interaction for RNAIII and RsaA. A. RNAIII structure with
the hybrid reads identified in CLASH interacting with RsaA outlined in
black. The nucleotides in between the green line were taken for in silico
folding analysis as shown in C. B. RsaA structure with the hybrid reads
interacting with RNAIII in black. The UCCC motif is labelled. C. In
silico predicted structure of RNAIII (7th – 11th helices) interacting with
RsaA. The nucleotides surrounded by the black border were identified
in CLASH. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.4 Structure probing of RNAIII interacting. A. Primer extension gel after
NAI treatment. Asterisks indicate sites of modification. B. The structure
of RNAIII interacting, taken from the full length structure of RNAIII
as produced by (Kolb et al., 2000), with sites of modifications marked
with asterisks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
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5.5 Structure probing of RsaA interacting. A. Primer extension gel after
NAI treatment. Asterisks indicate sites of modification. B. The structure
of RsaA, as predicted by RNAcofold, with sites of modifications marked
with asterisks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
5.6 In vitro interaction of RsaA and RNAIII. A. Left: Structure of RNAIII
with the ‘RNAIII interacting’ and ‘RNAIII non-interacting’ constructs
indicated. Right: EMSA between radiolabelled RsaA and increasing
molar concentrations of RNAIII interacting and non-interacting B. Quan-
tification of RsaA – RNAIII interaction. Left: histogram showing the
formation of the duplex as a percentage of the total RNA. Right: binding
curves fit to non-linear regression analysis. . . . . . . . . . . . . . . . . 148
5.7 In vivo dynamics of RsaA and RNAIII A. Number of hybrids between
RsaA and RNAIII in TSB and RPMI. B. Expression of RsaA (blue) and
RNAIII (orange) after shift to TSB (dashed line) and RPMI (solid line)
as measured by qPCR. The statistics are generated from comparing the
expression in RPMI at that particular timepoint to TSB. C. Expression of
RsaA and RNAIII after overexpression of the other, as measured by qPCR.
Far right panel shows the efficiency of overexpression D. Expression of
the targets of RsaA and RNA after TSB (orange) and RPMI (blue) shift.
In all panels, * = 0.05; ** = 0.01; *** = < 0.01 in Student’s unpaired
t test, and error bars relate to standard error of the mean. . . . . . . . 150
5.8 Nascent transcription of RNAIII, RsaA and their targets following the
shift to RPMI in USA300. Data obtained through performing CRAC
on the polymerase. The polymerase data represents two independent
biological replicates, while the RNase III data represents four. . . . . . 156
5.9 Validation of novel targets of RsaA and RNAIII. A. Predicted secondary
structures of RsaA and qacAB, and RNAIII and esxA. The reads mapping
to each RNA in the CLASH data were extracted and folded with each
other in silico. The sRNA is shown in black and the mRNA in grey.
The start codon is highlighted in blue. B. FACS sorting showing the
effect that overexpression of RsaA and RNAIII has on qacAB and esxA
respectively. * = 0.05; *** = < 0.01 in Student’s unpaired t test, error
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5.10 Validation of novel targets of RsaA and RNAIII. Interaction between
RsaA, and srn_2860 and RsaX28. RsaA is shown in black, and the
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read was added. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
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5.11 The interaction between RsaA and RNAIII responds to stress. During
unstressed conditions, e.g. in TSB, RNAIII and RsaA interact but the
consequences of this are unknown. As cells grow and increase in
density, the level of RNAIII increases (red arrow) and this drives virulent
behaviour. This is in part due to the repression of sbi and rot. After the
imposition of stress, it is theorised that RsaA inhibits RNAIII activity
and recruits RNase III, which induces RNAIII destruction. This, in
combination with decreased RNAIII transcription, causes RNAIII levels
to fall (blue arrow). Additionally, RsaA is upregulated, theorised due to
an increase in stability (red arrow). The destruction of RNAIII leads to
its target transcripts being relieved of their repression, while targets of
RsaA are now subject to regulation. . . . . . . . . . . . . . . . . . . . . 168
5.12 Hypothesised dual role of RNAIII in regulating host cell survival and
lysis. A. During the early infection stage of a host non-immune cell
(e.g. an endothelial cell), RNAIII promotes the translation of esxA,
which is then secreted into the host cell. EsxA then promotes host
cell survival, facilitating S. aureus replication in a safe, nutrient-rich
environment. After division, RNAIII then switches to promoting hla
translation, which then integrates into the host cell membrane and
induces lysis, facilitating S. aureus escape. B. Following internalisation
by a host phagocyte, S. aureus may use hla in order to escape from
the lysosome. At the same time, EsxA is secreted in order to offset
any cytotoxic effects of bursting the lysosome due to its promotion of
host cell survival. This potentially allows S. aureus to stay within a
favourable environment. . . . . . . . . . . . . . . . . . . . . . . . . . . 171
6.1 Predicted interactions between RsaE and its known targets. RsaE is
shown in grey and the mRNA targets in black. Structures were gener-
ated by extracting the CLASH read sequences as input for RNAcofold,
which was used to predict the interaction structure. Due to the fact
that short read fragments were recovered for purK, opp3-B and sucD,
20 nucleotides from either side of the hybrid were added to the 5’ and
3’ end. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
6.2 Shaping the expression profile of RsaOG and RsaE. Top panels: RNA
steady state levels of RsaOG and RsaE after the shift to RPMI, and a
control TSB shift as measured by RNAseq. Middle: RNA polymerase
binding to RsaOG and RsaE throughout the shift. Bottom: RNase III
binding to RsaOG and RsaE in TSB and after 15 minutes of RPMI shift 185
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6.3 In vitro interaction between RsaOG and RsaE. A. In silico predicted
structure of the RsaE – RsaOG interaction. RsaE is shown in grey and
RsaOG in black. Structures were generated by extracting the CLASH
read sequences as input for RNAcofold, which was used to predict the
interaction structure. The two UCCC motifs are highlighted. B. EMSA of
radiolabelled RsaOG with RsaE WT, the single RsaE UCCC mutant, and
the double mutant. Asterisk (*) indicates the proposed trimer, while the
chevron (>) indicates the proposed dimer. Quantifications are shown
below the gel, in which the amount of dimer was compared to the total
monomer plus dimer signal. . . . . . . . . . . . . . . . . . . . . . . . . 187
6.4 The interaction between RsaE and RsaOG responds to RPMI stress
and may dictate the fate of RsaE’s targets. A. Number of interactions
found between RsaE and RsaOG in TSB and after 15 minutes in RPMI.
B. Expression of RsaOG, rocA, fumC and citB after the shift to RPMI,
as measured by qPCR. Statistical significance was calculated through
comparing the expression value in RPMI versus TSB. p values: * = 0.05,
** = 0.01, *** = <0.01 C. RNA polymerase binding to citB, fumC, and
rocA following the shift. . . . . . . . . . . . . . . . . . . . . . . . . . . 190
6.5 Interaction between RsaE and PSMα3 (A.) and PSMα2 (B.). Top:
predicted interactions between RsaE and the respective PSMs. RsaE is
shown in grey and the PSMs in black. Structures were generated by
extracting the CLASH read sequences as input for RNAcofold, which
was used to predict the interaction structure. The two UCCC motifs are
highlighted. Bottom: EMSA between the respective radiolabelled PSMs
with RsaE WT, the single RsaE UCCC mutant, and the double mutant.
The chevron (>) indicates the proposed dimer. . . . . . . . . . . . . . 192
6.6 Predicted interactions between RsaE and novel targets as predicted by
CLASH. RsaE is shown in grey and the mRNA targets in black. Structures
were generated by extracting the CLASH read sequences as input for
RNAcofold, which was used to predict the interaction structure. . . . . 194
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